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ABSTRACT
The availability of large numbers of engineered organs would offer significant 
benefits to the clinical management of surgery. Tissue engineering offers the 
potential of providing tissues that can mimic the morphology, function and 
physiologic environment of native ones. Cells could grow in vitro within a 
biodegradable polymer to construct tissue for implantation. However no generic 
bioreactor design currently exists. There is now a need to establish a robust 
process for the production of engineered tissues using autologous cells. A key 
challenge will be the prediction of the supply of nutrients and removal of 
metabolites.
Models of transport phenomena were developed in order to predict the fluid flow 
and mass transfer requirements of a prototype bioreactor for the formation of 
engineered tissues. These models were solved to generate windows of 
operation which relate key operating parameters with the feasibility of tissue 
preparation. Examples highlight how the windows of operation can be used to 
visualize rapidly the region of operating conditions that satisfy the design 
constraints.
The impact of the cell concentration, tube geometry, alginate diffusivity, 
substrate and metabolite concentration levels, feed and recycle rate on the 
design of the bioreactor is illustrated. The result of this analysis determines the 
best configuration of the bioreactor which can meet the cellular transport 
requirements as well as being reliable in performance whist seeking to reduce 
the amount of valuable nutrients to be used.
Micro scale experiments were designed in order to evaluate from 
measurements, effective diffusivities of substrates and metabolites in alginate 
matrices as well as substrate consumption and metabolite production rates in 
matrices with immobilized growing cells. The oxygen diffusivity and oxygen 
uptake rate of alginate immobilized neonatal fibroblasts were evaluated using 
integrated oxygen sensor spots. Additionally, alginate cylindrical constructs with 
immobilized neonatal fibroblasts were prepared in transwells in order to
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evaluate the effective diffusivities of glucose and lactate as well as the glucose 
consumption and lactate production rate.
The advantage of such micro scale experiments was that greater data sets 
could be generated with the small number of cells available but in a way which 
predicts the larger scale. The database which was created was used to 
construct the windows of operation to give quantitative solutions of how 
engineered tissues may be prepared and to visualize process operability in a 
more explicit way.
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Chapter 1 
Introduction
One of the most common, and costly problems confronted by the healthcare 
providers of today, is treating patients who have suffered from the loss or failure 
of an organ or tissue. Current solutions to this problem include medication, 
transplantation of organs, surgical reconstruction, and use of mechanical 
devices. None of these solutions is ideal. For example, organ and tissue 
transplantation is characterized by a number of limitations. Firstly, there is a 
large mismatch between the number of donors and waiting list numbers. 
Additionally, transplantation recipients are obliged to follow lifelong 
immunosuppression regimens with unwanted side effects at increased risks of 
infection and tumour development. Transplant surgery in general is hampered 
by both a lack of available donor tissue and donor morbidity. Finally, the use of 
mechanical devices or artificial organs is associated with infection, 
thromboembolism and finite durability. The field of tissue engineering emerged 
as an alternative way to face up to the problem of replacing a damaged tissue 
with living tissue that is “designed and constructed to meet the needs of each 
individual patient” (Fuchs, 2001). However no generic bioreactor design 
currently exists upon which a robust process for the production of engineered 
tissues will be established. A key challenge will be the prediction of the supply 
of nutrients and removal of metabolites. This thesis focuses on integrating 
transport phenomena models with scale down experiments so as to specify the 
design constraints and optimal operating conditions required to successfully 
produce artificial vascular tissues.
This introductory chapter provides an overview of tissue engineering. Its 
progress in restoring function in several tissue types is analyzed. Emphasis is 
given on the vascular tissue engineering as the thesis objective to design a 
bioreactor for artificial arteries. The significance of scaffolds, cells sources, 
oxygen, substrates, mechanical stimulation and bioreactor design in tissue 
engineering is presented. Finally, the aims and organisation of the thesis are 
presented.
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1.1 Tissue engineering principles
1.1.1 Basic principles
Tissue engineering is “an interdisciplinary field that applies the principles and 
methods of engineering and the life sciences toward the development of 
biological substitutes that restore, maintain, or improve tissue function” (Fuchs, 
2001; Nasseri et al., 2001). The goal of tissue engineering is to “restore function 
through the delivery of living elements which become integrated into the patient” 
(Nasseri et al., 2001). To render this goal realistic, cell biologists, engineers, 
material scientists, mathematicians, genetists, and clinicians have to cooperate 
and combine their knowledge. The first tissue engineering attempts were made 
in the early 1980s. Chick et al. (1986) managed to control glucose levels in 
patients with diabetes by using encapsulated pancreatic islet cells in semi 
permeable membranes. Yannas et al. (1980) designed a collagen, 
glucosaminoglysan scaffold, which aided in regeneration of dermis for burns 
patients. Bell et al. (1983) added fibroblasts to a contracted collagen gel to 
replace skin. Lately, the construction of vascular-engineered tissue by seeded 
cells in 3D, porous, biodegradable, synthetic scaffolds is a reality and offers 
promise for the future (Nasseri et al., 2001).
Tissue engineering is based on the three basic components of biologic tissues, 
namely: the cells, the extracellular matrix (ECM-made up of a complex of cell 
secretions immobilized in spaces continuous with cells) and signalling systems 
(biological communication mechanisms which act through differential activation 
of genes or cascades of genes, whose secreted products are responsible). 
Scaffolds may be fabricated from both natural and synthetic polymers which 
may or may be not biodegradable. Construct is a combination of scaffold and 
cells (Garner, 2004; Lanza et al., 2000).
Several attempts at making constructs for a broad range of tissues have been 
reported in the literature. These range from skin to blood vessels to liver tissue 
and are elaborated upon further in the following section.
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1.1.2 Progress of tissue engineering in restoring function in several 
tissue types
Skin was the first engineered tissue to receive FDA approval for clinical 
application. Today, tissue-engineered skin products are made of ECM 
components, cells, or a combination of cells and matrices. They are not a true 
skin replacement since they are not based on the patient’s own tissue. In reality, 
they act as “super bandages” which promote wound healing and, over time, they 
are thought to be replaced by the recipient’s own tissue (Lalan et al., 2001). 
Currently one of the most successful tissue-engineered skin products is Apligraf 
marketed by Organogenesis Inc. (Canton Massachusetts, USA). It is approved 
for the treatment of venous leg ulcers and diabetic foot ulcers. Like human skin, 
Apligraf has two primary layers, a dermis and an epidermis. The epidermal layer 
is composed of human keratinocyte cells that form an outer protective layer. The 
dermal layer lies beneath the epidermis and is made up of human fibroblast cells. 
While matrix proteins and cytokines found in human skin are present in Apligraf, 
Apligraf does not contain Langerhans' cells, melanocytes, macrophages, 
lymphocytes, white blood cells, blood vessels, hair follicles or sweat glands. In a 
study of all patients with venous ulcers of greater than one month in duration 
(n=240), more patients achieved complete wound closure by 24 weeks with 
Apligraf plus compression therapy (57%) than with the previous preferred 
treatment using compression bandage therapy alone (40%). The median time to 
wound closure was 65 days for diabetic foot ulcers treated with Apligraf versus 90 
days for ulcers treated with conventional therapy (debridement plus saline 
dressings) (Lalan et al., 2001).
Tissue engineering techniques have produced new cartilage from autologous 
isolated cartilage cells (chondrocytes). Chondrocyte-seeded polyglycolic acid 
tubes or meshes have been used for the treatment of hydrocephalus or to close 
full-thickness cranial defects. A commercial process to grow chondrocytes for 
use in treating damaged articular cartilage of knee (not associated with 
ostearthritis) has been employed by Genzyme Biosurgery. The procedure is 
called Autologous Chondrocyte Implantation and the autologous cultured 
chondrocytes products are called Carticel (Lalan et al., 2001).
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Vascular tissue engineering is focused on small and medium blood vessels (< 
6mm inner diameter). Each year over 1 million surgical procedures require 
grafts of less than 4 mm diameter. Current treatment includes replacing a 
blocked blood vessel with autologous vessel harvested from elsewhere in the 
patient but this is far from ideal. The use of synthetic grafts such as ePTFE 
(expanded polytetrafluoroethylene; woven form of polytetrafluoroethylene that 
creates a mesh-like structure) and Dacron is unfortunately unsatisfactory (Lalan 
et al., 2001). Vascular tissue engineering can be loosely categorized in three 
categories. These include using cells seeded in non-biodegradable scaffolds, 
using cells seeded in biodegradable scaffolds and using smooth muscle cells 
and fibroblasts seeded to form a monolayer which is rolled around a mandrel to 
form tissue layers in a tubular wall (Ratcliffe et al., 2000; Teebken and Haverich,
2002). These approaches are discussed in more detail in section 1.5.
For peripheral nerve repair research synthetic nerve guidance is being used. 
Tubular nerve guidance conduits have been created using a polyglycolic acid 
(PGA) scaffold and cultured Schwann cells (cells which function as physical 
support for neurons) possessing the macroarchitecture of a peripheral nerve. 
Also, nerve regeneration conduits have being created using material originally 
designed for drug delivery applications. In an animal model, the presence of 
inosine (believed to promote axomal extension after neural injury) resulted in 
neural regeneration whose histological features suggested possible superior 
long-term movement control (Lalan et al., 2001; Nasseri et al., 2001).
Tissue engineering of the liver is based on hepatocyte transplantation using 
polymer devices to encapsulate the cells, but the problem of insufficient 
engraftment and survival of an adequate transplanted hepatocyte mass in the 
polymer scaffold has not yet been solved. Flowever, recent results suggest the 
use of a co-culture of small hepatocytes (considered as progenitor cells) with 
nonparenchymal cells (parenchymal cells are these cells which are specific to 
an organ and are contained in and supported by the connective tissue) can lead 
to the fabrication of liver tissue on 3-dimensional polymer scaffolds producing a 
liver-like structure (Nasseri et al., 2001).
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A potential treatment of patients with dysfunctional intestines is based on tissue 
engineered intestinal transplantation, where intestinal progenitor crypt cells are 
seeded onto sheets of nonwoven PGA, which are in turn wrapped around a 
silastic stent (expandable wire form or perforated tube made of silastic which is 
a flexible, inert silicone elastomer). Following transplantation in mice stratified 
epithelium 5-7 cell layers thick was grown in two weeks. However, this method 
led to fetal gut being produced which is different from the adult gut required by 
the patient (Nasseri et al., 2001).
1.2 Biomaterial scaffolds
1.2.1 Introduction
Biomaterials play the role of an artificial ECM which is the material that 
surrounds cells in tissue and provides space for new tissue formation. The 
biomaterials serve as scaffolds to provide cells with a suitable growth 
environment, optimal oxygen levels, effective nutrient transport and mechanical 
integrity as well as to guide differentiation and vascularisation. Ideally, the 
scaffold’s degradation rate must be synchronized with the deposition of ECM 
produced by the cells in order to form 3D structures that will be a close mimic of 
the native tissue architecture. However, the current fabrication methods cannot 
provide engineered tissues which are larger than a few hundreds of 
micrometers due to oxygen diffusion limitation (Khademhosseini et al., 2006).
There are two approaches to make a biomaterial to promote specific cellular 
responses and direct new tissue formation mediated by specific interactions. 
The first approach is to construct biomaterials which incorporate soluble 
bioactive molecules such as growth factors and plasmid DNA into biomaterial 
carriers so that the bioactive molecule can diffuse out and modulate tissue 
formation. The other approach is the chemical or physical modification of the 
biomaterial by incorporating cell-binding peptides. Cell-binding peptides include 
a native long chain of ECM proteins as well as peptide sequences derived from
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ECM proteins which can incur specific interactions with cell receptors (Augst et 
al., 2006; Shin etal.,2003).
Materials like glass and ceramics have been used as scaffolds to engineer 
artificial bone. Their strong mechanical properties are an asset in bone 
engineering. In contrast, biodegradable polymers, either synthetic or biological, 
have a widespread usage for cardiac, liver skin and nerve engineering (Park et 
al., 2007).
Commonly used and FDA-approved hydrolytically biodegradable synthetic 
polymers are homopolymers and copolymers of poly(L-lactic acid), 
poly(glyconic acid) and poly(lactide-co-glycolide) (PLA, PGA, PLGA) (Atala, 
2002; Park et al., 2007). Their biodegradation can vary from days to years and 
is a function of their molecular weights and co-polymer ratio. They have been 
used to engineer artificial cartilage (Freed et al., 1994; Vacanti et al., 1991), 
cardiac muscle (Bursae et al., 1999; Caspi et al., 2007; Levenberg et al., 2003) 
blood arteries (Niklason et al., 1999; Shin’oka et al., 1998), bladder (Atala, 
2006) and ligament (Lu et al., 2005). However, their poor cell attachment 
properties, their non-uniform degradation rate in vivo and their hydrophobic 
nature which made cell entrapment a challenging task has led the interest in 
biological polymers (Park et al., 2007).
Biological polymers which have been used extensively in tissue engineering 
applications include alginate, collagen, hyaluronic acid and self-assembling 
peptides. Their degradation times vary from days to years without by-product 
accumulation. They are highly hydrated (above 90%) and they promote cell 
adhesion, proliferation and differentiation. Chemical or physical modifications of 
the biological polymers offer control over the physical and chemical signals to 
the cells (Park et al., 2007). These polymers and their applications are 
discussed in more detail in the following section.
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1.2.2 Alginate
Alginate is a common term for a family of unbranched polymers. It consists of 
1,4-linked p-D-mannuronic (M) and a-L-guluronic acid (G) residues and is 
derived from brown seaweed and bacteria. The monomers are distributed 
sequentially in repeating or alternating blocks in varying proportions, sequence 
and molecular weight (Drury and Mooney, 2003; Smidsrod and Skjak-Braek, 
1990). The monomers are arranged in a pattern of blocks along the chain, with 
homopolymeric regions (termed M and G blocks) interspersed with regions of 
alternating structure (MG blocks) (Smidsrod and Skjak-Braek, 1990). The 
amount and distribution of the monomers depends on the species, age and 
location of the seaweed.
Alginate gelation occurs when divalent or multivalent cations (usually Ca2+) 
interact ionically with blocks of guluronic residues between two different chains 
resulting in a three-dimensional network. The model that best describes this 
interaction is the “egg-box model” (Grant et al., 1973). The alginate chains of 
the gel are orientated preferentially perpendicular to the direction of gel growth. 
When the alginate solution and the salt solution are brought into contact, an 
amorphous gel layer is formed. Capillary formation requires this layer to reach a 
thickness of several micrometers. The diameter of the capillaries usually varies 
between about 5-300 pm, depending on the guluronic acid content of the 
alginate and the concentrations of salt solution and alginate solution. After some 
time of gel growth, the capillary comes to an end although gel growth goes on. 
Capillary formation does not take place at very small concentrations of the 
crosslinking cation, nor at very large alginate concentration in solution (larger 
than 5% w/v) (Sabra et al., 2001). The gel formation time is increased by 
decreasing temperature (calcium diffusion rate is reduced) and increasing 
phosphate concentration (phosphate binds with calcium ions reducing the 
number of ions available for crosslinking) (Drury et al., 2004).
The compression modulus of non-modified alginate gels ranges from 1 to 1000 
kPa and the shear modulus ranges from 0.02 to 40 kPa. Their stiffness is a 
function of the MG block ratio and the stoichiometry of the reaction. Alginate
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gels with a high G content are stronger mechanically than high M alginate gels 
(Constantinidis, 1999; Drury et al., 2004). Alginate hydrogels do not specifically 
degrade but undergo slow uncontrolled dissolution. Their strength increases by 
increasing calcium concentration and it stabilizes at the calcium concentration 
of 0.02 M (Drury et al., 2004; Smidsrod and Haug, 1972). Alginate gels do not 
specifically degrade in culture medium but undergo slow uncontrolled 
dissolution. The alginate gel loses mechanical strength over time due to loss of 
crosslinking from competition between the calcium and the sodium ions and it 
swells with a decrease in its solid volume fraction (Drury et al., 2004; LeRoux et 
al., 1999).
Cells immobilized in the alginate gel can be recovered by reversing the alginate 
gel formation. This can be achieved by placing the alginate gel in solutions rich 
in monodivalent ions or chelators of divalent ions (sodium citrate, EDTA). The 
monovalent ions and the chelators dissociate the alginate matrix by reacting 
with its divalent ions (Lee et al., 1991; Martinsen, 1989).
Cells do not naturally attach to alginate (Rowley et al., 1999). The fibronectin 
derived adhesion peptide arginine glycine aspartic acid (RGD) and its subtypes 
have been coupled to alginate to promote adhesion. Rowley et al. (1999) have 
demonstrated that myoblasts can adhere, proliferate and fuse to RGD coupled 
alginate (Rowley et al., 1999). They showed that the myoblast phenotype can 
be controlled by manipulating the RGD concentration and composition of the 
gel. The same group uses models to predict the organization of the peptides 
and the changes in clustering of the cell receptors. Additionally, it has been 
shown that the presence of RGD peptide in alginate does not affect its 
mechanical properties (Drury et al., 2004).
Alginate has been used to engineer artificial cartilage (Drury et al., 2203). It has 
been mixed with chrondrocytes and either injected into the site of interest (Atala 
et al., 1994; Bent et al., 2001; Paige et al., 1995) or moulded and then 
implanted (Chang et al., 2001). It has been demonstrated that chrondrocytes 
immobilized in alginate constructs were viable producing ECM proteins as early 
as four weeks after implantation (Atala et al., 1994; Chang et al., 2001).
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1.2.3 Collagen
Collagen is the most abundant protein in mammalian tissues and the main 
component of the ECM of the connective tissue. There are 19 types of collagen 
with the same triple-helix structure. This structure is composed of three 
polypeptide chains, which wrap around one another. The strands are held by 
hydrogen and covalent bonds. Stable fibres can be formed by self-aggregation 
of collagen, by introduction of chemical crosslinkers (glutaraldehyde, 
formaldehyde, carbodiimide chemistry), by crosslinking with physical treatments 
(UV irradiation, freeze-drying, heating) and by blending with other polymers 
(hydroxyapetite, PLA, PLGA, chitosan, PEO) (Drury and Mooney, 2003). 
Physically formed collagen gels have an overall porosity of 90 % with pore size 
in the range of 100-150 pm (Park et al., 2007). Additionally, they are thermally 
reversible, they promote adhesion and proliferation as well as being degradable 
by cell action (Drury and Mooney, 2003).
The type of the collagen of the construct has an effect on the metabolism of the 
immobilized cells. Cells immobilized in collagen type II showed greater 
chondrogenic activity than cells immobilized in type I collagen. On the contrary 
mesenchymal stem cells (MSCs) immobilized in collagen type I showed better 
biomechanical properties in vivo than MSCs immobilized in type II collagen 
(Fedorovich et al., 2007).
Weinberg and Bell (1986) used collagen to mimic the adventitial and medial 
layers of native artery using culture derived collagen / fibroblast gel sheets and 
a similar collagen / smooth muscle cell (SMC) sheet wrapped over each other to 
form a tubular construct. However, owing to the inherent physical weakness of 
the collagen gel and limited ECM deposition by cultured SMC, the mechanics of 
these grafts were insufficient for implantation (Weinberg and Bell, 1986; Garner,
2003). Additionally, collagen gels have been used to entrap MSCs, 
chrondrocytes and osteoblasts which maintain their differentiated phenotype 
and produced ECM. However, their low mechanical strength scaffolds and the 
loss of shape and consistency through shrinkage have restricted its use for 
tissue engineering applications (Fedorovich et al., 2007).
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1.2.4 Hyaluronic acid
Hyaluronic acid is a major component of the ECM. It is found in developing 
embryonic mesenchymal tissues, in the synovial fluid of the joints and it is 
prevalent during wound healing (Caplan, 2000; Drury and Mooney, 2003). It is a 
linear polysaccharide composed of a repeating disaccharide and (1-4)-linked (3- 
D-glucuronic acid and N-acetyl-P-D-glucosamine units. Specifically, it can be 
produced by crosslinking with hydrazide derivatives, by esterification and by 
annealing (Drury and Mooney, 2003). It can be modified chemically and 
physically into different physical forms including fibres, strands, ropes, films, 
woven and no-woven materials, sheets and sponges (Carlan, 2000). It is 
degraded naturally by hyaluronidase allowing the immobilized cells to control its 
presence in a localized manner (Drury and Mooney, 2003).
The hyaluronic acid is known for its dual functionality which is attributed to the 
effect of its molecular weight on its degradation rate. Analytically, hyaluronic 
acid with low molecular weight (below 35 kDa) breaks down in 7 to 10 days 
whereas high molecular weight hyaluronic acid (200-400 kDa) breaks down in 8 
to 10 weeks. It has been demonstrated that hyaluronic acid with a high 
molecular weight has chrondrogenic abilities and hyaluronic acid with low 
molecular weight has angiogenic abilities (Alison and Grande-Alien, 2004; 
Caplan, 2000). High molecular weight hyaluronic acid is commercialized under 
the name Hyaff-11 and low molecular weight hyaluronic acid under the name 
ACP (Caplan, 2000).
Hyaluronic acid on its own does not posses all the properties of ECM. It has 
been combined with collagen and gelatine and crosslinked with RGD peptide 
(carbodiimide chemistry) in order to improve cell attachment and proliferation 
(Alison and Grande-Allen, 2006; Duflo et al., 2006). Modified and non-modified 
hyaluronic acids have been used mainly to engineer artificial cartilage, bone 
and ligament. However, their weak mechanical strength (even with the 
modifications) and the presence of impurities compromise their use (Fedorovich 
al, 2007).
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1.2.5 Self-assembling peptide nanofiber scaffold
Self-assembling peptide nanofiber scaffolds (SAPNS) are synthetic biological 
materials which are formed through the ionic assembly of positive and negative 
8 to 16-residue peptide (» 2.5-5 nm in length) by changing to neutral pH or by 
adding physiological concentrations of salt solutions. The gelation leads to a 
hydrogel of interwoven nanofibers with a diameter in the range of 10 nm and 
with a water content greater than 99% w/v (Ellis-Behnke et al., 2006; Holmes et 
al., 2000; Zhang et al., 1995). These environments not only allow attachments 
between cells and the basal membrane, but also allow access to oxygen, 
hormones and nutrients, as well as removal of waste products (Gelain et al., 
2006). Immobilized cells can be recovered in a three-stage process which 
involves mechanical disruption, centrifugation and suspension in trypsin / EDTA 
(5-10 min) (Garreta et al., 2006).
The nanofibers of the SAPNS are 3 orders of magnitude thinner than other 
biopolymer microfibers. They are of a scale similar to native ECM providing a 
better in vitro mimic of the in vivo cell growth environment (Ellis-Behnke et al., 
2006). It degrades to L-amino acids which could be used potentially by nearby 
cells for growth and repair (Ellis-Behnke et al., 2006). It has been reported that 
in vivo most of it is excreted in the urine in 3-4 weeks. It is free of biological and 
chemical components as it is chemically defined (Ellis-Behnke et al., 2006). 
Additionally, it does not initiate inflammatory response when implanted in the 
human body (Ellis-Behnke et al., 2006).
SAPNS support proliferation, differentiation, migration and ECM production 
(Kisiday et al., 2002; Garreta et al., 2006; Zhang, 2003). Lately, Ellis-Behnke et 
al. (2006) showed that SAPNS promote the closing of neural tissue gaps 
enabling axon regrowth. They believe that this is attributed either to cell 
migration into the lesion area which creates a growth permissive environment or 
to a contractile process that brings the two lesions of the gap together.
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1.3 Cell sources used in tissue engineering
1.3.1. Introduction
The ideal cell for tissue engineering applications should possess characteristics 
such as the ability to proliferate rapidly in vitro\ be easily obtainable via biopsy; 
able to differentiate to a variety of tissue-specific cell lines; and to be acceptable 
from the recipient’s immune system without the need of immunosuppression 
therapy (Nasseri et al., 2001).
Currently, cells used in tissue engineering are allogeneic, xenogeneic, or 
autologous and they can be used as primary culture, as expanded in vitro and 
as cryopreserved (Lalan et al., 2001). Autologous cells are derived from a 
patient’s own cells thus harvest or donation in advance of need coupled with in 
vitro culture is required. However, there is no danger of immunogenicity / 
rejection and transmission of disease (Garner, 2004). Allogeneic cells are 
derived from an individual of the same species other than the recipient and 
xenogeneic cells are derived from a species different than the recipient. 
Allogeneic and xenogeneic cells are transplanted in an encapsulated fashion in 
order to avoid contact with the recipient’s immune system. Additionally, they 
have the advantage of constructs being prepared in advance of need (Garner, 
2004; Nasseri et al., 2001). Nevertheless, a therapy based on the use of these 
cell sources does pose the risk of transmission of a disease from the donor to 
the host as well as of the rejection of the transplant (Nasseri et al., 2001).
Some tissue-specific cell types proliferate rapidly in vitro but others, like cardiac 
muscle cells and hypatocytes, proliferate slowly or not all making their 
expansion difficult. Additionally, they can divide only a finite number of times 
(depending the age of donor) which limits their supply and they may accumulate 
genetic changes over time (Evans et al., 2006; Kuo and Tuan, 2003; Nasseri et 
al., 2001). Therefore, research in tissue engineering has shifted from the use of 
tissue-specific cells to the use of adult and embryonic stem cells as therapeutic 
agents, which are discussed in more detail in the following sub-sections.
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1.3.2 Adult stem cells
Adult stem cells are multipotent stem cells (can produce many cell types) which 
have been found in many tissues including bone marrow, peripheral blood, 
adipose tissue and umbilical cord (Evans et al., 2006; Huang et al., 2007; Riha 
et al., 2005). The benefits of using adult stem cells include immuno-compatibilty 
of autologous cells, ease of inducing differentiation, and availability (Barrilleaux 
et al., 2006).
Adult stem cells have the ability to regenerate damaged tissue in vivo 
throughout an entire human lifetime but they have limited proliferative capacity 
ex vivo. Research is underway in order to replicate the stem cell micro­
environment or “niche" in order to enhance their regenerative potential (Huang, 
et al., 2007).
The most widely studied stem cells in tissue engineering are the mesenchymal 
stem cells (MSCs). MSCs reside mainly in the stroma of bone marrow (Evans et 
al., 2006; Riha et al., 2005). They were first identified by Friedenstein et al., 
(1966) and they represent 0.01% of the total cell population in the bone marrow 
(Evans et al., 2006). Isolation has been reported from umbilical cord vein, adult 
fat, muscle, brain, synovial membrane tracebular bone and blood (Riha et al., 
2005). MSCs can form bone, cartilage, tendon, muscle fat, neural tissue and 
hematopoietic supporting stroma by selecting the appropriate culture conditions 
(Kopen et al., 1999; Kuznetsov et al., 1997; Mauney et al., 2005; Pittinger et al., 
1999; Prockop, 1997).
After aspiration, marrow cells are cultured in Dulbecco’s modified Eagle’s 
medium with 10% fetal bovine serum. Following removal of the nonadherent 
cells, adherent MSCs can be passaged and differentiated. When MSCs are 
attached to a plastic surface they resemble morphologically cells of the 
connective tissue. Phinney et al. (1999) have reported though that 10-20% of 
those cells showing plastic-adherent ability are actually MSCs. Therefore, cells 
derived from bone marrow with plastic-adherent ability are referred to as 
marrow stromal cells (Evans et al., 2006).
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The concentration of MSCs and partially differentiated progenitor cells in bone 
marrow can be highly variable. There can be variation between donors or even 
between aspirates from the same donor (Muschler et al., 1997). Additionally, 
the younger the donor the higher will be the concentration of MSCs in the bone 
marrow (D’ Ippolitto et al., 1999).
MSCs are defined by their behaviour and not by any molecules or structures 
they contain (Barrilleaux et al., 2006). There is no one specific cell marker which 
can be used to distinguish MSCs from their closest differentiated neighbours. 
This suggests that MSCs are adjacent to non-stem cells and that the 
maintenance of their stem cell properties may depend on adhesion to non-stem 
cells (Barrilleaux et al., 2006).
Cell surface markers are used to isolate and characterize MSCs using flow- 
activated cell sorting (Huang et al., 2007). The expression of cell surface 
markers like STRO-1 (a stromal cell surface antigen), CD29 (integrin pi), CD44 
(receptor for hyaluronic acid and matrix proteins), CD105 (endoglin, receptor for 
transforming growth factor p (TGF-p) and CD166 (cell adhesion molecule) has 
been related to a MSC phenotype. These markers though are also expressed 
by cells which are not MSCs. However, MSCs can be distinguished from these 
other cell types since MSCs do not express the following markers: CD14, CD34, 
CD45, HLA-DR (hematopoietic stem cell markers), CD11a (lymphocyte 
function-associated antigen), CD31 (platelet endothelial cell adhesion molecule) 
and integrins a4 (hematopoietic stem cells) and p2 (T-lymphocytes) which are 
not related with a MSC phenotype (Barrilleaux et al., 2006; Huang et al., 2007; 
Riha et al., 2006).
Studies have shown that there are marrow cells which co-purify with MSCs and 
they can be expanded for more than 80 population doublings (Jiang et al., 2002; 
Oswald et al., 2004). These cells have been termed multipotent adult progenitor 
cells (MAPCs). It has been shown that MAPCs can differentiate not only into 
mesenchymal lineage cells but also endothelium and endoderm (Jiang et al.,
2002). Their existence though is still debatable (Riha et al., 2005; Rouffose et 
al., 2004).
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1.3.3 Embryonic stem cells
Human embryonic stem cells (hESCs) are pluripotent stem cells which are 
derived from the inner cell mass of reimplantation embryo. As a result of their 
pluripotency they possess the ability to form derivatives of all three embryonic 
germ layers while remaining stable karyotypically and phenotypically (Thomson 
et al., 1998). Their enhanced telomere activity makes them capable of unlimited 
undifferentiated proliferation in vitro. They express Oct-3/4 (transcription factor), 
Nanog (homodomain protein), SSEA-3/4 (surface marker) and TRA 1-60/1-81 
(surface marker) markers and in addition they possess enzyme activities for 
alkaline phoshatase and telomerase (Baker et al., 1997; Mitsui et al., 2003; 
Thomson et al., 1998; Wobus et al., 1984).
Human ESCs are cultured in the presence of mouse embryonic fibroblasts 
(MEF) feeder cells in order to maintain their self-renewal without differentiation. 
In the absence of MEFs they form embryoid bodies (EBs) comprised of 
undifferentiated and differentiated cell types (Huang et al., 2007; Xu et al., 
2001). The practice of using MEFs is challenging technically for large scale 
production of hESCs because it depends on routine availability of large 
numbers of MEFs requiring methods amenable to scale up (Xu et al., 2001). 
Additionally, this practice has raised concerns about the therapeutic potential of 
hESCs exposed to animal cells (Huang et al., 2007). The development of 
feeder-free culture systems is a way to alleviate the above difficulties. 
Specifically, the hESCs are cultured on Matrigel (murine basement membrane 
matrix extracted from Engelbreth-Holm-Swarm sarcoma) in MEF-conditioned 
culture medium (Xu et al., 2001).
It has been demonstrated that hESCs can differentiate into contractile 
cardiomyocytes and vascular cell types in EBs (Kehat et al., 2004; Laflamme 
and Murry, 2005; Levenberg et al., 2002). However the therapeutic potential of 
ESCs is limited by the induced immunogenecity upon differentiation after ESC 
transplantation and by the risk of formation of teratomas after implantation (Cao 
et al., 2005; Huang et al., 2007; Henderson et al., 2002; Swijnenburg et al.,
2005).
28
1.4 Non-invasive techniques for tissue engineering applications
The use of direct non-invasive methods is essential in tissue engineering 
applications for monitoring the interactions among cells, biomolecules, and the 
scaffolds that support them in vitro and in vivo without disrupting its integrity or 
damaging the cells. Direct non-invasive methods, which are used in tissue 
engineering, include nuclear magnetic resonance (NMR) and optical coherence 
tomography (OCT).
NMR detects the presence of compounds and determines their concentration 
through the exposure of the construct to magnetic fields. Analytically, the 
unpaired nuclei (nuclei that contain odd numbers of protons or neutrons) in a 
construct tend to align at an applied magnetic field at a specific frequency for a 
given nucleus due to their intrinsic magnetic moment and angular momentum. 
This alignment of nuclei produces a magnetisation (property of a material that 
describes to what extent it is affected by magnetic fields, and also determines 
the magnetic field that the material itself creates), which can be manipulated by 
an additional magnetic field orthogonal to main one. If the frequency of the 
additional magnetic field is at resonance with the magnetization, it will nutate 
(rock) it away from the alignment with the main field. This generates a 
radiofrequency signal that is detected by a sensitive antenna placed around the 
specimen (Burg et al., 2002).
NMR data are acquired in the form of a spectrum or an image (Constantinidis 
and Sambanis, 1999). The spatial resolution of NMR can reach 10 pm and it is 
not dependent on the opacity or thickness of the construct but on the intensity of 
the applied magnetic field (Burg et al., 2002; Jacobs and Cherry, 2001). Nuclei 
like 13C, 19P and 1H can be detected but the higher sensitivity of 1H nucleus 
makes 1H-NMR spectroscopy more favourable to study changes in the 
concentrations of proton-containing metabolites at concentrations as low as 1 
mM (Constantinidis and Sambanis, 1998).
Some of the applications of NMR in tissue engineering include the 
determination of cell number, the measurement of the permeability of
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engineered meniscal constructs, the monitoring of changes in metabolic activity 
of entrapped cells and the study of alterations in cell volume and water 
exchange time on perfused cells (Stabler et al., 2005; Neves et al., 2006; 
Pfeuffer et al., 1998; Constantinidis et al., 1997).
OCT can produce cross-sectional images in biological systems by measuring 
the back-scattered / back-reflected intensity of light from structures in tissue 
(Fujimoto et al., 1995; Bagnanichi et al., 2007; Ko et al., 2006; Mason et al., 
2004). It is as a technique analogous to radar except it uses near-infracted light 
instead of radio waves. The sufficient number of scattering objects 
(membranes, organelles, nuclei, etc.) in most biological tissues produce 
contrast in OCT images making tissue imaging possible (Ko et al., 2006). OCT 
can achieve spatial resolutions of 1 pm but the imaging depth is limited to 2-3 
mm due to light scattering in most tissues (Fujimoto et al., 1995; Mason et al., 
2004). A wide range of tissues can be accessed by catheter or by an 
endoscope (Fujimoto et al., 1995; Mason et al., 2004).
OCT has been used in tissue engineering to image constructs with immobilized 
mouse embryonic fibroblast, smooth muscle cells, endothelial, tendon, bone 
and neuronal cells (Bagnanichi et al., 2006; Mason et al., 2004; Morgan et al., 
2006; O’Halloran Cardinal et al., 2006; Tan et al., 2004). Additionally, it has 
been combined with elastography to characterize biomechanical properties of 
biological tissue (Chan et al., 2004; Ko et al., 2006; Rogowska et al., 2004; 
Schitt, 1998).
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1.5 Tissue engineering of blood vessels
1.5.1 Introduction
Having provided an overview of the overall status of tissue engineering efforts, 
the thesis will now focus on vascular tissue engineering in more detail. The role 
of the vascular system is to channel blood in a controlled manner around the 
entire human body. It consists of arteries, veins and capillaries with varying size, 
different mechanical properties and cellular content depending on their location 
and function. The arteries are relatively thick-walled, viscoelastic tubes which 
work at high pressure. The large arteries carry blood from the heart to smaller 
arteries which deliver the blood to the organs and tissues through a distribution 
of smaller arterioles and capillaries. Veins are thinner walled than arteries but 
they have a larger calibre. They operate at low pressure and return the blood to 
the heart. The wall structure of the blood vessels could be described by three 
distinct, well-defined, and well-developed layers. These three layers are reduced 
in the arterioles and they are almost absent in the capillaries. From innermost to 
outermost, these layers are the thinnest tunica intima, the thickest tunica media 
and the tunica adventitia. Tunica intima consists of a continuous lining (the 
vascular endothelium) of a single layer of simple squamous (thin, sheetlike) 
endothelial cells, resting on a thin subendothelial connective tissue bed of 
basement membrane and matrix molecules to form the subendothelium. This 
endothelium sheet works as a barrier to the plasma proteins and also secretes 
many vasoactive products. Its integrity protects the blood vessel from the 
development of atherosclerosis. It is separated from the next adjacent wall layer 
by a thick elastic tissue band called the internal elastic lamina. The thickest 
tunica media offers mechanical strength and contractile power. It is composed of 
a significant amount of smooth muscle cells arranged concentrically in radial 
layers, embedded in a matrix of circularly arranged elastic and collagen fibers. It 
is separated from the next adjacent wall layer by another thick elastic band 
called the external elastic lamina. Finally, the medium-sized tunica adventitia is 
an outer vascular sheath with no distinct outer border consisting entirely of 
fibroblasts, nerves and blood vessels (vasa vasorum), which carry blood to the
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tunica media. It serves to add rigidity and strength to the blood vessel wall 
(Palsson et al., 2003; Ratcliffe, 2000).
The ECM surrounding the vascular cells is complex and combines to provide the 
biomechanical properties of the tissue (Wight, 1996). The molecular network 
consists primarily of collagen (primarily types I and III), elastin in the form of 
fibers, proteoglycans (including versican, decorin and biglycan, lumican and 
perlican), hyaluronan, glycoproteins (for example, laminin, fibronectin, throm- 
bospondin and tenascin). The mechanical properties critical to blood vessel 
function include the tensile stiffness, elasticity, compressibility and 
viscoelasticity. The collagens provide the tensile stiffness, the elastin the elastic 
properties, whereas the proteoglycans contribute to the compressibility, and 
combined with the collagen and elastin they are responsible for the viscoelastic 
properties. This complex mixture of molecules and their organization provide the 
blood vessels with their properties that allow them to function throughout life 
(Ratcliffe, 2000).
1.5.2 A completely biological tissue-engineered human blood vessel
L’ Heureux et al. (2005) have presented a tissue-engineered blood vessel by 
using cultured human cells without employing an artificial scaffold. They 
hypothesize that this way of fabricating a vessel has several advantages over 
scaffold-based approaches, which will result in increased overall patency. 
Firstly, its biological matrix can be remodelled by the body according to the 
need of the environment. Secondly, the absence of synthetic material will 
prevent foreign body reaction and allow complete graft integration. Their blood 
vessel appeared histologically identical to normal artery (L’ Heureux, 2005).
L’Heureux et al. (2005) constructed a human tissue-engineered blood artery 
exclusively with fibroblasts. Their engineered arteries were composed of 3 
components: a living adventitia, a decullarized internal membrane and an 
endothelium. Analytically, fibroblast sheets with a thickness of 43 mm were 
produced in 6 weeks. Their thickness increased at a rate of 5 mm per week
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through 15 weeks. The internal membrane was assembled by wrapping the 
sheet around a Teflon-coated stainless steel temporary support tube for 3 
revolutions. Following 10 weeks maturation, this tissue was dehydrated to form 
an acellular membrane for endothelial cell seeding. A secondary role of the 
membrane was to provide a barrier against cell migration in the lumen. The 
adventitia was formed in a similar manner by wrapping a living sheet of 
fibroblasts around the internal membrane. After a second maturation, the Teflon 
support was removed and the tube was seeded with endothelial cells in the 
lumen of the artificial artery. The vessel was then subjected to pulsatile flow for 
a 3-day preconditioning period.
The engineered arteries had an internal diameter of 4.2 mm and a wall 
thickness of 400 pm with mechanical properties similar to saphenous veins. A 
long-term implantation study was conducted in rats. After 225 days, the patency 
was 85%. Graft diameter remained stable, which indicates mechanical stability 
whereas cell and ECM organisation were similar to native arteries. There was 
no sign of aneurysm (localized dilation or ballooning of the blood vessel due to 
weakening of its wall), reendothelialisation of the internal membrane or 
formation of vasa vasorum (smaller blood vessels that supply the cells which 
are located at the outer wall of the main blood vessel) (L’Heureux et al., 2005).
1.5.3 Tissue engineered blood vessel from collagen and cultured 
cells
Weinberg and Bell (1986) have mimicked the adventitial and medial layers of 
native artery using culture derived collagen / adventitial fibroblast gel sheets and 
a similar collagen / bovine aortic SMC sheet wrapped over each other to form a 
tubular construct. These were then lined by anbovine aortic EC monolayer.
The middle layer of the blood vessel model, corresponding to the media of an 
artery, was prepared by casting culture medium, collagen, and SMCs together 
in an annular mold. The mixture jelled after a few minutes at 37°C and 
contracted within a few days to produce a tubular lattice around the central
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mandrel. After 1 week, an open Dacron mesh sleeve was slipped over the 
lattice to provide additional mechanical support. The outer layer, corresponding 
to the adventitia, was cast around the first lattice with adventitial fibroblasts 
rather than SMCs. Two weeks later, when the outer layer was fully contracted, 
the tube was slipped off the mandrel with jeweller's forceps and either used for 
mechanical testing or lined with ECs. For the latter, the model was cannulated, 
a suspension of ECs was injected into the lumen, and the vessel was rotated 
around the longitudinal axis at 1 rpm for 1 week to distribute ECs uniformly on 
the luminal surface (Weinberg and Bell, 1986).
The model resembled a muscular artery, except for the Dacron mesh. Electron 
microscopy showed that the SMCs are well-differentiated bipolar cells 
containing bundles of filaments with dense bodies. They appeared to be 
secreting collagen into the extracellular space, thus contributing to the matrix. 
Examination revealed that the entire luminal surface was covered by ECs 
covered (92.1 ± 2.5% of the surface) (Weinberg and Bell, 1986).
The endothelial lining of the blood vessel model functioned like a normal 
endothelium in several respects, including producing von Willebrand factor and 
forming a permeability barrier for large molecules such as albumin. ECs 
release prostacyclin in vivo. This is a potent inhibitor of platelet aggregation and 
it is believed to prevent thrombosis (blood clotting in the lumen). The ability of 
the blood vessel model to withstand intraluminal pressure depended on several 
factors including the mesh, collagen concentration, initial cell concentration and 
time elapsed after casting. The burst strength of the model was proportional to 
the logarithm of the collagen concentration. The increase in strength with time 
was probably due to greater cross-linking of the collagen. The decrease in 
strength after long times may be caused by collagenase secreted by the SMCs 
and fibroblasts in the lattices. To maximize the burst strength, they optimized 
the above parameters and produced models with burst strength of 320 mmHg 
(42 kPa) (Weinberg and Bell, 1986).
Their model resembled the structure of a native blood vessel but there were 
substantial differences between them. Firstly, elastin, the principal connective
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tissue protein besides collagen was absent. Secondly, the orientation of SMCs 
was longitudinal as the contraction of the lattice layers around the mandrel was 
radial rather than in the alternating left and right handed spirals of blood 
vessels. Finally, the densities of the SMCs were approximately 12-25% of those 
of a normal blood artery (Weinberg and Bell, 1986).
1.5.4 Cell and non-biodegradable scaffold
Ratcliffe et al. (2000) made use of polyurethane, a non-biodegrable scaffold, to 
provide the necessary mechanical properties needed for a blood vessel to 
function immediately after implantation. Specifically, polyurethane scaffolds with 
immobilized allogeneic SMCs were cultured in vitro and seeded on the luminal 
surface with ECs under fluid flow. The resultant constructs were substituted for 
the carotid arteries of dogs, and were found to remain patent and retain an 
endothelial lining for 4 weeks. Their mechanical properties were similar to native 
vessels in terms of elasticity, tensile stiffness, and failure strength. They had 
SMCs oriented circumferentially with an ECM containing collagen, elastin and 
proteoglycan, and they had an endothelial layer with the cells oriented parallel 
to the fluid flow and able to inhibit thrombosis. The use of a non-degradable 
material provided a method to prevent burst or rupture (Ratcliffe, 2000). 
However, such a system will not be remodelled into the host into a natural form 
and it has the potential to become infected (Germain et al., 2000; Ratcliffe, 
2000).
1.5.5 Cell seeded in biodegradable polymer
Once cells are immobilized to a three-dimensional biodegradable polymer, the 
resulting tissue construct can be implanted in vivo, where the cells continue to 
grow and develop ECM. While the cellular structure and matrix develop, the 
polymer degrades, leaving only the engineered tissue without foreign material. 
Approaches for the development of a functional artery using biodegradable 
polymer can further be classified into these that adopt and these that do not 
pulsatile flow. These are discussed further in the following sub-sections.
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1.5.5.1 Pulsatile Flow
Niklason et al. (1999) used a system composed of bioreactors containing 
engineered vessels assembled in a parallel flow system. In initial experiments, a 
suspension of SMCs isolated from the medial layer of bovine aorta was pipetted 
onto tubular biodegradable polyglyconic acid (PGA) scaffolds that were secured 
in bioreactors. The surface of the PGA scaffolds was modified chemically with 
sodium hydroxide, which caused ester hydrolysis on the surface of the fibres, 
leading to increased hydrophilicity, increased adsorption of serum proteins, and 
improved SMC attachment. After an initial SMC seeding period of 30 min, the 
bioreactors were filled with medium and the SMCs were cultured under 
conditions of pulsatile radial stress for 8 weeks. Control vessels were cultured 
without pulsatile radial stress under otherwise identical conditions (Niklason et 
al., 1999).
After 8 weeks of culture, the gross appearance of the vessels was identical to 
that of native arteries except the wall thickness was considerably bigger. 
Histological examination of pulsed vessels revealed that SMCs migrated inward 
to envelop PGA fragments in the vessel wall; resulting in a smooth luminal 
surface onto which bovine aortic ECs could easily be seeded. In contrast, 
nonpulsed controls exhibited no such inward SMC migration through the 
polymer scaffold and possessed an uneven layer of polymer fragments in the 
vessel lumen. Thus, vessels cultured under pulsatile conditions had a 
histological appearance more similar to that of native arteries.
The mechanical properties of native arteries rely on contractile SMCs, collagen 
and elastin. Models of the wall mechanics of muscular arteries have shown that 
structured bundles of collagen fibers contribute most of the incremental elastic 
modulus at intraluminal pressures above 100 to 200 mmHg (130-260 kPa). Due 
to fact that the mechanical properties of vessel derive from the SMCs and their 
ECM they optimize its production by supplementing in the culture ascorbic acid, 
copper ion and amino acids (Niklason et al., 1999).
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Pulsatile culture conditions did not significantly affect SMCs density although 
these SMCs densities were higher than those reported in systems where 
collagen gels were used as matrix. The difference in calculated cell density 
between engineered and native vessels may be due to the volume occupied by 
the polymer fragments in the engineered vessel wall. The SMCs of vessels 
cultured under pulsatile conditions stained more intensely for myosin heavy 
chains, a late marker in SMCs development as compared with nonpulsed 
vessels. The application of pulsatile stress did not increase the mitotic rate in 
dense cellular areas. However, the percent of stained SMCs in the polymer 
scaffold regions of endothelialized vessels was decreased to 0.5 ± 0.7%, as 
compared with vessels that did not contain ECs. This result was consistent with 
the expected inhibition of replication of SMCs by confluent ECs and would 
decrease the likelihood of hyperplasia of SMCs and vessel stenosis (narrowing) 
after implantation (Niklason et al., 1999).
1.5.5.2 No pulsatile flow
Shin’oka et al. (1998) examined the feasibility of a tissue engineering approach 
to constructing tissue-engineered “living” pulmonary artery. Ovine or vein 
segments were harvested from 20-day old lambs, separated into individual 
cells, expanded in tissue culture and seeded onto synthetic biodegradable 
(polyglactin / polyglyconic acid) tubular scaffolds (20 mm long x 15 mm 
diameter). After 7 days of in vitro culture, the autologous cell / polymer vascular 
constructs were used to replace a 2 cm segment of pulmonary artery in lambs. 
One other control animal received an acellular polymer tube sealed with fibrin 
glue without autologous cells (Shin’oka et al., 1998).
Two weeks after implantation, echocardiography showed patent conduits. 
Thrombus formation was identified in the control animal causing narrowing of 
the artery. After 10 to 12 weeks, tissue engineered conduits showed no 
evidence of thrombus formation or calcification. In addition, the high-density 
material in the conduit wall had disappeared. The gross appearance of the 
tissue-engineered conduits resembled the native pulmonary artery although
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they were somewhat thinner. The specimens from the animals showed 
disappearance of PGA polymer and the tissue-engineered conduit had the 
same structure as the native artery (Shin’oka et al., 1998).
Levelberg et al. (2003) engineered tissue-like constructs derived from human 
embryonic stem cells (hESCs) by using polymer scaffolds. They created a 
series of 3D culture conditions using biodegradable scaffolds and Matrigel 
(protein mixture extracted from Engelbreth-Holm-Swarm (EHS) mouse 
sarcoma) and they evaluated attachment and 2-week survival of differentiating 
human embryonic stem cells by using two methods of seeding. The first one is 
by seeding the cells onto the scaffold with Matrigel and the second one by 
coating the scaffold with fibronectin (Levenberg et al., 2003). Comparison of 
vessel-like structures in the scaffolds in the presence and absence of Matrigel 
indicated that Matrigel was not required, as samples seeded on fibronectin- 
coated scaffolds resulted in higher levels of endothelial differentiation and 
vascularization. The differences might be caused by effects of fibronectin or 
growth factors still present in the Matrigel after growth factor reduction 
(Levenberg et al., 2003).
1.6 Control of cell metabolism
1.6.1 Oxygen
Oxygen plays a significant role in the cell metabolic behaviour. Mammalian cells 
require oxygen for energy production through adenonosine triphosphotate 
(ATP). Energy production through aerobic metabolic pathways yields 38 ATP 
moles per mole of glucose whereas through anaerobic metabolic pathways 
yields only 2 ATP moles per mole of glucose. The proximity of a cell to an 
environment rich of oxygen regulates the dominant mechanism of energy 
production. For example, chrondrocytes being in a low oxygen environment (1- 
6% tension) follow primarily anaebobic metabolic pathways in order to produce 
energy (Malda et al., 2007).
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Oxygen not only acts as substrate but also influences cell-fate processes. 
Ezashi et al. (2005) suggest that the maintenance of hES cells under low 
oxygen tension of the order of 1-4% should be preferred against 21% if 
differentiation need to be avoided. Additionally, oxygen tension has been 
reported to control differentiation in bone marrow. Under 5% O2 the cells are 
maintained in an early progenitor stage whereas under 21% O2 the production 
of mature phenotypes is enhanced (Hevehan et al., 2000; Mostafa et al., 2000). 
Low oxygen conditions which mimic the in vivo cartilage environment promote 
collagen type II and GAG instead of collagen type I which is enhanced at 
ambient oxygen tension (Malda et al., 2004, Murphy and Sambanis, 2001). 
Human dermal fibroblasts regulate mRNA-VEGF expression under 2% O2 
(Steinbrech et al., 1999). Studies of the effect of oxygen tension on cell 
proliferation have given contrasting results. Examples include studies of Malda 
et al. (2004) and Murphy and Sambanis (2001) on chrondrocytes where 
reduced oxygen tension had no effect on proliferation. On the contrary, Grayson 
et al. (2005) reported that the proliferation of human mesenchymal stem cells is 
enhanced under low oxygen tension.
There is a wide variation in oxygen levels in tissues. For example in newborn 
embryos it is 1.5-5.3%, in bone marrow 5-7%, in lungs -16%, in arteries -14% 
and in veins -8%  (Ezashi et al. 2005; Mostafa et al., 2000). Additionally, there is 
a variation in oxygen consumption with the cell type (hematopoietic stem cells, 
0.047-0.330x1 O'18 mol cell'1 s'1; fibroblasts, 0.4-0.7x1 O'18 mol cell'1 s'1; 
granulocytes and monocytes, 0.06-1.80x1 O'18 mol cell'1 s'1; hypatocytes 
0.038x1 O'18 mol cell'1 s'1; chondrocytes, 0.2-0.4x10'18 mol cell'1 s'1;
cardiomyocytes, 0.25x1 O'18 mol cell'1 s'1) (Foy et al., 1992; Grayson et al., 2005; 
Lewis et al., 2005; Malda et al., 2004; Muschler et al., 2004; Radisic et al., 
2005; Zhao et al., 2005).
There is a recent understanding of the way mammalian cells sense and 
respond to low oxygen levels (hypoxia). Analytically, oxygen interacts with a 
heterodimeric basic helix-loop-helix protein the hypoxic-inducible factor 1 (HIF- 
1a) independently of the mitochondric respiration causing its inactivation. HIF- 
1a is activated after the dissociation of the oxygen followed by a decrease in its
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level. Consequently, this leads to the activation of various genes. For example 
HIF-1 activates glycolytic genes and stimulates the conversion of glucose to 
pyruvate and consequently to lactate (Kim, 2006; Malda et al., 2007). Studies 
of Jiang et al. (1996) have shown that the HIF-1 a expression in FIELA cells 
varies exponentially over a physiologically range of oxygen tension. They also 
calculated the half-maximal response or the 50% inhibitory concentration of 
catalytic function to occur at 1.5-2% with the maximal response at 0.5%. They 
also concluded that above 6% O2 the levels were constant.
In vivo, oxygen diffuses from the lumen of a capillary to a cell membrane with 
the maximum diffusion distance to be in the order of 40-200pm. This distance is 
characteristic of the oxygen requirements because a balance between delivery 
and consumption has to be maintained. Up to now tissue engineered constructs 
are avascular so when they are transplanted in the human body the cells are 
competing for oxygen. Studies that describe the interaction between the oxygen 
profile and cell distribution have shown significantly higher cell density in the 
peripheral layers than in the interior of the construct as well as uneven ECM 
distribution (Dunn et al., 2006; Lewis et al., 2005; Malda et al., 2004; Martin et 
al., 1999, Wendt et al., 2006). It has been concluded that the critical variables 
are the oxygen concentration at the surface of the construct, its size and 
geometry, the metabolic state of the cell and the cell density (Foy et al., 1992; 
Malda et al., 2004; Radisic et al., 2005; Zhao et al., 2005).
In order to avoid having significant variations in oxygen concentration within the 
construct, the size of the construct has either not to overcome the maximum in 
vivo distance of the cells from the vessels or the construct has to be seeded 
with less cells assuming though that its integration in the human body will not be 
affected (Muschler et al., 2004). Alternatively, the construction of scaffolds 
which will include interconnected pores formed by laser drilling or 3D printing 
techniques will enhance the oxygen transfer into the construct (Malda et al., 
2007). Additionally, the construction of biomaterials with controlled-release 
capabilities of angiogenic signals can stimulate angiogenesis enhancing the 
oxygenation of the construct (Malda et al., 2007)
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1.6.2 Substrates and metabolites
In mammalian cells the main carbon and energy source is glucose and the main 
nitrogen source is glutamine. Glucose is metabolized mainly through the 
glycolysis (anaerobically) to form lactate but also through oxidative 
phosphorilization (aerobically) to form CO2 . When lactate is produced only 2 
moles of ATP are obtained in comparison with 36 moles of ATP through 
oxidative phosphorilization. Lactate is produced in order to maintain the 
oxidative state of the cell but its accumulation causes inhibition to cell 
proliferation especially when it is accompanied by a decrease in pH. Patel et al. 
(2000) noted that the inhibition in the proliferation of peripheral blood 
mononuclear cells was around 60% when the lactate concentration was 
increased to 25 mM and the pH decreased from 7.2 to 6.9. This inhibition 
though was around 25% when the pH was maintained relatively constant (7.1- 
7.3) and the lactate was allowed to reach 30 mM.
Glutamine is metabolized through glutanimolysis to ammonia and glutamate. 
Glutamate is further metabolized to a-ketoglutarate then degraded in the TCA 
cycle. Ammonia is also formed from the first order spontaneous degradation of 
glutamine. The pH has a strong influence on the decomposition rate and the 
half-life of glutamine. On the contrary, serum concentration has no noticeable 
effect unless it contains glutaminase. A typical Iscove’s medium culture without 
pH control can be initiated at pH 7.2 and end up at pH 6.8 causing a change in 
the decomposition rate by a factor of 2.5. If the chemical decomposition of 
glutamine is neglected, it will be calculated with a 200-300% error leading to 
false conclusions (Ozturk and Palsson, 1990).
A concentration between 2 and 10 mM has been reported to reduce cell 
proliferation rate and final cell concentration with the mechanisms of its toxicity 
to remain unclear (Patel et al., 2000; Schneider et al., 1996). Different effects on 
metabolic pathways have been reported like reduction of the sialylation of 
granulocyte colony-stimulating factor (G-CSF) in recombinant CHO cells, 
increase in the intercellular pool of UDP-acytylglucosamine and UDP- 
acetylgalactosamine in several mammalian cell lines and cell apotopisis in
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hybridomas (Maranga and Goochee, 2005). Due to this low limit a few 
strategies have been associated to reduce its formation. The two basic 
strategies are the optimization of the fresh medium feeding strategy and the use 
of glutamine based dipeptides such as L-alanine-L-glutamine. The latter is split 
up gradually by cellular released aminopeptidases to give alanine and 
glutamine. This gradual release resembles the continuous addition of glutamine 
in fed-batch cultures operated to maintain its concentration low (Christie and 
Butler, 1994).
Under oxygen excess, the stoichiometric ratio of glucose to lactate and glucose 
to glutamine is relatively constant on the order of 0.7-1.5 mol mol'1 (Xie and 
Wang, 1993) and 0.2-0.5 mol mol'1 respectively (Zeng et al., 1998). Additionally 
studies from Xie and Wang (1993) have shown that 80% of glutamine is 
metabolized to ammonia. Typical consumption rates for glucose and glutamine 
has been reported to be on the order of 2.8-13.8x1 O'18 mol cell'1 s'1 (Palsson 
and Bhatia, 2003). It has been reported though that those values are lowered 
considerably when the glucose and glutamine concentration are around 0.25 
mM without causing any alteration in the cell proliferation rate. Glucose is used 
in a more efficient way reducing the produced amount of lactate and ammonia. 
Above these concentrations, the stoichiometric ratios are relatively constant and 
independent of the cell type (Gambhir et al., 2003; Zeng et al., 1998). This 
desirable metabolic shift has not been recently exploited for mammalian cells 
therefore it is not yet well understood how it affects cell-fate processes.
1.6.3 Mechanical stimulation
Application of mechanical stimulation to cells immobilized in a scaffold has been 
shown to increase their biosynthetic activity improving and accelerating tissue 
regeneration in vitro (Martin et al., 2004). A complete simulation of the in vivo 
environment has not yet been achieved but a variety of effects of mechanical 
stress in cell shape, proliferation, differentiation, synthesis and secretion of 
proteins, mechanical stiffness and intracellular signalling have been studied. 
Additionally, this has been extended to the level of gene expression and
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messenger RNA regulation (Ziegler and Nerem, 1994). The types of mechanical 
stimulation which have been used are cyclic tensile and shear strain, static and 
dynamic compression, pulsatile radial stress, fluid shear stress and 
hydrodynamic pressure.
Analytically, Kim et al. (1999) observed that engineered smooth muscle cells 
subjected to cyclic tensile strain for 20 weeks has 12 fold and 34 fold increase 
in tensile strength and Young’s modulus respectively compared to controls. 
Additionally, they noticed a significant increase in cell alignment in the direction 
perpendicular to the cyclic strain in stimulated tissues. Similar results about 
vascular smooth muscle cells have been reported by O’Callaghan and Williams 
(2000) and Selictar et al. (2003). Studies have also demonstrated that 
mesenchymal stromal cell either in monolayer or 3D culture follow osteogenic 
differentiation under either chemical or combined chemical and cyclic tensile 
strain stimulation (Bruder et al., 1997; Halvorsen et al., 2001; Jaiswal et al., 
2000; Jagodzinski et al., 2004; Simmons et al., 2003, Sumanasinghe et al.,
2006).
Dynamic compression using frequencies ranges from 0.01 Hz to 3 Hz of 
articular cartilage constructs enhanced their mechanical properties. (Bonassar 
et al., 2001; Buschman et al., 1995; Lee et al., 2000; Sah et al., 1989). Static 
loading instead resulted in a decrease of matrix biosynthesis (Buschman et al., 
1995; Davisson et al., 2002; Lee and Bader, 1997). A further improvement of 
the mechanical properties was achieved with the synergistic use of chemical 
stimulation (transforming growth factor TGF-p1, insulin-like growth factor IGF-1 
and dihydropyridine agonist Bay K8644) and dynamic loading (Mauck et al., 
2003; Wood et al., 2006).
Static and cyclic hydrostatic pressure culturing has been shown to improve 
matrix synthesis. Its effect is defined by its duration, magnitude and frequency. 
Specifically, Hall et al. (1991) observed an increase in GAG production as a 
result of a short 20 s stimulus in the range of 7.5 to 20 MPa followed by 2 h in 
static culture in bovine explants but pressure from 2.5 to 10 MPa with the same 
20 s / 2 h culture had the opposite result. Additionally, when pressures were
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applied for the full two hours the production of collagen and GAG increased but 
was followed by a decrease in cellular production. Parkkinen et al. (1993) tested 
bovine cartilage extracts with 5 MPa under cyclic hydrostatic loading at 0.0167, 
0.05, 0.25 and 0.5 Hz but achieved increased GAG production in bovine 
cartilage extracts only at a frequency of 0.5 Hz. Smith et al. (1995) have 
demonstrated the duration of loading as a regulatory factor of matrix production. 
They used a monolayer culture of adult bovine cells under 10 MPa peak 
pressure at 1 Hz for 2, 4, 8, 12 and 24 h observing increased collagen 
production for the 4 h cyclic loading.
Shear stimulation either as fluid shear or direct shear has been demonstrated to 
induce ECM production. Shear produced by flow entering on one side of a 
construct with immobilized cells and exerting on the other has increased 
proliferation rates, GAG and collagen production. The mechanical properties 
though of those constructs have not been examined (Davisson et al., 2002; 
Pazzano et al., 2000). Concerning the direct shear loading, Jin et al. (2002) 
concluded that dynamic tissue shear above 1.5% strain amplitude significantly 
stimulated protein and proteoglycan synthesis, by maximum values of 35 and 
25%, respectively, over statically held control specimens. Additionally, the 
combined stimulatory action of IGF-I and dynamic tissue shear deformation was 
greater than that of either stimulus alone.
Pulsatile radial stress has been tested successfully as a way of mechanical 
conditioning to tissue engineer valves and small calliper vascular grafts 
(Dumont et al., 2002; Elizondo et al., 1999; Hoerstrup et al., 2000; 
Jockenhoevel et al., 2002; Niklason et al., 1999; Sodian et al., 2000; Williams et 
al., 2004; Wolfinbarger et al., 2002). The most representative study is the one of 
Niklason et al. (1999) where bovine smooth muscle cells immobilized in tubular 
biodegradable polyglycolic acid (PGA) scaffolds were cultured under conditions 
of pulsatile radial stress for eight weeks (165 beats per minute, 5% radial 
strain). Following seeding of endothelial cells onto the luminal surface, the 
artificial arteries were implanted into pigs and remained patent for four weeks. 
Their rupture strength was around 2000 mmHg (263 kPa), their suture retention 
strength was 90 g, their collagen content was around 50% and their final cell
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density 1.19x108 cells mL"1. The values of cell density and suture retention 
strength were 3 times lower and the value of wall thickness was 30% higher 
than the physiological ones. The rupture strength and the collagen content had 
physiological values.
1.6.4 Bioreactors for tissue engineering
1.6.4.1 Introduction
Bioreactors are defined generally as a cell culture system in which biological or 
biochemical process take place under controlled environmental and operating 
conditions (Martin et al., 2004). In tissue engineering a bioreactor should be 
designed to establish uniform concentrations of cells in biomaterial scaffolds, to 
control the conditions of culture medium in terms of pH, temperature, dissolved 
gas concentration, nutrients, metabolites and regulatory molecules and provide 
relevant physical signals in terms of fluid flow, hydrostatic pressure and 
mechanical / electrical stimulation (Vunjak-Novakovic et al., 2006). Each of 
those variables can be studied individually to understand its influence on the 
properties of the engineered tissue (Bilodeau and Mantovanni, 2006). 
Mathematical models can be used to rationalize data and predict the 
bioreactor’s behaviour under different operating conditions (Chung et al., 2006; 
Ma et al., 2007; Malda et al., 2004; McGuigan and Sefton, 2007; Radisic et al., 
2005; Sengers et al., 2005; Ye et al., 2006; Zhao et al., 2007). The models can 
be used to predict the development of engineered tissue with time and to 
enable timely planning of the surgery from acquired on-line data (Martin et al.,
2004).
Furthermore, the bioreactor should be integrated into a manufacturing system 
which will include cell seeding, cell growth, freezing, shipping and storage of 
tissue-engineered products in order to maintain sterility, reduce labour and 
eliminate the need for sterile repacking (Neughton, 2002). Additionally, the 
automated operation of the bioreactor is crucial for controlled, reproducible 
basic studies and for future routine manufacturing of tissues for clinical
45
application. A detailed description of representative bioreactors for tissue 
engineering is given below.
1.6.4.2 Dishes-flasks-roller bottles-microplates
Tissue culture flasks, petri dishes, roller bottles and microplates have been 
developed mainly for the monolayer culture of adherent cells. The mass transfer 
of nutrients and metabolites in these systems is based on molecular diffusion 
which is adequate for the 10 pm thickness tissue under construction. They are 
easy to use, disposable and low-cost. Nevertheless, they require individual 
manual handling which limits their use in large numbers. This can be overcome 
to some extent with the use of sophisticated robotics.
These culture systems have been also used to study the performance of three- 
dimensional cell cultures (Glicklis et al., 2000; Malda et al., 2004; Radisic et al.,
2005) and specifically to measure diffusional gradients of oxygen, distribution of 
cell viability and ECM. The results of these studies demonstrated a decrease in 
cell numbers and a lack of homogeneity of cell and matrix distribution with 
greater values for these parameters close to the surface of the construct. 
Measurement of the oxygen profile and of the ratio of lactate produced to 
glucose consumed indicated oxygen depletion at depths beneath 100-200 pm 
and anaerobic metabolism. When constructs were exposed to medium flow the 
oxygen concentration in the construct interior was higher and the cell 
distribution more homogenous. This effect is attributed to the decrease of the 
thickness of the mass transport boundary layer around the construct.
The first generation bioreactors which alleviated the diffusion limitation by 
continuous stirring were the spinner flasks. A spinner flask is a simple cylindrical 
glass container with two to four needles being inserted into its cap, holding the 
tissue constructs in fixed positions. Each needle is holding three constructs 
separated by small silicone spacers. The cells immobilized in these constructs 
are grown in a mixed environment provided by a magnetic stirrer. The mass 
transfer of nutrients and metabolites is based on turbulent convection. The
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shear stress is not constant along the surface of the construct and it has a 
maximum value close to the stirrer of the flask. The morphology and the 
biochemical composition of the construct are a function of the mass transfer 
rate and hydrodynamics of the bioreactor. However, their responses cannot be 
predicted due to incomplete understanding of the mechanism involved.
Such bioreactors have been used mainly for preparation in vitro 
chrondrogenesis. Studies from Freed et al. (1993) and Vunjak-Novakovic et al. 
(1999) have shown that scaffolds cultured in stirrer flasks weighed twice those 
cultured in mixed dishes and contained 2.5 times more GAG and collagen. 
However close to the surface of the construct 300 pm capsules of elongated 
cells were formed with high collagen content but little GAG. The authors 
attributed this effect to the turbulent flow on cells immobilized close to the 
surface of the construct. Spinner flasks have been used lately for the large 
scale expansion and differentiation of murine embryonic stem cells as 
aggregates. The level of cell aggregation and differentiation was effectively 
controlled by adjusting shear forces and inoculation density, achieving a 31-fold 
expansion in five days (Cormier et al., 2006).
1.6.4.3 Perfusion bioreactors
A perfusion bioreactor for tissue engineering applications uses a pulsatile pump 
to deliver fresh nutrients to the cells, which are immobilized in a scaffold (Martin 
et al., 2004). The quality of tissue engineered products in perfusion bioreactors 
has been shown to be a function of the flow rate of the culture medium 
(Bancroft et al., 2002; Bagnaninchi et al., 2007; Cartmell et al., 2003; Davisson 
et al., 2002; Dvir et al., 2006). A balance between feed rate of the nutrients, 
removal of the waste products of the cells, retention of newly synthesized ECM 
within the construct and shear stress within the pores of the scaffold is crucial to 
establish optimum operation (Martin et al., 2004). Common types of perfusion 
bioreactors in tissue engineering are hollow fibre bioreactors, perfused 
cartridges and tubular bioreactors. An overview is given below.
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1.6.4.3.1 Hollow fibre bioreactors
The hollow fibre bioreactors consist of a closed vessel which is transversed by a 
large number of small diameter tubes. Cells are located either within the fibres 
(intracapillary space) or on the shell side (extracapillary space). Medium or 
blood plasma is perfused in the compartment which does not contain cells. The 
surface of the fibres is used for cell attachment as well as a barrier against the 
patient’s immune system (Palsson et al., 2003). Other techniques to provide 
adhesion support to cells include gel embedding, attachment to microcarriers 
and microencapsulation (Planchamp et al., 2003).
The development of hollow fibre bioreactors evolved from ultrafiltration 
haemodialysis cartridges and enzyme reactors; hence there are well-recognized 
limitations in their use for mammalian cell cultures (Palsson et al., 2003). 
Specifically, several researchers have reported nutrient axial and radial 
gradients which arise from the pressure gradient along the fibre lumen. These 
gradients can alter the cell metabolism resulting in nonuniform cell proliferation 
and death. Additionally, protein deposition on the fibre walls has been observed 
over time especially with fluids containing high levels of proteins like plasma 
causing decrease in fibre permeability (membrane fouling) (Palsson et al.,
2003).
A high pressure difference along the fibre length combined with high fibre 
permeability induces convective flow across the fibre wall and through the shell 
compartment. Analytically, intercapillary medium enters the extracapillary space 
near the entrance of the reactor, travels down the length of the reactor and re­
enters the intercapillary flow near the exit of the reactor. This secondary flow is 
called Starling flow (Gramer et al., 1999; Martin and Vermente, 2005; Palsson 
et al., 2003). It can improve nutrient and oxygen mass transfer but its effect is 
detrimental for solid-like scaffolds or for bioreactors at packed cell densities 
(Brotherton and Chau, 1996; Gramer et al., 1999; Piret and Cooney, 1991).
Alternative methods to operate hollow fibre bioreactors have been proposed 
that do not cause inhomogeneities of the cell and protein distribution. These
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include the periodical reversal of the flow direction of the intercapillary medium 
(Heath et al., 1990; Piret et al., 1990), the rotation of the bioreactor to avoid 
gravitational protein sedimentation (Piret and Cooney, 1990), the addition of an 
oxygenation membrane close to the cells to eliminate the axial oxygen gradient 
(Robertson and Kim, 1994) and the addition of convection by forcing medium 
through the extracapillary space to increase nutrient delivery and waste removal 
(Brotheron and Chau, 1995). However, the first two methods cannot affect the 
operation of the bioreactor at high cell densities and the last two require a more 
complicated design than the one required for a conventional bioreactor. 
Additionally, none of those methods offer a solution to the long-term problem of 
membrane fouling (Gramer et al., 1999).
Hollow fibre bioreactors are used mainly as liver assist devices (LADs) to 
sustain liver function and to cover the time between liver failure and 
implantation. This is a first step towards the construction of an artificial 
implantable liver which will offer a solution to the problem of severe donor liver 
shortage, high cost, and complexity of orthotropic liver transplantation (Chan et 
al., 2004; Kulig and Vacanti, 2004). LADs pass the blood through active 
charcoal column, oxygenators and heaters and finally through the hollow fibre 
module before being introduced to the patient’s body (Kulig and Vacanti, 2004). 
There are four LADs in different stage of clinical trials which are the HepatAssist 
(Cedar-Sinai Medical Centre, Los Angeles, California USA), the ELAD (Vitagen, 
Inc., La Jolla, California USA), the modular extracorporeal liver support (MELS, 
Charite Virchow, Berlin, Germany) and the Bioartificial Liver Support System 
(BLSS, Excorp Medical Oakdale, Minnesota USA). Studies for improvements on 
the design of LADs are focused towards the maximization of the functional 
stability of the hepatocytes in an inhospitable environment, the manufacture of 
scalable units without creating transport limitations or excessive priming 
volumes that must be filled with patient’s blood or plasma, the identification of a 
reliable cell source and a way to procure the large number of cells needed for a 
clinically effective device (Chan et al., 2004).
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1.6.4.3.2 Perfused cartridges
In a perfusion bioreactor based on perfused cartridges, culture medium is 
forced through the porous network of the scaffold (Bancroft et al., 2003, Dvir et 
al., 2006; Vunjak-Novakovic et al., 2006). The design of a flow path which 
ensures that the fresh medium is flowing through the scaffold and not around its 
edges is crucial to achieve perfusion through the scaffold (Bancroft et al., 2003). 
Characteristics of this type of perfusion bioreactor include enhanced external 
and internal mass transfer as fresh medium is delivered not only around but 
also through the internal porous network of the scaffold (Bancroft et al., 2003; 
Cartmell et al., 2002, Vunjak-Novakovic et al., 2006). Additionally, the internal 
flow provides mechanical stimulation through shear forces with their variability 
to be dependent on the scaffold’s microarchitecture. The intensiveness of the 
mechanical stimulation can be regulated by varying the flow rate (Bancroft et 
al., 2003). However, it has to be under consideration that the shear rates will 
increase with culture time as the produced matrix will decrease the porosity of 
the scaffolds causing an increase in the shear forces to a stimulatory for the cell 
metabolism levels (Bancroft et al., 2002). Non-invasive monitoring of the 
changes in the microarchitecture of the scaffold can be used to control the flow 
rate within the porous network.
Perfusion bioreactors with cartridges have been used in bone and cardiac 
tissue engineering. All studies have shown higher viability, increased cell 
proliferation, enhanced ECM production and constant cardiac contraction 
frequency (cardiac cell constructs) in comparison with static cultures (Bancroft 
et al., 2002; Carrier et al., 2002; Cartmell et al., 2003; Dvir et al., 2003; Freed et 
al., 2000).
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1.6.4.3.3 Tubular reactors
Tubular reactors have been used to engineer artificial arteries (Hoerstrup, et al., 
2001; Mironov et al., 2003; Narita et al., 2004; Niklason et al., 1999; Sodian et 
al., 2002; Thomson et al., 2002; Weinberg and Bell, 1986; Williams and Wick,
2004). The tubular bioreactors are fed with fresh medium, which diffuses to the 
tubular shaped scaffold, and it is consumed by the immobilized cells. They are 
composed also of an oxygenator, a pump and a medium culture reservoir 
(Bilodeau and Mantovanni, 2006). Pulsatile radial stress has been applied in 
order to improve collagen composition and promote mechanical properties 
(Hoerstrup, et al., 2001; Kim et al., 1999; Niklason, 1999; O’Callaghan and 
Williams, 2000; Seliktar et al., 2003). Bioreactor design for artificial arteries is 
still at an early stage of development and, up to now, the engineered arteries do 
not possess the physiological functions of the native arteries. In future, a better 
understanding of the physiological environment of the cells will help to design 
bioreactors capable of producing engineered artery substitutes.
1.6.4.4 Rotating wall vessel reactor
The rotating wall vessel (RWV) reactor, also referred to as the slow turning 
lateral vessel (STLV) reactor, is a cylindrical vessel that maintains cells in 
suspension by slow rotation about its horizontal axis with a coaxial tubular 
silicon membrane for oxygenation. It was designed initially at NASA’s John 
Space Centre to simulate the effects of microgravity on cells in a ground-based 
system and protect tissue culture during space flight (Barron et al., 2003; 
Navran, 2006). To date, it has been used both for Earth-based and space 
experiments focusing on the construction of engineered bone, cardiac and 
cartilage tissue as well as on cell biology research including work with adult 
stem cells, cancer cells and haematopoietic cells (Martin and Vermente, 2006, 
Navran, 2006).
An updated version of the STLV is the high aspect ratio vessel (HARV). Its 
design is similar to the design of the STLV but it permits lower speeds to keep
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the constructs stationary. Additionally, the oxygenation has been enhanced by 
the presence of a gas exchange membrane at its base. The area for exchange 
is more than twice as large as the area of the STRV (Martin and Vermente,
2005). The SLTV and HARV reactors are commercialized by Synthecon Inc. 
(Synthecon Inc., Houston, USA).
A perfusion-based version of rotating wall vessel reactor is also commercially 
available from Synthecon Inc. In this version the culture medium is added 
continually to and removed from the reactor. Additionally, two of these 
chambers have been linked together sharing the same nutrient loop (Eisenstein,
2006). This gives the capability for coculture experiments in which growth 
factors and other molecules can be secreted in the first chamber and they can 
be taken up to the second chamber as in a helper-cell or feeder-cell format 
(Eisenstein, 2006).
The procedure to build 3D constructs with immobilized cells in the rotating wall 
vessel reactor starts with the inoculation of cells on microcarriers. When 100 to 
200 cells are formed on each of microcarrier, they attach to form larger tissue 
assemblages under a mechanism which has not been established yet. Cartilage 
cell assemblages have reached 5 mm in diameter whereas human liver cell 
ones have reached 3 mm in diameter. Scaffolds instead of beads have also 
been used to generate engineered tissues (Martin and Vermente, 2005).
The RWV reactor offers a solid body rotation so when the vessel is rotating the 
culture media rotates at the same angular velocity as the vessel wall with 
laminar fluid flow. Gravitational, centrifugal and Coriolis forces (force which 
causes deflection of objects from a straight path if the objects are viewed from a 
rotating frame of reference) are applied to the culture medium and result in a 
slow sedimentation of cells as the vessel turns, minimizing damaging shear 
forces and allowing cells to form 3D tissue-like assemblages. This gentle mixing 
of media is induced also by particle sedimentation. Unlike roller bottles, the 
vessel chamber is completely filled with culture media, avoiding the turbulence 
created by a headspace. Oxygenation via a coaxial silicone membrane prohibits 
bubble formation and consequently creation of cell-damaging turbulence 
(Navran, 2006).
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The orbit of the assemblages orbit depends on the vessel dimensions, fluid 
rotational rate, external gravitational fields, particle sedimentation rate, viscosity 
and density of the culture medium. The rotation is slower in space than in Earth 
because it has only to enhance the mass transfer of nutrients to the cells. For 
example for a 2 mm cancer-cell assemblage the Reynolds number in Earth and 
space was 86 and 0.19 respectively whereas the shear stress was 0.11 Pa and 
0.2x1 O'3 Pa respectively (Martin and Vermente, 2005).
The size of the assemblages may change during the culture due to cell 
proliferation and / or recruitment of additional cells into an assemblage, causing 
an increase in sedimentation velocity by the square of the radius. To counteract 
the increase in sedimentation velocity, the speed of rotation should be 
increased to prevent the assemblages from hitting the vessel wall. At some 
point their size may become so large that it is impossible to maintain them in 
suspension without striking the vessel wall. Even with this limitation, tissue-like 
assemblages approaching 10 mm are possible (Goodwin and Parker, 2006).
1.7 Organisation of thesis
The preceding sections have provided a description of tissue engineering efforts 
to date and the challenges involved in the design and operation of bioreactors 
to generate these tissues. The importance of being able to predict the supply of 
nutrients and removal of metabolites has been highlighted. Hence the aims of 
the thesis were (a) to develop models of transport phenomena in order to 
predict the fluid flow and mass transfer requirements of a prototype bioreactor 
for the formation of engineered tissues and and (b) to design micro scale 
experiments in order to evaluate from measurements, effective diffusivities of 
substrates and metabolites in alginate matrices as well as substrate 
consumption and metabolite production rates in matrices with immobilized cells. 
The advantage of such micro scale experiments was that greater data sets 
could be generated with the small number of cells available but in a way which 
predicts the larger scale.
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The layout of the thesis is as follows. Chapter 2 presents the materials and 
methods which were used for the development of the mathematical models and 
the conduction of micro scale experiments. Chapter 3 presents the use of 
windows of operation to predict the fluid flow and oxygen mass transfer 
requirements of a prototype bioreactor for the production of artificial tissues. 
Chapter 4 presents a theoretical analysis to predict substrate and metabolite 
concentration profiles and cell proliferation in the artificial artery as an effect of 
feed and recycle rate. Chapters 5 and 6  describe the design of scale-down 
experiments in order to measure indirectly the oxygen, glucose and lactate 
effective diffusivity in an alginate gel / cell mix and the oxygen uptake rate, 
glucose consumption rate and lactate production rate of human adult cells. 
Chapter 7 outlines the final conclusions and suggests directions for future work.
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Chapter 2 
Materials and methods
2.1 Protocols for fibroblast cell culture
2.1.1 Creation of frozen cell bank
Normal human dermal fibroblasts under passage 11 (Karocell Tissue 
Engineering AB, Sweden) were kindly provided by Dr. S. Minger (Kings 
University, London UK). A vial was thawed in a tissue culture flask with 75 cm2 
surface area (T-75, Corning, Fisher Scientific, Loughborough UK) containing 20 
mL Iscove’s modified Dulbecco’s medium (IMDM) supplemented with 4 mM 
glutamine, 25 mM HEPES, 10 % heat inactivated foetal bovine serum (all from 
Invitrogen, Paisley UK) and 100 U mL' 1 penicillin/streptomycin (BioWhittaker, 
Walkersville, MD) and in a humidified 37°C, 5% C 0 2 environment (Heraeus, 
HERAcell 150, Jencons-PLS, East Sussex, UK). Upon 80% confluency, the 
cells were passaged into one T-150 flask. They were then expanded as above 
using one to three flasks progression till obtaining nine T-150 confluent flasks. 
Following trypsinization and cell counting in the Guava cytometer (Guava 
Technologies, Hayward, California USA) the cells were centrifuged and 
resuspended in cryopreserved medium to yield a cell suspension with a cell 
density of 106 cells mL'1. The cryopreserved medium was 95% complete 
medium with the same formulation used in the cell passaging and 5% DMSO 
(Sigma, Gilligham UK). Upon addition of around 1 mL of cell suspension into 
cryovials (Nalgene, Nalge Nunc International, Rochester, New York USA) the 
cells were frozen slowly in an insulated Styrofoam box in a -80°C freezer 
overnight and were transferred to liquid nitrogen for long term storage.
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2.1.2 Cell passaging in tissue flasks
The fibroblasts were thawed and cultured in cell tissue culture flasks with a 
surface area of 150 cm2 (T-150, Corning, Fisher Scientific, Loughborough UK) 
in a humidified 37°C, 5% CO2 environment. The culture medium was Iscove’s 
modified Dulbecco’s medium (IMDM) supplemented with 4 mM glutamine, 25 
mM HEPES ,10% heat inactivated foetal bovine serum (all from Invitrogen, 
Paisley UK) and 10 U mL' 1 penicillin/streptomycin (BioWhittaker, Walkersville, 
Maryland USA). From here on this is denoted as the “complete medium”.
The fibroblasts were passaged every two days (at 70-80% confluence) at one 
T-150 flask to three new T-150 flasks split using 0.25% trypsin / 0.02% EDTA 
(Sigma, Gilligham UK) for their detachment. Analytically, the spent medium was 
removed and 15 mL free of calcium and magnesium phosphate buffered saline 
solution (PBS, BioWhittaker, Walkersville, Maryland USA) were added to 
remove residual serum proteins which are otherwise decreasing trypsin activity. 
The PBS was removed and 5 mL of 0.25% trypsin / 0.02% EDTA solution were 
added. After 300 s, the cells were dislodged by tapping the flask against the 
palm of the hand and 10 mL of complete medium was added to deactivate the 
trypsin. This is necessary because eventually the trypsin will diffuse through the 
cell membrane initiating apoptosis. A sample was withdrawn for cell counting in 
a Guava Easy-Cyte cytometer (Guava Technilogies, Flayward, California USA) 
and then 5 mL of cell suspension were added in each T-150 flask which had 
previously been supplemented with 25 mL of complete medium. The flasks 
were placed in the incubator and the cultures were monitored for cell 
morphology characteristics like confluency, changes in the colour of medium as 
an indication of pH change and amount of cell debris.
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2.2 Fibroblast-alginate construct
2.2.1 Fibroblast suspension and alginate mixture preparation
Sterile sodium alginate Pronova SLG-100 (FMC Biopolymer AS, Drammen 
Norway) with the molecular weight in the range of 20-30x103 Da, the guluronic 
to mannuronic acid ratio above 60% and the apparent viscosity at 25°C of the 
1% (w/v) aqueous solution above 100 mPa s was used for all the experiments. 
Calcium-free Dulbecco’s Modified Eagle’s medium DMEM supplemented with L- 
glutamine and 10% heat inactivated foetal bovine serum (all from Invitrogen, 
Paisley UK) was used to dissolve the alginate and obtain a 2% (w/v) solution 
after mixing overnight at room temperature on a platform roller (Roller Mixer 
SRT2, Bibby Stuart Scientific, Stone UK). The 2% (w/v) alginate solution was 
mixed with the cell suspension at equal volume to yield a cell - alginate mixture 
with an alginate concentration of 1 % (w/v).
Upon reaching 80% confluency the fibroblasts were detached from the surface 
of T-flasks (Corning, Fisher Scientific, Loughborough UK) using 0.25% trypsin / 
0.02% EDTA solution (Sigma, Gilligham UK). A sample was withdrawn for cell 
counting using a Guava cytometer. The cell suspension was centrifuged (581 OR 
Centrifuge, Eppendorf AG, Hamburg Germany) in 50 mL centrifuge tubes at 
200 g at low deceleration for 300 s. The supernatant was removed and 
discarded and the cell pellet was resuspended in calcium free Dulbeccos’s 
Modified Eagle’s medium DMEM supplemented with L-glutamine and 10% heat 
inactivated foetal bovine serum (all from Invitrogen, Paisley UK) in order to 
dilute the residual EDTA. The second resuspension is necessary because 
EDTA binds Ca2+ therefore it would inhibit the formation of the alginate 
construct. The cells were centrifuged again and resuspended in medium with 
the previous composition. The cell density in the cell suspension was double the 
desired one in the alginate-cell mixture as it was mixed later on with an equal 
volume of alginate solution.
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2.2.2 Set up of alginate in cell culture inserts and customized 
microplates
Falcon cell culture inserts (BD Labware, Frankin Lakes USA) were used in 
order to create alginate-cell construct at their bottom. The volume of the 
alginate-cell mixture in each one was 0.15 mL. The inserts incorporate a non 
tissue culture treated polyethylene terephthalate (PET) track-etched membrane 
with a pore size of 3 pm and a pore density 8x105 pores cm'2. This pore size 
does not allow the passage of cells through the membrane so substrates and 
metabolites are consumed and produced only within the alginate construct. 
Additionally, the “non tissue culture” membrane inhibits the cell attachment 
which can otherwise slow down the mass transfer of nutrients and metabolites. 
The inserts were placed in 12-well Falcon companion plates (BD Labware, 
Frankin Lakes USA) and immersed in 1.25 mL Iscove’s modified Dulbecco’s 
complete medium (IMDM) supplemented with 1% (w/v) cell culture tested CaCI2 
solution (Sigma, Gilligham UK) and the plates were placed in the incubator (5% 
C 02, 37° C). After 1.0 h, the supplemented with CaCI2 culture medium was 
discarded and replaced with complete IMDM medium. Its amount in each insert 
was 0.75 mL and in the well 2.3 mL. Additionally, the inserts were tilted while 
they were lowering into the well in order to avoid trapping air under them. 
Trapped air can delay the mass transfer of substrates and metabolites through 
the membrane and affect the calculations of any consumption / production rates 
and diffusivities. In order to improve nutrient delivery, oxygen transfer and waste 
removal from the alginate construct the companion plate was shaken at 2 2 0  
rpm in an orbital shaker (IKA KS260, Camlab, Cambridge UK). At the end of the 
experiment, photos of the companion plate and the Falcon cell culture inserts 
were taken under the microscope to verify the non attachment of cells at their 
bottom.
Low volume, non tissue culture treated microwells (Luxcel Biosciences, Cork 
Ireland) were cut into individual wells and were glued to the bottom of the wells 
of ultra low attachment 24-well plates (Corning Life Sciences, New York USA). 
Then, oxygen or pH sensor spots (Presens, Regensburg Germany) were glued
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(Nusil, Polymer Systems, Ltd., Buckinghamshire UK) at the bottom of each of 
the low volume wells (Figure 2.1). The sterilization of the customized plates was 
conducted by gamma irradiation (Isotron, Swindon UK). The selection of this 
type was based on the surface coating used which inhibits the attachment of 
any cells released from the alginate construct. Additionally, the spots are highly 
hydrophilic thus they do not support cell attachment on their surface. Following 
sensor spot calibration, an alginate-cell mixture was slowly syringed through a 
sterile 0 .1  mm diameter blunt needle and dripped into the low volume well. 
Individual millicell (Millipore, Bedford UK) with a polycarbonate membrane with 
a pore size of 3 pm and a pore density of 8x106 pores cm' 2 were filled with 
complete IMDM medium supplemented with 1% (w/v) CaCL solution and were 
placed on top of the low volume wells in each of the wells of the customized 24 
well plate. The plate was transferred to the incubator and the CaCI2 started 
diffusing through the polycarbonate membrane of the millicell, reacting with the 
alginate and forming the alginate gel. After an hour the transwells were 
removed and 1 mL of complete medium was added to the wells after having 
washed them twice with it in order to remove residual CaCI2. The plate was 
placed in the incubator again where oxygen and pH measurements were 
carried out by using the oxygen and pH meter devices (Presens, Regensburg 
Germany). At the end of all the experiments, the sensor spots were exposed to 
the calibration standards solutions to check their performance. Additionally, 
photos of the customized plate were taken under the microscope to check in 
case any cells had attached to the well bottom.
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Figure 2.1: Construction of a customized plate. Low volume non tissue culture 
treated microwells (Luxcel Biosciences, Cork Ireland) were cut into individual 
wells and were glued to the bottom of the wells of ultra low attachment 24 well 
plates (Corning Life Sciences, New York USA). Then, either oxygen or pH 
sensor sports (Presens, Regensburg Germany) were glued at the bottom of 
each of the low volume wells. The sterilization of the customized plates was 
conducted by gamma irradiation (Isotron, Swindon UK). After the addition of cell 
/ alginate solution to the low volume well, a millicell (Millipore, Bedford UK) filled 
with 1 % (w/v) CaCI2 (Sigma, Gilligham UK) will be placed on the top of it for an 
hour. The CaCI2 will diffuse through the millicell’s membrane and cause the 
alginate to gel. Optical coherence tomography was used to validate the flatness 
of the alginate surface. It was conducted at Professor Ruikang Wang’s Lab at 
Cranfield University, UK.
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2.3 Fibroblast/alginate evaluation
2.3.1 Fibroblast recovery from alginate constructs
The fibroblasts were recovered by dissolution of the alginate constructs in a 
solution of 0.3 M trisodium citrate in trypsin / EDTA (both from Sigma, 
Gillingham UK). Trisodium citrate plays the role of chelator of calcium ions 
dissociating them from the alginate hydrogel (Lee, 1991; Smidsrcd and Skj&k- 
Braek, 1990). The trypsin / EDTA solution was used in order to achieve a single 
cell suspension.
The dissolution of the alginate constructs formed in cell culture inserts was 
conducted by placing the insert in 15 mL of the above solution in 50 mL 
centrifuge tubes (Corning, Fisher Scientific, Loughborough UK). Then, the tubes 
were placed in a roller (Roller Mixer SRT2, Bibby Stuart Scientific, Stone UK) 
for 1 0  min.
The dissolution of the alginate constructs formed in customized microplates was 
conducted by replacing the culture medium with 1 mL of 0.3 M trisodium citrate 
in trypsin / EDTA. The plate was placed in an orbital shaker (IKA KS260, 
Camlab, Cambridge UK) for 10 min. In both cases the recovery of the 
fibroblasts in a single cell suspension was verified by phase contrast 
microscopy.
2.3.2. Flow cytometric methods 
2.3.2.1 Guava Easy-Cyte cytometer
A Guava EasyCyte cytometer (Guava Technologies, Hayward, California USA) 
was used for cell enumeration, cell cycle analysis and recognition of Ki-67 
expression. It is an automated desktop single-cell analysis system which 
accommodates both a 96-well plate and microcentrifuge tubes. The system
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uses a flow cell with an inner diameter of 100 |jm. It is made of fused silica with 
a polyimide coating that requires no alignment following replacement. There is a 
high-pressure purge of the flow cell available for removing obstructions in the 
flow cell and the sample is aspirated through the flow cell using a high precision 
microsyringe. Sheath fluid is not required for operation. The particles are 
excited by light from a suitable light source such as a diode laser (488 nm) and 
scattered light is detected providing an absolute count of all particles passing 
through. Three fluorescence detectors / photomultipliers with 583 ± 26 nm 
(PM1), 680 ± 30 nm (PM2), and 525 ± 30 nm (PM3) filters are used. The 
instrument requires as little as 20 pL of neat sample and as few as 1000-2000 
total cells to perform an analysis and works with both adherent and non­
adherent cells. However, accurate results are only obtained for a cell size 
between 7 to 60 pm (Goix, 2004).
2.3.2.2 Cell enumeration
The Guava ViaCount assay distinguishes between viable and non-viable cells 
based on the differential permeability of two DNA-binding dyes in the ViaCount 
Reagent; the laser dye styril (LDS) and the propidium iodide (PI) dye. The LDS 
(Exciton Laboratories, USA) is membrane permeable, stains all nucleated cells 
and its fluorescent signal is detected by the PM2. The PI dye (Sigma, USA) will 
only penetrate cells with compromised membrane integrity (non-viable cells) 
and is detected by the PM1. Events are counted if they emit nucleated cell 
fluorescent signal and if the forward light scatter (FSC) intensity is appropriate 
to a particle of the size of a cell (Figure 2.2) (Phi-Wilson et al, 2002).
Cell suspension, 196 pL, with a cell concentration in the range of 0.01 to 0.50 
x106 cells mL' 1 was added in each wells of a 96 well plate. Viacount dye, 4 pL, 
was added in each well and the sample was mixed by pipeting repeatedly. The 
96-well plate was incubated at room temperature for 15 min in the dark to allow 
dye to equilibrate. The data acquisition was achieved by using the Express Plus 
application software within Cytosoft. Cell samples were assayed for cell count 
and viability.
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Figure 2 .2 : Typical results obtained using the Guava EasyCyte cytometer for 
cell concentration and cell viability determination. The results are presented in 
three plots. Plot 1 shows the fluorescent signal which is detected by the 
photomultiplier 1 (PM1) versus the forward side scatter signal (FSC). The PM1 
detects PI which penetrates cells with compromised membrane integrity (non- 
viable cells) and the FSC is related with the size of the particle with a low 
intensity signal to correspond to low size particles. Plot 2 shows the fluorescent 
signal which is detected by the PM2 versus the one which is detected by the 
PM1. The PM2 detects the LDS which stains all nucleated cells. Plot 3 uses 
Plot 1 to help define different cell type in Plot 2 and help create two quadrants, 
UL and UR which are containing the live cell (UL) and the apoptotic and dead 
cell population (UR). The table gives the cell count and cell concentration for 
each of these regions.
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2.3.2.3 Cell cycle analysis
Cell cycle describes the process by which a cell becomes two. It is divided into 
four phases of which the two basic ones are the DNA synthesis phase (S 
phase) and the mitosis phase (M phase) (Alberts et al, 1994). During the S 
phase DNA replicates and during M phase the cell divides to form two daughter 
cells. S and M phases are separated by two “gaps” (G1 and G2 phases). G1 
phase controls entry into the S phase by checking if the cell is large enough, 
DNA is undamaged and if external conditions are favourable. G2 phase controls 
entry into the M phase. It checks if DNA has been replicated without damage 
and if the cell is big enough to divide into daughter cells (Alberts et al, 1994). 
Cells in a quiescent state are out of the cell cycle and they are in the so-called 
GO phase. They can remain there for days, weeks or even years. (Alberts et al, 
1994)
By using PI the nuclear DNA can be stained and cells can be discriminated at 
different stages of cell cycle. Cells at GO / G1 phase contain two copies of each 
chromosome. They start synthesizing DNA by entering the S phase. As a result 
the PI fluorescence intensity is increasing till it reaches twice the intensity of the 
GO / G1 population. At this point cells have entered the G2 / M phase and 
eventually they will divide into two cells.
PI staining requires cell fixation in order to make the cells permeable to the dye. 
Analytically, 200 pL of cell sample with an adjusted concentration between 0.5 
to 1x106 cells mL/ 1 were transferred to a round bottom 96 well plate. The plate 
was centrifuged twice at 450 g for 300 s with the brake on low at room 
temperature. After the first centrifugation the supernatant was replaced with 200 
pL of phosphate buffer saline (Sigma, UK) and after the second one with 200 pL 
of 70% ice cold ethanol which was added dropwise. The plate was sealed and 
refrigerated for 12 h. Following cell fixation the plate was centrifuged twice 
under the same conditions as above. After the first centrifugation the 
supernatant was replaced with 200 pL PBS and after the second one with 200 
pL cell cycle reagent (Guava Technologies, Hayward, California USA). The 
plate was incubated at room temperature in the dark for 0.5 h and it was then
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located in the Guava EasyCyte cytometer. The data acquisition was achieved 
by using the Express Plus application software within Cytosoft. The file was 
exported to Modfit 3.1 software (Verity Software House, Topsham USA) for 
gating and deconvolution of the curves (Figure 2.3).
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Figure 2.3: Typical results from cell cycle analysis using the Guava EasyCyte 
cytometer. The cells are fixed, permealized and stained with the Guava cell 
cycle reagent. Following incubation in the dark at room temperature for 0.5 h, 
cell cycle data are acquired in the Guava Express software within Cytosoft and 
are exported as a single parameter FCS 2.0 file to Modfit 3.1 software (Verity 
Software House, Topsham USA) for gating and deconvolution of the curves.
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2.3.2.4 Ki-67 expression as a cell proliferation marker
The Ki-67 antigen can be detected within the nucleus of cells. Detailed analysis 
has revealed that it was presented in all the phases of the cell cycle but absent 
from resting cells in the GO phase (Scholzen and Gerdes, 2000). Therefore, it 
can be used as a marker to determine the proliferative fraction of a cell 
population (Scholzen and Gerdes, 2000).
Cells have to be fixed in order to be permeabilized and stained with Ki-67 
antibody. The protocol prior to cell staining is identical to the one followed for 
the cell cycle analysis. The amount of fluorescein isothiocyanate (FITC)- 
conjugated anti-human Ki-67 antibody and PI dye (50 pg mL'1) (both from BD 
Biosciences, Oxford UK) which was added to a 200 pL cell sample was 4 pL 
and 2 pL respectively. The plate was incubated at room temperature in the dark 
for 0.5 h and it was located in the Guava EasyCyte cytometer. The same 
procedure was followed for the FITC-conjugated Mouse lgG1 kappa isotype 
control (BD Biosciences, Oxford UK). This is to provide an estimate of the non­
specific binding of the specific antibody as it has no specificity to any 
component of the cells. The FITC-conjugated Ki-67 antibody and its isotype 
control are detected by the photomultiplier 3 (PM3). PI dye is needed to gate 
the cell population in the PM2-PM1 plot and apply that gate in the PM3 - FSC 
plot. The data acquisition was achieved by using the Express Plus application 
software within Cytosoft. Data were exported in the FCS Express software (De 
Novo Software, Ontario Canada). Samples were assayed for percentage of 
cells expressing Ki-67 (Ki-67 positive cells) (Figure 2.4).
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Figure 2.4: Typical results from Ki-67 expression analysis using the Guava 
EasyCyte cytometer. The cells are fixed, permeabilized and stained with FITC- 
conjugated Ki-67 antibody and PI dye. FITC-conjugated lgG1 kappa antibody is 
used as an isotype control. Cells are incubated in the dark at room temperature 
for 0.5 h. Data derived from staining with Ki-67 and lgG1 (isotype control) 
antibodies are acquired in the Guava Express software within Cytosoft and 
exported to FCS Express software (De Novo Software, Ontario Canada). FCS 
Express has been chosen because it offers the capability to overlay data 
derived from Ki-67 antibody staining with data derived from isotype control 
antibody staining. Plots 1 and 2 contain overlaid events from PI staining derived 
from the cell sample stained with Ki-67 antibody and from the one stained with 
its isotype control. The cell population is gated and that gate is applied in Plot 3 
and Plot 4 which contain events derived from isotype control and Ki-67 staining 
respectively. The quadrants in Plot 3 are applied in Plot 4 and events within the 
upper left quadrant are corresponding to Ki-67 positive cells.
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2.4 Metabolic Analysis
The Nova Bioprofile analyser (Nova Biomedical, Flintshire UK) was used to 
measure glucose, lactate, glutamine, ammonium and pH in order to evaluate 
indirectly effective diffusivities of nutrients and metabolites as well as to 
evaluate the nutrient consumption and metabolic production rates in alginate 
constructs containing human dermal fibroblasts. These experiments were 
performed with constructs prepared in transwells.
The device uses potentiometric electrodes to measure pH, sodium, potassium 
and ammonium concentrations and amperometric electrodes to measure 
glucose, lactate, glutamate and glutamine concentrations (Nova Bioprofile 400 
Reference Manual, 2002).
Potentiometric-based electrodes measure charged ions and have a sensing 
membrane that is selective to the ion being measured. They develop a voltage 
which can be described by the Nernst equation:
R T
Em = E0 + 2.303——log10 a, (2.1)
nF
where Em is the membrane potential, a, is the activity of the ion, R is the 
universal gas constant, T is the temperature, F is the Faraday’s constant and n 
is the charge of the measured ion.
The potential of the sample is compared against the potential of a standard 
solution and their difference is dependent on the ratio of the activity of the ion of 
interest in the sample and the activity of the ion of interest in the standard 
solution. This statement is expressed mathematically by the following equation 
(Nova Bioprofile 400 Reference Manual, 2002)
AE = Ex - E sld=S\og,0^ ~  (2.2)
std
where S is the electrode slope (30.8 mV per decade change in activity for a 
divalent ion and 61.6 mV for a univalent ion), Ex and ax are the potential and 
activity of the measured ion in the sample, Estd and asW the potential and activity 
of the measured ion in the standard solution.
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The activity of an ion is the product of its concentration and ionic coefficient. 
The latter relates concentration and activity and is a function of the ionic 
strength of the solution. The standard solution has been formulated to reflect 
the same ionic strength as that of serum and therefore the difference in 
potential between the sample and the standard solution is only dependent on 
the concentration (Nova Bioprofile 400 Reference Manual, 2002). It can be 
expressed mathematically as follows:
A E = Slog10 -St- (2.3)
C std
cx = csld10*E/s (2.4)
where cx is the concentration of the ion of interest.
Amperometric electrodes consist of a membrane with immobilized enzymes and 
a platinum electrode. The substrate or metabolite diffuses through the 
membrane and is oxidised. Consequently, the hydrogen peroxide produced is 
oxidized at the platinum electrode producing electrons. The current generated 
by the flow of electrons is proportional to the concentration of the substrate or 
metabolite (Nova Bioprofile 400 Reference Manual, 2002).
The relevant chemical equations are the following 
for glucose
13-D-glucose + H20 — gluconic acid + H20 2
H20 2 -2e' >0 2 + 2H+
for lactate
lactate + H20 — ^ e—> pyruvate acid + H20 2
H20 2 2e - >0 2+ 2H+
for glutamine and glutamate
glutamine + H20 — 9lutamina-se- > glutamate + NH3
glutamate + 0 2 — 9l^ f ee-—> ketoglutarate + NH3+ H20 2 
H20 2 ~2e > Q2 + 2H+
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2.5 Oxygen and pH measurements
The Presens 4-channel fiber-optic oxygen and pH meters (Presens GmbH, 
Regensburg, Germany) based on 2 mm spots (polyester base) were used to 
acquire oxygen concentration and pH measurements on-line. The spots were 
glued at the bottom of customized wells and measurements were acquired non- 
invasively and non-destructively from outside through the bottom of the 
customized microplate.
Oxygen is measured in the range of 0 to 250% of air saturation and pH in the 
range of 5.5 to 9. The accuracy and the resolution of the oxygen measurements 
depend on its level. Specifically, at 1% oxygen of air saturation (20°C) the 
accuracy and resolution of the measurements are 0.15% and 0.05% of air 
saturation respectively, whereas at 250% oxygen of air saturation (same 
temperature) are 0.5% and 1% of air saturation respectively. Similarly, the pH 
can be measured in the range of 5 to 9 (20°C) with an accuracy of 0.05 pH units 
and a resolution of 0.005 pH units. The drift of the sensor spots is 0.5% oxygen 
of air saturation per 100000 measurements and 0.1 pH units per 5000 
measurements. The response time (90% of the signal change) for gaseous and 
dissolved oxygen (non-stirred solution) is 10 and 40 s respectively while the 
response time for pH is 30 s. A two-point calibration in oxygen free water and 
humidified air or air-saturated water is followed for the oxygen sensor and a 
calibration based on a series of buffer solutions for the pH sensor (Presens 
Fibox-3 Instruction Manual, 2004).
The principle of measurement is based on the effect of dynamic luminescence 
quenching which is caused by collision between molecular oxygen / protons and 
luminescent dye molecules in the excited state. After collision, energy transfer 
takes place from the excited indicator molecule to the quencher. As a result, the 
indicator molecule does not emit luminescence and the measurable 
luminescence signal decreases (Presens Fibox-3 Instruction Manual, 2004).
Both the devices use the phase-modulation technique to evaluate the 
luminescence decay time of the indicators. If the luminophore is excited with a
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sinusoidally intensity modulated light, its decay time causes a time delay in the 
emitted light signal. In technical terms, this delay is the phase angle between 
the exciting and the emitted signal. The relation between decay time r and the 
phase angle 0  is shown by the following equation (Presens Fibox-3 Instruction 
Manual, 2004)
r - ^ T ~  (Z 5 )
where fmoCj is the modulation frequency.
The phase-modulation technique is used because the decay time does not 
depend on the intensity of the light source, the sensitivity of the detector or the 
concentration of the dye. Additionally, it is not influenced by the shape and size 
of the sensor spot or by variations in the optical properties of the sample 
including turbidity, refractive index and coloration (Presens Fibox-3 Instruction 
Manual, 2004).
The dual luminophore reference method (DLR) is used exceptionally to 
measure pH because the decay time of the pH-indicator dyes is in the 
nanosecond time scale. A direct measurement in this time scale requires 
expensive and sophisticated instrumentation. Instead, the DLR method uses the 
measurement of average decay times. Analytically, the pH sensor consists of 
an indicator with short decay time (ns time scale) and a reference dye with long 
decay time (ps time scale). Ideally, the two luminophores have overlapping 
excitation and emission spectra. The reference luminophore gives a constant 
background signal while the fluorescence signal of the indicator depends on the 
proton concentration. The average phase shift directly reflects the intensity of 
the indicator dye and, consequently, the proton concentration (Presens pH-1 
mini Instruction Manual, 2004).
The relation between the oxygen concentration in the sample and the 
luminescence intensity as well as the luminescence decay time is described by 
the Stern-Volmer equation (Presens Fibox-3 Instruction Manual, 2004).
[o_ = lc 
I  T
° - ' ° - 1  + Ksv[02]  (2.6)
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where t 0 and t  are the luminescence decay times in absence and presence of 
oxygen, l0 and I are the respective luminescence intensities in absence and 
presence of oxygen, [O J  the oxygen concentration and Ksv the overall 
quenching constant.
The Boltzman equation describes the relationship between pH and phase angle 
because of the sigmoidal shape of the pH calibration curve (Presens pH-1 mini 
Instruction Manual, 2004).
0 -00 -  ^ m m  max 0  / o  7 )
(p H -p H 0 ) max V * - - ' /
1+e dpH
where 0 m/n, 0 max are the minimum and maximum phase angle, pH0 defines the 
pH where the phase angle is equal to the average of the two limiting phase 
angles (0 = (0 min + 0 max)/2) and dpH is the width of the pH range which the 
phase angle changes significantly.
2.6 The finite element method
The mathematical formulation of the whole class of transport phenomena due to 
conservation of mass, momentum species and energy leads to partial 
differential equations in the continuum approximation (Zimmerman, 2006). Their 
solution by exact methods of analysis is often impossible either because of 
complex geometry and material properties or because of the complicated 
functions involved. In such cases approximate methods of analysis are used.
The finite element method is a technique where a given domain is divided into 
subdomains. Each subdomain is called an element and their union gives the so 
called finite element mesh. When all elements are of the same length the mesh 
is characterized as uniform; otherwise it is called a non-uniform mesh. The 
points where the elements are connected to each other are called nodes. This 
subdivision allows the accurate representation of complex geometries and 
inclusion of materials with anisotropic properties as well as accurate 
approximation of local large gradients in the solution (Reddy, 2003).
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The functions which approximate the solution are developed over each of the 
elements. They are usually based on the idea that any continuous function can 
be represented by a linear combination of suitable algebraic polynomials and 
undetermined coefficients. The latter are obtained by satisfying the governing 
equations in a weighted-integral sense over each element with the nodes to 
play the role of interpolation points. This is needed in order to obtain as many 
algebraic equations as there are unknown coefficients in the approximation of 
the dependent functions of the equation (Reddy, 2003).
The dimensionality of the elements depends on the dimensionality of the 
problem to be solved. In one-dimensional problems the element is a line 
segment. In two-dimensional problems the fundamental element is a triangle 
and in three-dimensional problems the fundamental element is a tetrahedron. 
Additionally, the elements are categorized according to the type of interpolation 
functions used with them. The elements are called simplex if the interpolation 
polynomials have linear parts and complex if the interpolation polynomials have 
high-order polynomial parts (Zimmerman, 2006).
There are three sources of error in a finite element method. They are those due 
to the approximation of domain, those due to the approximation of the solution 
and those due to the numerical computation (numerical integration and round­
off errors in a computer). The higher the number of elements the higher will be 
the accuracy of the solution and the larger will be the computation time. 
However, above a number of elements the sensitivity of the accuracy becomes 
negligible. There is no formula which can predict the optimum number of 
elements (Reddy, 2003). When the solution cannot be verified by comparing the 
results to values from the literature a convergence test is necessary to 
determine if the mesh density is sufficient. The approach is to begin with a 
mesh which is believed to be adequate and solve the problem. Then, a finer 
mesh is selected and a new solution is obtained. If the difference between the 
two solutions is significant further mesh refinements are needed till the obtained 
solution agrees with the previous one to the desired number of significant 
figures (Comsol Multiphysics manual, 2006; Reddy, 2003; Zimmerman, 2006).
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The model is solved using the finite element solver Comsol Multiphysics v.3.3a. 
Data analysis and visualization can be extended by combining Comsol 
Multiphysics with technical computing languages like C++ and Matlab (Comsol 
Multiphysics manual, 2006). The set up of a model in Comsol Multiphysics is 
shown in the following flowchart:
START
choose application mode
1r
^  insert parameters ^
r
draw geometry
1 f
specify equations
1 f
generate mesh
1 f
f1
solve model
need to refine mesh ?
postprocessing the results
STOP
Figure 2.5: Flowchart for the formulation and solution of a model in Comsol 
Multiphysics. There are 7 steps involved. In the first step the application mode 
which describes the physics phenomena in a model has to be selected. In the 
second step the values of the parameters of the model are inserted in the 
model. In the third and fourth step the geometry is drawn and meshed. In the 
fifth step the equations are specified in the subdomains and boundaries. In the 
sixth step the model is solved and if the solution is not satisfactory the mesh is 
refined and the model is solved again. In the last step the results are exported 
for processing.
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2.7 Inverse method
The inverse method was used to evaluate from measurements the substrate / 
metabolite effective diffusivities as well as the substrate consumption and 
metabolite production rates in alginate constructs with immobilized human 
dermal fibroblasts (Figure 2.6). The measurements have to be sensitive to the 
parameters of interest in order to achieve the parameters’ accurate evaluation.
The inverse method was implemented in Comsol Multiphysics wrapped around 
Matlab in four steps. In the first one the partial differential equation of the mass 
transfer of substrates and metabolites in alginate constructs was solved for 
values of parameters derived from literature. In the second step the Comsol 
model was saved as a Matlab file. This file was edited as a function having as 
input the parameters of interest and output the concentrations of nutrients and 
metabolites. It was referred to as the forward model function. Its role is to help 
Matlab to recognize which are the parameters of interest of the Comsol model 
which will be estimated. In the third step the function which gives the sum of the 
squares of the relative errors between experimental and simulated nutrient / 
metabolite concentration values at various instants was created having as input 
the forward model function. The function of the third step was referred to as the 
error function. In the fourth step the best-fit values of the parameters of interest 
were estimated by creating a new Matlab file which was based on the non-linear 
programming Matlab function “Isqnonlin” and was referred to as the optimizer 
function. This function was minimizing the output of the error function by 
changing repeatedly the initial estimates of the values of the parameters of 
interest following the Levenberg-Marquardt algorithm. Additionally, the Matlab 
statistical toolbox function “nlparci” was used to obtain the parameters’ 
confidence intervals.
In equations with non-linear parts the above algorithm could converge to a local 
minimum instead of a global minimum. In this case the algorithm will give wrong 
best-fit values for the parameters of interest. In order to check the accuracy of 
the results the algorithm was rerun with different initial guesses of the values of 
the parameters of interest.
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START
Y E S
is it the minimum ?
N O
STOP
new guesses for parameters
solve model in Comsol
best fit values
create forward model function
create error function
derive output of error function
Figure 2.6: Flowchart for evaluating from measurements the glucose and lactate 
effective diffusivities as well as the glucose consumption and lactate production 
rates in alginate constructs with immobilized human dermal fibroblasts by using 
the inverse method implemented in Comsol Multiphysics and Matlab. The 
algorithm involved four steps. In the first step the model is solved in Comsol 
Multiphysics. In the second step the forward model function is created and 
helps Matlab to recognize which are the parameters of interest of the Comsol 
model which will be estimated. In the third step the error function is created and 
gives the sum of the squares of the relative errors between experimental and 
simulated glucose and lactate concentration values at various instants having 
as input the forward model function. In the last step the optimization function is 
created and finds the best-fit values for the parameters of interest by minimizing 
the value of the error function.
76
2.8 The use of Comsol Multiphysics wrapped around Matlab in 
the construction of windows of operation
The data needed to construct the windows of operation for the artificial artery 
reactor were obtained by using Comsol Multi physics wrapped around Matlab. 
The procedure involved three steps. Firstly the Comsol Multiphysics model of 
the artificial artery reactor was created and saved as a Matlab file. In the second 
step this Matlab file was converted to a Matlab function. Its input was the 
flowrate in the lumen and its output was the profile of the oxygen concentration 
at the exit of the artificial artery at its outer wall during cell proliferation. In 
Matlab this profile is given as a matrix. Every element of this matrix and 
consequently every oxygen concentration corresponds to a cell concentration at 
the exit of the artificial artery at its outer wall. In the third step a Matlab program 
with a double loop structure gave the oxygen concentration at the exit of the 
artificial artery at its outer wall as a function of the cell concentration there and 
the flowrate in the lumen.
2.9 Statistical Analysis
One-way analysis of variance (ANOVA) was used for statistical analysis and it 
was performed with Minitab 13.2 (Minitab Ltd., Coventry, UK). Differences were 
considered significant when p values were <0.05. All data are presented as 
means ± standard error.
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Chapter 3 
Oxygen transfer and metabolism in the artificial artery
3.1 Introduction
The availability of large numbers of engineered tissues would offer significant 
benefits to the clinical management of surgery. In this scheme, bone marrow 
stromal cells will be isolated from bone marrow aspirates and seeded onto the 
polymer scaffold designed to facilitate and direct the growth of a fully functional 
tissue. During operation, nutrients are fed through the lumen, diffuse though the 
scaffold and are consumed by the cells; the products of cell respiration / 
metabolism would diffuse back to the lumen. No generic bioreactor design 
currently exists. There is a need to establish a robust, automated manufacturing 
process for the production of engineered tissues.
A critical issue of this tissue engineered construct is the supply of sufficient 
oxygen. Cells within the scaffold can be supplied with oxygen by diffusion so the 
oxygen concentration decreases between the lumen and the outer limit of the 
construct. Within any particular simulation of scaffold preparation it is assumed 
that the effective oxygen diffusivity in the scaffold remains constant and that the 
only way to control diffusion is by increasing the convective transport in the 
lumen.
Models of transport phenomena are developed in order to predict the fluid flow 
and oxygen mass transfer requirements of a prototype bioreactor for the 
production of artificial tissues. The use of windows of operation is demonstrated 
to accommodate design variables.
A “window of operation” can be characterized as an operational space 
determined by the system and process constraints and correlations governing a 
particular process or operation under consideration (Woodley and Titchener- 
Hooker, 1996). Windows of operation enable the engineer to visualize rapidly 
the variable region in which it is possible to achieve a specific level of
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performance and to investigate the effects of altering the key operating 
variables (Zhou and Titchener-Hooker, 1999).
3.2 Governing equations
A mathematical model was set up to describe oxygen mass transfer 
phenomena in the tubular reactor. This involved setting up equations to predict 
mass transfer during cell proliferation. The tubular reactor can be considered as 
having two key zones; the lumen, where oxygen and nutrients are supplied and 
the alginate matrix where cell proliferation occurs (Figure 3.1).
The mathematical model includes the following simplifying assumptions.
For the lumen: (i) the system is isothermal, (ii) the flow is laminar with a 
parabolic, developed velocity profile, (iii) no reaction occurs in the bulk of the 
lumen, (iv) the diffusion coefficient is a time-independent variable, (v) diffusion 
obeys Fick’s first law, (vi) the culture medium has water-like physical properties.
For the alginate matrix: (i) the suspension is homogenous, (ii) component 
consumption follows Monod kinetics, (iii) there is no convective transport, (iv) 
the effective diffusion coefficient is a time-independent variable and equal to the 
75% of its diffusion coefficient in culture medium, (v) diffusion obeys Fick’s first 
law, (vi) there is no cell differentiation.
The continuity equation for oxygen in cylindrical coordinates is expressed 
mathematically by the following equation:
dc dc .1 dc. dc _,1 d , dc. 1 d2C d2C.
—  + ^  —  + v9 ) + vz —  = D(~— ( r — ) + — — 2 + ^ j )  + q (3.1)
dt dr r  86 dz r  dr dr r  86 dz
where c is the concentration, r,Q,z are the radial, angular and axial coordinate
respectively, vr, vQ, vz are the radial, angular and axial velocity respectively, Dis
the diffusion constant and q is the production rate.
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dcThe term —  represents the accumulation rate per unit volume. The term
1 d . dc. 1 d c d c
 ( r — ) +  — — z- +  — ;
r  dr dr r  dO dz1
D ( - — ^ f )  represents the rate per unit volume of mass
laminar. Additionally, the term — — j  is zero because the artificial artery is
transfer by diffusion, the term vr -  + ve( - — ) + vz—  represents the rate per
' d r  e r  89 2 dz
unit volume of mass transfer by convection and the term q represents the
production rate per unit volume based on cell metabolism. It is negative for the
consumed substrate and positive for produced metabolite.
In the lumen, there is no chemical reaction so q is zero. The radial velocity vr 
and angular velocity vq are zero as well because the flow in the lumen is
1 d2c .
7~de'‘
rotationally symmetric due to its cylindrical shape. After the above
considerations the equation (3.1) gives for the lumen:
dclumen dclumen _ a  a f dclum9\  d2c lume\  n _ , + v 7 = Dlnman( ( r  ) + ------ 5— ),0<r<R 1 0<z<L (3.2)
d t  Z d Z  lumen\ r d r \  ^  > ^ 2  > ’ ^  V >
where c lumen, Dlumen is the concentration and diffusivity of the component n in the
lumen, R? is the radius of the lumen and L is the length of the artificial artery. In
1 d2c
the alginate matrix the terms — — =-, vr and vq are zero for the reasons that
r 2 892
have been mentioned for the lumen. Therefore, equation (3.1) simplifies to the 
following equation:
^ . - a l g i n a t e  ~ > ^ a \g in a te  h  o  p ,n a \ g in a t e  p ) 2 n a \g in a te
= Dal9,nate #■ <r  + ^ 4 - 5 - ) + q  (3-3)dt dz r  dr dr dz
where cal9/nafeand Dalg/nafe are the oxygen concentration and oxygen effective 
diffusivity in the alginate scaffold.
The boundary conditions are specified as follows. At r=0 there is radial 
symmetry because of the cylindrical shape of the artificial artery. This condition 
is expressed mathematically by the following equation:
p,  lu m e n
D l u m e n ^  = Q  ( 3  4 )
dr
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At r=R^ the molecular flux of oxygen per unit area in the lumen is equal to its 
molecular flux per unit area in the alginate-matrix as there is no accumulation at 
the interface. This statement is expressed mathematically as
p .r  lumen  ^ _ a lg / 'n a te
Q lu m e n  u ^ _______ __  £ ) a l g inate  _________  / o  c \
dr dr
g lu m e n  _  ^ a lg in a te  ^
In the lumen at the exit of the artificial artery, the diffusive flux for the 
component n which is perpendicular to this boundary is zero. This statement 
can be described by the following equation:
1 d fir lumen
Dlumen( ( r  )) = 0, 0<r<Ru z=L (3.7)
r  dr dr
At r=R2, the molecular flux of component n per unit area out of the reactor is 
zero. This can be stated by the following equation:
alginate
D8'9inate   = 0  (3.8)
dr
Finally, in the alginate matrix at the end of reactor the molecular flux of 
component n per unit area is zero. Stated mathematically,
^ a lg in a te
Da,g^ e    = 0 (3.9)
dz
The kinetic expression for oxygen considers consumption for proliferation and 
maintenance and it is described by the following equation.
1 r lY
R=-— -—-+mX, (3.10)
Y d t1 X/n U l
where is yield coefficient of cell concentration on the concentration of the
component n, X  is the cell concentration, m is the specific maintenance rate.The 
kinetic term for consumption due to proliferation is given by the following 
expression:
1 dX 
Y x / n  dt
and the kinetic term for consumption due to maintenance by the expression: 
mX
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The cell proliferation cannot continue indefinitely even if there is not substrate 
depletion or metabolite inhibition. Instead, the cell concentration will reach a 
maximum value due to space limitations within the alginate construct. The 
logistic equation has been chosen for phenomenological description of the cell 
proliferation. In the specific case it assumes an inhibition in proliferation 
proportional to the square of the cell concentration. The mathematical definition 
of the logistic equation is given by the following equation 
dX X
=fJX ( 1 - - — ) (3.11)
MAX
where f j  is the specific proliferation rate and X Ma x  is the maximum cell 
concentration achievable.
It is possible that the proliferation is oxygen limited. Such a dependency of the 
specific proliferation rate to the concentrations of limited oxygen can be 
described by Monod kinetics as follows:
lJ ~ l J MAX . (3.12)
k m + c
where i j Ma x  is the maximum specific proliferation rate and k M is the half 
saturation constant of oxygen. The equation (3.10) becomes
(3'13)
K M  C  MAX
where qmax is the maximum specific oxygen uptake rate and is equal to the 
maximum specific proliferation rate divided by the yield coefficient of cell 
concentration on the oxygen concentration. The specific maintenance rate is 
assumed to be equal to 1 0 % of the specific oxygen uptake rate.
The system of the above equations was solved by using the finite element 
method with the commercial software package Comsol Multiphysics 3.3a 
(Comsol Ltd., Cambridge UK). One half of the system was simulated due to 
symmetry at the tubular reactor’s centreline. It was chosen to use the transient 
non-linear solver as the proliferation rate is a nonlinear term. The convergence 
was tested by refining the mesh up to 1800 elements. Each simulation took 
around 4 h on a Pentium IV PC with a 3 GHz processor and 2 Gb memory.
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3.3 Windows of operation
The use of windows of operation has been chosen to describe the operation of 
the tissue-engineered construct. This kind of technique visualizes the key 
parameters for the design of the reactor in a clear and rapid way. The sensitivity 
of the operation can be defined by how the area enclosed by the window of 
operation alters by changing the values of the key parameters. This area can 
even shrink to a point for a singular, optimal and design solution. The window of 
operation approach gives the opportunity to someone to conceive the 
engineering evaluation of such a complex system without the need of having 
advanced mathematical knowledge.
The windows of operation were set up for cell concentration against flow rate in 
the lumen. They define the area in order to simulate coronary artery function. A 
short analysis, which explains the way to set up the windows of operation, is 
given below.
Oxygen in the scaffold is being provided by diffusion (convective flow is 
assumed negligible). The only way to enhance diffusion in the scaffold is by 
increasing the flow rate in the lumen. The higher the flow rate is, the lower the 
oxygen gradient in the lumen will be. Thus, oxygen concentration at the 
interface between lumen and scaffold will be almost equal to the oxygen 
concentration at the entrance of the reactor. As a consequence, all the cells 
along the reactor will have almost equal access to it and as a result similar 
metabolic behaviour.
The upper limit of oxygen concentration is identified at the entrance of the 
reactor in the interface between lumen and alginate matrix and the lower limit is 
identified in the exit of the reactor. The difference between the upper and the 
lower limit is high then the creation of microenvironments of varying 
characteristics is very possible. This problem can be avoided by arranging the 
oxygen concentration to be at that level, which exists in the bone marrow and it 
has been reported to be 52.0 ± 14.5 mmHg (0.069 ± 0.020 mM) (Ishikawa and 
Ito, 1988). By solving the mathematical model a correlation between cell
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concentration and flow rate can be achieved as the values for the lowest and 
highest oxygen concentration are known. This correlation is not enough to set 
up the window of operation. It needs a second figure to visualize the cell 
concentration constraints. The upper limit of this range is defined by the 
maximum cell concentration in a coronary artery, which is 262x106 cells mL' 1 
(Dahl et al, 2007; Niklason et al., 1999). The lower one is defined by the 
minimum cell concentration that has to be achieved in a tissue engineered 
coronary artery to lead to a physiological coronary artery when it will be 
implanted in a patient. This limit is equal to 116x106 cells mL' 1 (Dahl et al, 2007; 
Niklason et al., 1999). The overlap of the two figures gives the window of 
operation.
3.4 Results
Figure 3.3 shows the cell concentration and the oxygen concentration in the 
alginate at the exit of the artificial artery at its outer wall as a function of the 
culture time for a representative flow rate. Initially, the oxygen concentration 
decreases because of the high metabolic activity of the proliferating cells. It 
increases when the cells start entering the less metabolically demanding 
maintenance phase. The oxygen concentration is minimum when the cell 
concentration in the construct reaches the value of 130x106 cells mL'1.
The window of operation, which describes the effect of cell concentration in the 
scaffold, has been set up for an initial cell concentration of 10x106 cells mL' 1 
and a final one of 116x106 cells mL'1. The oxygen diffusivity in the tissue- 
engineered construct is 2.25x10'9m2 s' 1 (Table 3.1), its length is 0.33 m, its wall 
thickness is 300 pm and the specific oxygen uptake rate is 0.11x10' 18 mol cell' 1 
s'1. The procedure to set up a window of operation is described below (Figure 
3.4).
In the Figure 3.4A the light shaded area indicates the region where it is possible 
to provide sufficient oxygen to maintain it above the minimum prescribed level. 
The unshaded area indicates the region where is not possible to supply oxygen
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at a sufficient rate to support cell proliferation while maintain oxygen level above 
the prescribed minimum. So the bioreactor has to operate in the shaded area.
In Figure 3.4B the light shaded area defines the cell concentration constraint. The 
reactor has to operate in the shaded area, which corresponds to concentrations 
higher than 116x106 cells mL"1 and lower than 262x106 cells mL"1. By combining 
the two last figures Figure 3.4C is obtained which also defines the window of 
operation as the dark-shaded region. From this figure it can be concluded that 
there is a critical flow rate in the lumen below which it is not possible to maintain 
proliferating cells at an acceptable concentration. Concerning the non-shaded 
area below the concentration of 116x106 cells mL"1, it has to be mentioned that 
not only the concentration range has larger value, but the cell concentration is 
lower than 116x106 cells mL'1. In the light-shaded area below the cell 
concentration of 116x106 cells mL"1 the range is acceptable, but the cell 
concentration is lower than 116x106 cells mL"1. Above the cell concentration of 
262x10s cells mL"1, the cell concentration is higher than the maximum cell 
concentration in a coronary artery.
The effect of wall thickness, length and effective oxygen diffusivity in the area 
which is defined by a window of operation is presented below. For every 
window of operation the minimum required cell concentration is 116x10s cells 
mL"1 and the specific oxygen uptake rate is 0.11x10"18 mol cell"1 s"1 (Figure 3.5). 
Each variable was changing by 10% and the effect on the critical flow rate in 
particular was addressed.
It can be concluded that the critical flow rate is more sensitive to changes in the 
tube wall thickness than in the length and effective oxygen diffusivity. It can be 
increased either by increasing the feed rate in the reactor or by increasing the 
recycle rate in the artificial artery. The former will lead to the increased usage of 
fresh culture medium which will raise the operational cost of the reactor and the 
latter will lead in the recycle of the waste products of the cells which will inhibit 
their metabolism and consequently it will increase the time for the artery to be 
ready for implantation. Later on a more detailed discussion of the acceptable 
flow rates is given.
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The previous windows of operation have been set up based on the assumption 
that there is no error in the values of specific oxygen uptake rate, wall thickness, 
length and diffusivity coefficient. Those errors have to be taken into account in 
order to achieve a functional operation of the tissue engineered construct. The 
worst case scenario could be when there is a positive error in the values of cell 
concentration, length and wall thickness of the scaffold and a negative one in 
the value of the oxygen diffusivity.
The effect of a positive error in the above variables can be eliminated by 
increasing the flow rate in the lumen. Concerning the diffusivity, a lower value 
decreases the rate of diffusion in the scaffold according to the first Fick’s law. A 
way to re-establish the diffusional flux is to increase the concentration gradient 
in the scaffold by increasing the concentration at the interface between scaffold 
and lumen. This can be achieved by decreasing the concentration gradient 
along the axial direction of the construct through an increase of the flow rate in 
the lumen.
As the purpose of this chapter is not to give quantitative solutions to specific 
values of variables, realistic values for the errors in the variables have been 
chosen. The above window of operation was set up again assuming a +5% 
error for wall thickness and specific oxygen uptake rate, a +1 % for the length, 
and a negative error -5% for the oxygen diffusivity (Figure 3.6). If the errors are 
taken account to the set up of the window of operation the flow rate to sustain a 
cell concentration 116x106 cells ml_‘ 1 has to rise from 3600 mL h' 1 to 8100 mL 
s ' 1.
The effect of geometry and oxygen diffusivity of the alginate matrix on the 
critical flow rate is presented in Figure 3.7. The critical flow rate is expressed as 
the ratio of the critical flow rate to the one for the initial setting as it is defined in 
Figure 3.4. This interaction is visualized for the case of the original setting with 
no errors in the mentioned variables and for the case of the robust one (Figure 
3.7).
8 6
In Figure 3.8 the effect of the mean oxygen concentration and critical flow rate 
on the range of the oxygen concentration in the artificial artery is explored. The 
range is expressed as deviation of the maximum (entrance of the artificial 
artery) and minimum oxygen concentration (exit of the artificial artery at the 
outer limit of the alginate). Assuming no changes in the metabolic behaviour of 
the cells for the range of the oxygen concentrations studied it can be concluded 
that the higher the critical flow rate the smaller the difference between the 
maximum and minimum concentration in the artificial artery will be. Use as an 
example the mean oxygen concentration of 0.07 mM. When the critical flow rate 
is low and specifically 470 mL h"1, the minimum oxygen concentration, the 
maximum oxygen concentration and their difference is 0.039, 0.101 and 0.062 
respectively. For medium values of critical flow rate and specifically 1500 mL 
s‘ 1 the minimum oxygen concentration, the maximum oxygen concentration and 
their difference is 0.046, 0.095 and 0.049 mM respectively. Similarly, for high 
values of critical velocity and specifically 7000 mL h' 1 the minimum oxygen 
concentration, the maximum oxygen concentration and their difference is 0.053, 
0.088 and 0.035 mM.
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Table 3.1: Parameters used in Chapter 3
Parameter Value Unit Reference
lum en radius (R i ) 1.7x1 O'3 m
outer radius (R 2 ) 2x1 O'3 m
axial length (L) 0 .33 m
initial cell concentration ( Cinitiai) 10x106 cells m L '1
cell concentration of native coronary artery
(Xmax)
2 6 2 x 1 06 cells m L '1 Dahl et al., 2 007
cell concentration of engineered coronary  
artery (X eng)
116x106 cells m L '1 Dahl et al., 2 007
specific oxygen uptake rate (qmax) 10.6x1 O'18 mol ce ll'1 s '1
Peng and Palsson, 
1996
oxygen half-saturation constant {Kox) 10 '3 m M
Peng and Palsson, 
1996
oxygen diffusivity in the lum en (DoXmen) 3x1 O’9 m 2 -1 m s Palsson et al., 2 0 0 3
Afead
feed pump
B
direction 
of the flow
cells + alginate
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recycle pump
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waste
Figure 3.1: Prototype bioreactor for the production of artificial arteries. The 
bioreactor operates in recycle mode with feed and bleed of medium (Figure 
3.1 A). The artificial artery is composed of two concentric cylindrical zones 
corresponding to two regions: the lumen and the alginate matrix. The oxygen 
and other nutrients are supplied by flow through the lumen, diffuse through the 
alginate matrix and are consumed by the cells (Figure 3.1B).
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oxygen concentration (mM) 
■ 0.088
0.080
Figure 3.2: The oxygen distribution has been modelled for a tubular bioreactor 
of length 0.33 m, wall thickness 300 pm and inner diameter 3.4 mm. The 
oxygen effective diffusivity in the scaffold is assumed to be 2.25x1 O' 9 m2 s'1, the 
flow rate in the lumen is 3600 mL h' 1 and the maximum and minimum oxygen 
concentration are 0.049 mM and 0.088 mM respectively. The cell concentration 
is 116x106 cells mL' 1 with a specific oxygen uptake rate equal to 0.11x10' 18 mol 
cell' 1 s'1.
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Figure 3.3: Cell concentration and oxygen concentration in the alginate at the 
exit of the artificial artery at its outer wall as a function of the culture time for a 
representative flow rate (3600 mL h'1).
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Figure 3.4: Development of a window of operation for cell growth in a scaffold. 
Figure 3.4A: Shaded region is that area where the oxygen transfer rate 
available exceeds the oxygen transfer rate required to support cell growth for a 
range of cell concentrations. In this case the conditions are defined for tube of 
length 0.33 m, wall thickness 300 pm and inner diameter 3.4 mm. The oxygen 
diffusivity in the scaffold is assumed to be 2.25x1 O' 9 m2 sec' 1 and the maximum 
and minimum oxygen concentrations are 0.088 mM and 0.049 mM respectively. 
The specific oxygen uptake rate of the cells is 0.11x10' 18 mol cell' 1 s '1. Oxygen 
transfer is via flow of nutrient solution over the internal surface of the tube at the 
average velocity given.
Figure 3.4B: Shaded region is that area where cell concentration is considered 
to be acceptable for tissue engineering purposes. The lower limit is defined by 
the value of 116x106 cells mL'1; the upper limit is defined by the value of
262x106 cells mL'1.
Figure 3.4C: The overlap of figures 3A and 3B gives a window of operation 
where an acceptable concentration of cells is achieved without exposing them 
to oxygen concentrations above or below specified values.
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Figure 3.5: Analysis of window of operation for feasibility of cell-scaffold 
preparation as determined by the critical flow rate needed for sufficient oxygen 
supply.
Figure 3.5A: Conditions as defined in Figure 2 - critical flow rate 3600 mL h’1. 
Figure 3.5B: Effect of 10% decrease in the effective oxygen diffusivity of the 
alginate-matrix (2.25x1 O' 9 to 1.99x1 O' 9 m2 s'1) - new critical flow rate 3750 mL
h'1.
Figure 3.5C: Effect of 10% increase in tube length (0.33 to 0.36 m) -  new 
critical flow rate 4800 mL h'1.
Figure 3.5D: Effect of 10% increase in tube wall thickness (3 to 3.30x1 O' 3 mm) - 
new critical flow rate 8050 mL h'1.
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Figure 3.6: Impact of errors in variables in the window of operation.
Figure 3.6A: Original window of operation with conditions as defined in Figure 
3.1 - critical average velocity 3600 mL h"1.
Figure 3.6B: Robust operating window under the effect of +5% error for wall 
thickness and specific oxygen uptake rate, a +1% for the length, and -5% for 
the oxygen diffusivity-new critical flow rate 8100 mL h'1.
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Figure 3.7: Effect of geometry and oxygen diffusivity on the dimensionless 
critical flow rate (ratio of the critical flow rate to the initial one as it is defined in 
Figure 3.4) for the original setting (—) (as defined in Figure 3.4) and for the 
robust setting (—) (as defined in Figure 3.6).
Figure 3.7A: Effect of wall thickness.
Figure 3.7B: Effect of length.
Figure 3.7C: Effect of effective oxygen diffusivity.
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Figure 3.8: Effect of the mean oxygen concentration and critical average 
velocity on the range of the oxygen concentration (values shown on 
relationship) in the artificial artery. This range is expressed as deviation around 
the mean oxygen concentration with the upper and lower limits defined by the 
maximum (entrance of the artificial artery) and minimum oxygen concentration 
(exit of the artificial artery at the outer limit of the alginate) respectively. It has 
been assumed that the metabolic behaviour of the cells does not change in the 
range of the oxygen concentrations studied. It can be concluded that the higher 
the oxygen acceptable mean concentration or critical flow rate the smaller the 
difference between the maximum and minimum concentration in the artificial 
artery will be.
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Chapter 4
Substrate and metabolite transfer and metabolism in 
the artificial artery
4.1 Introduction
The bioreactor for the production of artificial arteries operates in recycle mode 
with feed and bleed of medium. The oxygen and other nutrients are supplied by 
flow through the lumen, diffuse through the alginate matrix and are consumed 
by the mesenschymal stem cells. In the previous chapter a mathematical model 
was developed in order to predict the effect of the cell concentration, tube 
geometry, alginate effective diffusivity and oxygen concentration levels on the 
oxygen mass transfer in the alginate. Similar studies for other substrates have 
not been conducted because their mass transfer rates in alginate are 
considerably higher than that of the oxygen as a consequence of their higher 
concentration in the culture medium. However, the feed and recycle rate of the 
culture medium can influence the concentrations of substrates and metabolites 
and consequently the cell proliferation.
In this chapter a theoretical analysis has been conducted to predict the effect of 
feed and recycle rate on the substrate and metabolite concentration profiles and 
cell proliferation in the artificial artery. Glucose, glutamine and oxygen have 
been chosen as the main substrates and lactate and ammonia as the main 
metabolites. For simplicity reasons, the engineering analysis will be presented 
by giving the mass balance, mass transfer and kinetic expressions for the 
component n , instead of giving these expressions for every substrate and 
metabolite separately.
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4.2 Mathematical model to describe substrate and metabolite
concentration profiles in the artificial artery
4.2.1 Mass balance expressions for the recycle loop
The feed rate in the bioreactor is equal to its waste rate assuming equal 
densities at its entrance and exit. The overall material balance for the bioreactor 
is expressed mathematically as:
F =W , (4.1)
where F, Ware the feed and waste rate respectively.
The input rate to the artificial artery is equal to the sum of the feed rate to the 
bioreactor and the recycle rate assuming constant medium density. Thus the 
overall material balance expression between the entrance of the bioreactor and 
the entrance of the artificial artery states that
where R, V are the recycle and input rate to the artificial artery respectively.
The influx of the component n in the artificial artery is equal to the sum of its 
feed flux in the bioreactor and its recycle flux. This is expressed mathematically 
as:
where cFn, cRtn, cA,n are the feed, the recycle and the inlet concentration to the 
artificial artery respectively. Additionally, the output rate from the artificial artery 
is equal to the sum of the recycle and waste rate of the bioreactor assuming 
constant medium density. Accordingly, the outflux of the component n from the 
artificial artery is equal to its recycle flux and its waste flux from the bioreactor
Mathematically, the above statements are expressed as:
V=R+W, (4.4)
where W, cw,n are the waste rate and concentration of the component n in waste 
stream respectively.
F+R=V, (4.2)
(4.3)
VcA =RcRn+WcWi„ (4.5)
98
4.2.2 Mass transfer expressions in the artificial artery
The artificial artery can be considered as having two subdomains; the lumen 
and the alginate matrix (Figure 4.1). The artificial artery has a cylindrical shape 
so it is possible to reduce the problem from 3D to a 2D axi-symmetric problem. 
The mathematical equations which describe the mass transfer as well as the 
consumption of substrates and production of metabolites in the artificial artery 
are based on the following assumptions:
For the lumen: (i) the system is isothermal, (ii) the flow is laminar with a 
parabolic, developed velocity profile, (iii) no reaction occurs in the bulk of the 
lumen, (iv) the diffusion coefficient is a time-independent variable, (v) diffusion 
obeys Fick’s first law, (vi) the culture medium has water-like physical properties.
For the alginate matrix: (i) the suspension is homogenous, (ii) component 
consumption follows Monod kinetics, (iii) there is no convective transport, (iv) 
the effective diffusion coefficient of component a? is a time-independent variable 
and equal to the 75% of its diffusion coefficient in culture medium, (v) diffusion 
obeys Fick’s first law, (vi) there is no cell differentiation.
The continuity equation for the component n in cylindrical coordinates is 
expressed mathematically by the following equation:
dc dc .1 dc. dc _,1 d , d C .  1 d2C d2C. ..— + v -  + » /,(-— ) + \ / —  = D ( - — (r — ) + ^ — 2 + - T ) + q (4.6)
dt dr r  DO dz r  dr dr r  dO dz
where c is the concentration, r,Q,z are the radial, angular and axial coordinate
respectively, vr, v©, vz are the radial, angular and axial velocity respectively, D is
the diffusion constant and q is the production rate.
dcThe term —  represents the accumulation rate per unit volume. The term 
dt
1 d dc 1 d2C d2CD(------- ( r — ) + —5-— r  + — ?) represents the rate per unit volume of mass
r  dr dr r  dQ dz
dc 1 dc dc transfer by diffusion, the term vr —  + vA  ) + v_ —  represents the rate per
' d r  e r d 0  2 dz
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unit volume of mass transfer by convection and the term q represents the 
production rate per unit volume based on cell metabolism. It is negative for the 
consumed substrate and positive for produced metabolite.
In the lumen, there is no chemical reaction so q is zero. The radial velocity vr 
and angular velocity vQ are zero as well because the flow in the lumen is
1 d2c
laminar. Additionally, the term ~ j ~ ^ 2  is zero because the artificial artery is
rotationally symmetric due to its cylindrical shape. After the above 
considerations the equation (4.6) gives for the lumen:
rsn lumen psn lumen a  ^  lumen p Z ^ lu m e n
-  = D’r nC - ^ ( r  ) + ^ | v - ) , 0<r<R l, 0<z<L (4.7)
dt dz r  dr dr dz
where c'“men, D'umen is the concentration and diffusivity of the component n in the
lumen, R1 is the radius of the lumen and L is the length of the artificial artery. In
1 d2c
the alginate matrix the terms — — =-, vr and ve are zero for the reasons that
r 2 802
have been mentioned for the lumen. Equation (4.6) simplifies to the following 
equation:
d o n a t e  5 c alg«.ale 1 d  , d d ^ < n a l e
 2---------------+ V   0.--------------------------------------  / f -------- n \  + ---------- n_  --------- \  +  „  4 . 8
dt 1 dz r  dr dr dz2
where can'3'na,eand Dal9'nate are the oxygen concentration and oxygen effective 
diffusivity in the alginate scaffold.
The boundary conditions are specified as follows. At n=0 there is radial 
symmetry because of the cylindrical shape of the artificial artery. This condition 
is expressed mathematically by the following equation:
^  lumen
D l u m e n ^ n  =q (4 .9)
dr
At n=R1t the molecular flux of component n per unit area in the lumen is equal 
to its molecular flux per unit area in the alginate-matrix as there is no 
accumulation at the interface. This statement is expressed mathematically as
rsr  lum en a \g inate
j j lu m e n  -  Q a \g in a te  u u n________ (4 q )
dr " dr
1 0 0
£ lumen _  ^a \g in a te  ( 4 1 1 )
In the lumen at the exit of the artificial artery, the diffusive flux for the 
component n which is perpendicular to this boundary is zero. This statement 
can be described by the following equation:
1 r> pjrlumen
D ,um e n ( _ I | L ( r £ L ) )  = 0 , 0<r<Rh z-L  (4.12)
r  dr dr
At r=R2, the molecular flux of component n per unit area out of the reactor is 
zero. This can be stated by the following equation:
p .r  alginate
D alg i n a t e ^ n  =  q  ( 4  1 3 )
dr
Finally, in the alginate matrix at the end of reactor the molecular flux of 
component n per unit area is zero. Stated mathematically,
p,2  r  alginate
p a l g inate Q  O  _  Q  ( 4  1 4 )
dz
4.2.4 Species kinetic expression
The kinetic expression for component n considers consumption for proliferation 
and maintenance and it is described by the following equation.
1 HY
R=—— ——+mX, (4.15)
Y d t1 X/n UL
where Yx/n is yield coefficient of cell concentration on the concentration of the
component n, X  is the cell concentration, m is the specific maintenance rate.
The kinetic term for consumption due to proliferation is given by the following
expression:
1 dX 
y»n dt
and the kinetic term for consumption due to maintenance by the expression: 
mX
The cell proliferation cannot continue indefinitely even if there is not substrate 
depletion or metabolite inhibition. Instead, the cell concentration will reach a
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maximum value due to space limitations within the alginate construct. The 
logistic equation has been chosen for phenomenological description of the cell 
proliferation. The mathematical definition of the logistic equation is given by the 
following equation 
d X  X
fL - =tjX (1 --— ) (4.16)
MAX
where p is the specific proliferation rate and X Ma x  is the maximum cell 
concentration achievable.
It is possible that the proliferation is substrate limited and simultaneously there 
are inhibitions caused by high metabolite concentrations. Such a dependency of 
the specific proliferation rate to the concentrations of limited substrates and 
inhibited metabolites can be described by Monod kinetics as follows:
^ Y ^ - T ^ — k I c k V ~  (4 ' 17)n n n+1 n+1 ^  p C p ^ p + 1  L p+1
where j jm a x  is the maximum specific proliferation rate and k n , k n+1 are the half 
saturation constants of the substrates n and n+1 and Kp,Kp+1 are the inhibition 
constants of the metabolites p and p+1 (Bailey and Ollis, 1986).
The equation (4.15) becomes
r=o /_£>------ -----------------------1 s ^ _ _ )X ( i— ^ —)+mX (4.18)wmax./ii . . K + r K + r  X
n n K n+1 C n+1 ° p  *  p+1 L p+1 * M A X
where qmax is the maximum specific consumption / production rate of 
component n and is equal to the maximum specific proliferation rate divided by 
the yield coefficient of cell concentration on the concentration of the component 
n. The specific maintenance rate is assumed to be equal to 10% of the specific 
consumption/production rate of component n.
4.2.5 Numerical method
The system of the above equations was solved by the finite element method. 
The mathematical package which was used was Comsol Multiphysics 3.3 using
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two dimensional axial symmetry. It was chosen to use the transient non-linear 
solver as the proliferation rate is a nonlinear term. The convergence was tested 
by refining the mesh up to 3600 elements. The concentration profiles were 
obtained by solving the system of the above equations for different values of 
feed and recycle rate. Specifically, the Comsol model was connected to a 
Matlab loop structure which was providing the solution of the governing 
equations of the bioreactor in the range of 1-5 mL h' 1 for the feed rate and 
1000-6000 mL h' 1 for the recycle rate. The simulation took 95 h on a Pentium 
IV PC with a 3 GHz processor and 2 Gb memory.
4.3 Results and conclusions
The bioreactor operates in recycle mode with feed and bleed of medium. The 
culture medium is diffused in alginate through the lumen where the substrates 
are consumed by the mesenchymal stem cells producing metabolites. The 
culture medium is oxygenated via a gas exchanger located in the recycle loop. 
The initial cell concentration has been set to 10x106 cells mL"1 and the artificial 
artery is cultured in the bioreactor for 90 days. The critical cell concentration 
which has to be reached is 116x106 cells mL'1. This value is the one of 
constructs which has been used as tissue-engineered arteries (Dahl et al, 2007; 
Niklason et al., 1999).
Figure 4.2 gives the minimum required glucose, glutamine and oxygen as well 
as the maximum resulting lactate and ammonia concentration in the artificial 
artery during the proliferation of undifferentiated bone marrow mesenchymal 
stem cells immobilized in alginate as a function of feed and recycle rate. The 
minimum substrate and the maximum metabolite concentration exist at the exit 
of the artificial artery at its outer wall. The shaded area corresponds to 
combinations of feed and recycle rates which give after 90 days of culture a 
construct with a cell concentration below the critical one.
Glucose and glutamine concentration increase and lactate and ammonia 
concentration decrease by increasing the feed rate (Figure 4.2). High substrate
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concentrations favour cell proliferation therefore the higher the feed rate is the 
higher the cell concentration in the artificial artery will be (Figure 4.3).
A high recycle rate enhances the aeration of the artificial artery increasing the 
concentration of lactate and ammonia and decreasing the concentration of the 
glucose and glutamine (Figure 4.2). This can be explained from the fact that at 
high recycle rates the medium is passing through the artificial artery more times 
than at low ones. Thus more lactate and ammonia is produced and more 
glucose and glutamine is consumed after every pass of the recycled medium. 
Consequently, this will inhibit the cell proliferation resulting in constructs with a 
lower cell concentration (Figure 4.3).
Oxygen is provided through the oxygenator in the recycle loop where the flow 
rate is around two orders of magnitude higher than the flow rate of the fresh 
culture medium. Thus, the oxygen of the feed stream does not affect its 
concentration level in the artificial artery. At low feed rates oxygen concentration 
depends not only on the recycle rate but also on the feed rate. It is a result of 
the low glucose and glutamine supply which slows down the cell proliferation 
rate and consequently the oxygen uptake rate. At high feed rates the 
dependency of the oxygen concentration on the recycle rate prevails against its 
dependency on the feed rate. Therefore at high feed rates oxygen concentration 
is a function of the recycle rate only.
Figure 4.4 gives the time which is needed in order to obtain a construct with the 
critical cell concentration. The higher the feed rate is the sooner the construct 
will obtain the required cell concentration. This can be explained from the fact 
that at high feed rates there is excess of substrates therefore the cells are 
metabolically more active proliferating at a higher rate. On the opposite, this 
time increases as the recycle rate increases. As mentioned above high recycle 
rates increase the concentration of the metabolites. This increase inhibits cell 
proliferation and consequently increases the time for the cell population to reach 
a specific concentration.
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The concentration of the substrates decrease and the concentration of the 
metabolites increase in a direction towards the exit of the artificial artery as a 
result of the substrate consumption and metabolite production by the cells. 
Therefore, the cell concentration is lower in areas close to the exit of the 
artificial artery than in areas close to its entrance as a result of substrate 
limitation and metabolite inhibition. Figure 4.5 gives an indication of the 
homogeneity of cell concentration in alginate as a function of the feed and 
recycle rate. The homogeneity is expressed as the ratio of the cell 
concentration at the exit of artificial artery at its outer wall to the cell 
concentration at its entrance at its inner wall. It was calculated when the cell 
concentration at the exit of the artificial artery at its outer wall reaches the 
critical one (116x106 cells mL'1). It is relatively uniform for all the combinations 
of feed and recycle rates which can give within 90 days a construct with a cell 
concentration of a tissue-engineered artificial artery. Therefore, it can be 
concluded that there is sufficient substrate supply and efficient metabolite 
removal to produce an artificial artery with homogenous cell concentration even 
when the feed and the recycle rate are relatively low.
Figure 4.6 shows the substrate and metabolite concentrations in the alginate at 
the exit of the artificial artery at its outer wall as a function of the culture time for 
representative values of feed and recycle rate. Initially, the substrate 
concentrations decrease as the cells start proliferating but then they start 
increasing as a fraction of the cells enters the less metabolically demanding 
maintenance phase lowering the overall substrate uptake from the cells. The 
substrate concentrations stabilize when all cells have entered the maintenance 
phase. There is a sharp decrease in substrate concentrations early at the 
beginning of the culture which lasts till the priming of the reactor with fresh 
medium.
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Table 4.1: Parameters used in Chapter 4
Parameter Value Unit Reference
lum en radius (R i ) 1.7x1 O'3 m
outer radius (R 2) 2x1 O'3 m
axial length (L) 0 .3 3 m
initial cell concentration (Q n m a i) 10x106 cells m L'1
cell concentration of native coronary artery
(X m a x )
2 6 2 x 1 06 cells m L '1 Dahl et al., 2007
cell concentration of eng ineered  coronary  
artery (X eng )
116x106 cells m L '1 Dahl et al., 2007
glucose concentration in fresh m edium
( C g/ucO )
5 .5 5 m M m anufacturer’s data
glutam ine concentration in fresh m edium
( C g lu tO )
2 mM m anufacturer’s data
specific oxygen uptake rate (qmax) 10.6x1 O'18 mol cell'1 s '1
Peng and Palsson, 
1996
yield of g lucose from oxygen ( Y g iu/o x ) 1 mol m ol'1 Zeng  et al., 1998
yield of glucose from g lutam ine ( Y giu/ g in ) 0 .3 5 mol mol"1 Zeng et al., 1998
yield of lactate from glucose ( Y iac/g iu ) 1.3 mol m ol'1 Zhao  et al., 2005
yield of glutam ine from am m onia ( Y g in/a m m ) 0 .8 0 mol m ol'1 X ie  and W ang, 1994
glucose half-saturation constant (K g iu) 0 .7 5 m M Xie and W ang, 1994
lactate inhibition constant (K/ac) 60 m M assum ed
glutam ine half-saturation constant ( K gm ) 0 .1 5 m M Xie and W ang, 1994
am m onia inhibition constant (K a m m ) 2 mM assum ed
oxygen half-saturation constant (Kox) 10 '3 mM
Peng and Palsson, 
1996
glutam ine chem ical decom position rate  
constant ( K g iu td ec )
1.33x1 O'6 s"1 Glacken et al., 1986
glucose diffusivity in the lu m e n ( D g ™ n ) 0 .9 2 x 1 0 ‘9 m2 s '1 Sengers et al., 2005
lactate diffusivity in the  lum en (Djg^en) 1.4x1 O'9 2 -1 m s Sengers et al., 2 005
glutam ine diffusivity in the lum en (Dg™ten) 3x1 O'9 2 -1 m s Perry and G reen, 1984
am m onia diffusivity in the  lum en ( D g ^ n ) 3x1 O'9 2 -1 m s Perry and G reen, 1984
oxygen diffusivity in the lum en (Dg™en) 3x10 9 2 -1 m s Palsson et al., 2 003
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Figure 4.1: The bioreactor operates in recycle mode with feed and bleed of 
medium. The feed flow rate is in the order of 1-5 mL h' 1 and the recycle flow rate 
is in the order of 1000-6000 mL h'1. The artificial artery is composed of two 
concentric cylindrical zones corresponding to two regions: the lumen and the 
alginate matrix with the adult mesenchymal stem cells. The culture medium is 
diffused in alginate through the lumen where the substrates are consumed by the 
cells producing metabolites. The culture medium is oxygenated via a gas 
exchanger located in the recycle loop.
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Figure 4.2: Minimum substrate and maximum metabolite concentration 
expressed in mM as a function of the feed and recycle rate. The minimum 
substrate and maximum metabolite concentration exists at the exit of the 
artificial artery at its outer wall. The bioreactor for the production of artificial 
arteries operates in recycle mode with feed and bleed of medium. Alginate has 
been used as scaffold and it has been seeded initially with 10x106 cells mL' 1 
mesenchymal stem cells. The shaded area corresponds to combinations of feed 
and recycle rates which give after 90 days of culture a construct with a cell 
concentration below the critical one (116x106 cells mL'1).
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Figure 4.3: Cell concentration (in 106 cells mL"1) at the exit of the artificial artery 
at its outer wall after 90 days of culture as a function of feed and recycle rate. 
The bioreactor for the production of artificial arteries operates in recycle mode 
with feed and bleed of medium. Alginate has been used as scaffold and it has 
been seeded initially with 10x106 cells mL' 1 mesenchymal stem cells.
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Figure 4.4: Time (in days) which is needed in order to obtain a tissue- 
engineered artery. This artery should have a cell concentration above the 
critical one (116x106 cells mL'1) at its exit at its outer limit. The bioreactor for the 
production of artificial arteries operates in recycle mode with feed and bleed of 
medium. Alginate has been used as scaffold and it has been seeded initially 
with 10x106 cells mL' 1 mesenchymal stem cells.
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Figure 4.5: Homogeneity of the cell concentration in the artificial artery as a 
function of the feed and recycle rate when the cell concentration at the exit of 
the artificial artery at its outer wall reaches the critical cell concentration 
(116x106 cells mL'1). The homogeneity is expressed as the ratio of the cell 
concentration at the exit of the artificial artery at its outer wall to the cell 
concentration at its entrance at its inner wall. The shaded area corresponds to 
combinations of feed and recycle rates which give a construct with a cell 
concentration below the critical one.
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Figure 4.6: Minimum substrate and maximum metabolite concentration as a 
function of the culture time for a representative feed rate of 5 mL h' 1 and a 
representative recycle rate of 30 mL h'1. The minimum substrate and maximum 
metabolite concentration exists at the exit of the artificial artery at its outer wall. 
The bioreactor for the production of artificial arteries operates in recycle mode 
with feed and bleed of medium. Alginate has been used as scaffold and it has 
been seeded initially with 10x106 cells mL' 1 mesenchymal stem cells.
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5. Oxygen transfer and metabolism in alginate
5.1 Introduction
Scale-down experiments at 7 pL level were designed to measure oxygen 
gradients in an alginate gel / cell mix and hence evaluate the oxygen effective 
diffusivity and the oxygen uptake rate of human adult cells. In this way amounts 
of human cells in an alginate construct can be used to measure experimentally 
parameters which will define the windows of operation.
Alginate constructs with immobilized human dermal fibroblasts were formed in 
customized 24-well plates with integrated oxygen and pH sensor spots. Their 
volume was 7 pL and their shape was cylindrical with a diameter of 3 mm and a 
height of 1 mm. Human fibroblasts were selected as a cell source due to their 
availability and ease of handling (Alberts et al, 1994). Additionally, alginate 
constructs with and without cells were used to study the effect of immobilized 
cells on the oxygen effective diffusivity.
The fibroblasts were immobilized in alginate at the concentration of 7x106 cells 
mL' 1 and cultured in 1 mL of static IMDM medium. Oxygen transfer occurs from 
the gas phase of the well to the alginate construct by diffusion where it was 
consumed by the cells.
Oxygen concentration and pH were recorded for the first 2.5 days and during 
that time cell enumeration, viability determination, Ki-67 expression and cell 
cycle analysis were conducted in order to evaluate the cell culture in alginate. 
The evaluation of the cell culture was necessary as the state of the cells defined 
the assumptions of the mathematical model which simulated the experiment for 
the calculation of the parameters.
This experiment was initiated by lowering the oxygen level in the incubator from 
18.5% to 5 % and the decrease in the oxygen concentration at the bottom of the 
alginate construct was recorded. The fibroblasts were evaluated in terms of cell
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enumeration, viability, Ki-67 expression and cell cycle distribution after the end 
of the experiment in order to verify if the assumptions of the mathematical 
model had not been compromised. The oxygen decrease in the gas phase of 
the customized microwell was recorded in a separate experiment by using 
empty customized wells located at the same position in the plate as the wells 
used in the experiment for the calculation of the parameters.
The parameters and their confidence intervals were calculated by using the 
inverse method (section 2.6). Briefly, they are derived by minimisation of the 
sum of the squared differences between experimental and simulated data by 
using the Matlab Statistical Toolbox function “nlintool”.
An additional experiment with conditions that differed from those of the 
experiment above was conducted as a verification of the calculations. The 
oxygen tension in the incubator was lowered from 18.5% to 10% and kept at 
that level until the oxygen concentration at the bottom of the alginate construct 
was stable. The oxygen tension was then increased back to 18.5%. The 
fibroblast culture was characterized as above.
114
5.2 Mathematical models
5.2.1. Mathematical model for the simulation of the oxygen diffusion 
and consumption in alginate constructs with immobilized human 
dermal fibroblasts
As illustrated in Figure 5.1 the customized well is considered as having two 
subdomains: the culture medium and the alginate matrix. A mathematical model 
has been set up to describe the oxygen diffusion and consumption in the 
customized well based on the following assumptions.
For the culture medium: (i) the system is isothermal, (ii) no reaction occurs, (iii) 
diffusion obeys Fick’s first law, (iv) there is no convective transport, (v) the 
oxygen tension in the gas phase of the microwell is assumed to be equal to the 
one in the incubator, (vi) there is no resistance in the oxygen mass transfer at 
the air-culture medium interface, (vii) there is radial symmetry at the microwell 
centreline.
For the alginate matrix: (i) the system is isothermal, (ii) the cell suspension is 
homogenous, (iii) oxygen consumption follows Monod kinetics, (iv) there is no 
convective transport, (v) diffusion coefficient is a time independent parameter,
(vi) diffusion obeys Fick’s first law, (vii) the upper surface of the alginate
construct is considered to be flat, (viii) alginate does not contract, (ix) there is 
symmetry at the construct centreline.
The equation of continuity for oxygen states
t he  r a t e  o f  i n c r e a s e  n e g a t i v e  n e t  r a t e
o f  o x y g e n  m a s s  =  o f  a d d i t i o n  o f  o x y g e n  m a s s  + 
p e r  u n i t  v o l u m e  p e r  u n i t  v o l u m e
b y  c o n v e c t i o n  a n d  b y  d i f f u s i o n
t he r a t e  o f  c o n  s u m  p t i o n
o f  o x y g e n  m a s s
p e r  u n i t  v o l u m e  b y  r e a c t i o n
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For the culture medium
dc1 _ . 1 d . 8 c \  d2c ‘ .
^ T  = D i ( _ 7 _ +dt r  dr dr dz
where Di is oxygen diffusivity in culture medium and c1 is the oxygen 
concentration in culture medium.
For the alginate matrix
dc1 0 / l  d ( r d c \ t d2c \  „  c" v
2 (  ^  ^  ^  ~  2 ^ Q mAX is  , / /  ’dt r  dr dr dz KM + c
where c 1 is the oxygen concentration in the alginate matrix, X  is the cell
concentration, D2 is the oxygen diffusivity the alginate matrix, qMAx is the 
maximum uptake rate and Km is the Monod constant (concentration at which 
the half maximum oxygen uptake rate occurs).
dc1 dc"
The terms and represent the rate of increase of oxygen mass per unit
volume for the culture medium and the alginate construct respectively. The
1 d dc1 82c ' 1 d . dc" , d2c " , . ..terms D,(—— ( r — ) + — and 0 2 ( r — - )  + — — ) represent the
r  dr dr dz r  dr dr 8z
negative net rate of addition of oxygen mass per unit volume by diffusion,
for the culture medium and the alginate construct respectively. The term 
c"
~ Q m a x -------- i f X  represents the oxygen consumption rate per unit volume
+ c
based on cell metabolism which occurs according to the Monod kinetics. The 
latter states that when the KM constant becomes insignificant compared to the 
oxygen concentration the consumption rate is independent of the oxygen 
concentration. On the contrary, when the oxygen concentration becomes 
insignificant compared to the Km constant the consumption rate becomes 
linearly dependent on oxygen concentration.
No flux boundary conditions are applied at the microwell and alginate construct 
centrelines because of the radial symmetry of their cylindrical shape. This 
statement is expressed mathematically by the following equations for the 
microwell and alginate construct centreline respectively.
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The bottom and the side walls of the microwell and the side walls of the 
construct are considered impermeable to oxygen therefore no flux boundary 
conditions are applied there. This statement is expressed mathematically as
for the side walls and bottom of the microwell respectively and
dc1 dc1
D>— 0 ; D ^ 0 ’
for the side walls and bottom of the alginate construct respectively.
It was assumed that there is no resistance to oxygen mass transfer at the air- 
culture medium interface. Therefore the oxygen concentration at the top surface 
of the medium can be derived from the oxygen tension in the gas phase of the 
microwell using Henry’s law. The latter was acquired from the experiment where 
empty customized wells were used to record the oxygen tension decrease in 
the gas phase of the well caused by the oxygen tension decrease in the 
incubator. It was inserted into the mathematical model as an interpolation 
function using the cubic spline method.
The oxygen concentration profile which is developed in the microwell after 2.5 
days incubation is the initial condition of the mathematical model which 
simulates the experiment for the calculation of the parameters. It can be derived 
from a mathematical model which has been set up under the same assumptions
as the above and consists of the following equations and boundary conditions
for the culture medium:
.  _.,1 5 , 5c'. 5 V ,°  = D1( - — ( r — ) + — r ), 
r  dr dr dz
and for the alginate matrix:
No flux boundary conditions are applied at the microwell and alginate construct 
centrelines because of the radial symmetry of their cylindrical shape. This 
statement is expressed mathematically by the following equations for the 
microwell culture medium and the alginate construct respectively.
d r 1 d r "
= 0; D2 = 0 
dr 2 dr
The bottom and the side walls of the microwell and the side walls of the 
construct are considered impermeable to oxygen therefore no flux boundary 
conditions are applied there. This statement is expressed mathematically as
dc' _ _ dc1
D^  = ° ’ D^  = ° ’
for the side walls and bottom of the microwell respectively.
dc" dc"
d >1 F  = 0 ' d ^ 0 '
for the side walls and bottom of the alginate construct respectively.
The oxygen concentration at the top surface of the medium can be derived from 
the oxygen tension in gas phase of the microwell using Henry’s Law.
5.2.2 Mathematical model for the simulation of the oxygen diffusion 
in alginate constructs without immobilized cells
The mathematical model can be derived from the one which simulates the 
experiment for the calculation of the parameters in alginate constructs with 
immobilized cells by applying the same assumptions. The difference is that the 
term which describes the oxygen consumption has been eliminated as there are 
no immobilized cells.
For the culture medium:
For the alginate matrix:
dc" _ .1 d . dc". d2c", 
dr r dr dr dz
No flux boundary conditions are applied at the microwell and alginate construct 
centrelines because of the radial symmetry of their cylindrical shape. This 
statement is expressed mathematically by the following equations
dc1 d r 11
D1 — = 0; D2 = 0 
'd r  2 dr
for the microwell and the alginate construct respectively.
The bottom and the side walls of the microwell and the side walls of the
construct are considered impermeable to oxygen therefore no flux boundary
conditions are applied there. This statement is expressed mathematically as
d c * d c 1
for the side walls and bottom of the microwell respectively.
dc1 dc1D2^ -  = 0 , D 2^  = 0, 
dr dz
for the side walls and bottom of the alginate construct respectively.
The oxygen concentration at the top surface of the medium can be derived from 
the oxygen tension in gas phase of the microwell using Henry’s Law. It was 
inserted into the mathematical model as an interpolation function created from 
data acquired from the empty customised well experiment. The interpolation 
was conducted by using the cubic spline method.
5.2.3. Model solution and convergence
The system of the above equations was solved by using the commercial 
software package Comsol Multiphysics 3.3 (Comsol Ltd., UK). One half of the 
system was modelled due to symmetry at the construct centreline. Different 
solvers were used for the various mathematical models. A nonlinear time 
dependent solver was used for the mathematical model which simulates the
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experiment with the immobilized cells because of the nonlinearity of the Monod 
kinetics term. The linear dependent solver was used for the experiments with 
the alginate constructs without the immobilized cells as all terms in the 
differential equations are linear. The nonlinear stationary solver was used to 
simulate the oxygen profile which was developed in the microwell after 2.5 days 
in the incubator. The solver is stationary because based on the assumptions of 
the mathematical model the oxygen concentration is time independent and it is 
nonlinear because of the nonlinear Monod kinetics term.
The relative and absolute tolerance in the time dependent solver has been 
adjusted to 10‘ 3 and 10'4 respectively. The maximum number of iterations, the 
minimum step size and the tolerance for convergence in the stationary solver 
was adjusted to 25, 10'4 and 10' 6 respectively.
In all simulations, the alginate construct has been meshed with 595 triangular 
elements and the culture medium with 690. The convergence was tested by 
increasing the number of elements to 152320 and 176640 for the alginate 
construct and the culture medium respectively. The oxygen concentration 
simulated by using the new mesh was agreed up to 4 significant figures with the 
oxygen concentration simulated by using the default mesh.
The values of the oxygen effective diffusivity, oxygen uptake rate and the 
Monod constant with their confidence intervals are obtaining by using the 
inverse method implemented in Comsol Multiphysics wrapped around Matlab 
(section 2.6). Each parameter evaluation took 23 h on a Pentium IV PC with a 3 
GHz processor and 2 Gb memory.
120
5.3 Results and conclusions
The oxygen at the bottom of the alginate construct dropped to 1% within the first 
3 hours and increased to 6  % after a day. Following a medium exchange (peak 
in DOT) the oxygen tension stabilized at 9.5% (Figure 5.2). The experiments for 
the calculations of the oxygen related parameters of the alginate / cell mix were 
initiated after the oxygen concentration at the bottom of the construct had 
stabilized.
This initial decrease in oxygen tension can be attributed to the transition from a 
flask to an alginate based cell culture system. Analytically, anchorage- 
dependent cells cannot adhere within unmodified hydrophilic substrates like 
alginate (lack of adhesive peptides) therefore they cannot enter their cell cycle 
and proliferate (Alberts et al, 1994; Palsson, 2003). However, the anchorage 
control operates at the G1 phase of the cell cycle and cells in S, G2 and M 
phase do not require adhesion to a surface to complete the cell cycle (Alberts et 
al, 1994). Therefore, cells which were in S, M and G2 phase just before the 
incubation of the alginate construct managed to complete the cell cycle. The 
oxygen demand was higher at the beginning of the incubation of the construct 
and started decreasing as the cells in the S, G2 and M phase were completing 
the cell cycle and entering the GO / G1 phase which is less oxygen demanding. 
Thus, a decrease in oxygen concentration at the bottom of the construct was 
taken place the first 3  h followed by an increase as these cells were completing 
the cell cycle. The oxygen concentration at the bottom of the construct 
stabilized eventually at 9.5 % after 24 h, a time point when all cells had entered 
the less oxygen demanding GO / G1 phases.
The value of the cell concentration which was inserted in the mathematical 
model was equal to the initial one (7x106 cells mL'1) because there is no change 
in the live cell concentration till the end of the experiments (after 1.5 day 
incubation) (Figure 5.3). Additionally, no mathematical term describing the effect 
of cell death was inserted in the mathematical model as the viability was over 
97% and remained at this level till the end of the experiments (Figure 5.3). The
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slight deviation from 1 0 0 % can be attributed to loss of cells from their recovery 
from the alginate construct.
High levels of lactate or ammonia can inhibit the cell metabolism causing a 
decrease in the oxygen uptake rate. Their effect though was not taken into 
account in the mathematical model as the pH at the bottom of the construct was 
relatively constant and acceptable (7.20 ± 0.05) for fibroblast cell growth 
(Alberts et al, 1994) (Figure 5.4).
It has been reported that oxygen uptake rate depends on the distribution of cells 
in the cell cycle (Freyer et al, 1985; Ramirez and Mutharasan, 1990). Therefore, 
cell cycle analysis was necessary in order to set up a mathematical model 
capable of predicting the variations in oxygen uptake rate caused by changes in 
the distribution of the phases of cell cycle.
The initial decrease in oxygen tension is accompanied by an increase in GO / 
G1 fraction cell population and a decrease in the S fraction of the cell population 
(Figure 5.5). Analytically, the initial fractions of GO / G1, and S phase cells 
(64.9 ± 0.9%, and 13.6 ± 0.1% respectively) remained stable for the first 3 hours 
(p= 0.66 and p= 0.31 respectively) and then the fraction of GO / G1 phase cells 
started increasing, accompanied by a decrease in the fraction of S phase cells. 
Their values stabilized after a day from the beginning of the incubation at 72.9 ± 
1.4% (p= 0.87) for GO / G1 phase cells and 4.3 ± 0.3% (p= 0.97) for S phase 
cells. This increase in GO / G1 phase cells accompanied by a decrease in the S 
phase cells is expected as cells cannot attach to alginate and it has been 
reported that anchorage control operates at the G1 phase (Alberts et al, 1994).
Ki-67 analysis was used to determine the percentage of the cells in quiescent 
state (GO phase). Cell cycle analysis could not determine this characteristic. 
This was necessary because cells in GO phase are less active metabolically 
than proliferating cells. The rate of protein synthesis for example is 20% of its 
value in proliferating cells (Alberts et al, 1994). Therefore, a mathematical 
model which neglects changes in the percentage of quiescent cells may lead to 
erroneous calculations.
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The initial percentage of cells positive to Ki-67 expression was 85.8 ± 4.1%. It 
remained at this level throughout the experiments. However, after a week 
incubation a significant decrease was noted (Figure 5.6).
This experiment for the calculation of oxygen uptake rate, oxygen effective 
diffusivity and Monod constant was initiated by lowering the oxygen level in the 
incubator from 18.5% to 5%. The decrease in the oxygen concentration at the 
bottom of the alginate construct was recorded and analysed in a mathematical 
model which was set up in Matlab 7.1 and Comsol Multiphysics 3.3. The 
simulated data represented the best fit of the experimental data as obtained 
using the inverse method (section 2.6). The values for oxygen effective 
diffusivity, oxygen uptake rate and Monod constant with their 95% confidence 
intervals were 0.95 ±0.10x1 O' 9 m2 s'1, 19.42 ± 0.07x1 O' 18 mol cell' 1 s' 1 and 11.93 
± 1.28x1 O' 3 mM respectively. The average absolute relative error between 
experimental and predicted data is 7.3% (Figure 5.7). The confidence intervals 
of the values of the oxygen effective diffusivity and Monod constant are much 
higher than the confidence interval of the oxygen uptake rate. This indicates 
that the variations of the experimental data are affecting more these two 
parameters.
The overestimation of the simulated oxygen profile may be attributed to an 
actual smaller thickness of the alginate construct or an inhomogeous cell 
distribution in alginate. Analytically, if the actual thickness of the construct is 
smaller than the one assumed the oxygen diffusion from the gas phase of the 
customized well to the alginate construct will progress faster than predicted and 
will lead to an overestimated simulated oxygen concentration profile.
Additionally, if the cell distribution in the construct is inhomogenous, the cell 
concentration can be higher above the oxygen sensor than in other areas of the 
construct. In this case the oxygen concentration will be lower there than in other 
areas of the construct. A decrease in the oxygen tension in the incubator will 
initiate a diffusive flux from the gas phase of the incubator to the alginate 
construct. The diffusive flux will be higher above the oxygen sensor than in 
other areas of the construct. Therefore, faster oxygen diffusion will take place.
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Assuming a homogenous cell concentration, slower oxygen diffusion is 
predicted above the oxygen sensor which leads to an overestimation of the 
experimental oxygen concentration profile with the magnitude of the deviation to 
follow the progress of the oxygen diffusion.
The value of the oxygen effective diffusivity in alginate was 2.54 ± 0.57x1 O' 9 cm2 
s' 1 in constructs without cells and 0.95 ± 0.10x1 O' 9 m2 s’ 1 in constructs with 
immobilised cells. This can be attributed to the presence of ECM and cells 
which hinder the diffusion by occupying space within the alginate construct.
The average absolute relative error between experimental and simulated data 
was 6 .8 %. This error can be attributed in the error in the thickness of the 
construct. In this case it seems that the actual thickness of the construct is 
higher than the one assumed in the simulations producing an underestimated 
oxygen concentration profile due to slower oxygen diffusion from the construct 
to the gas phase of the customized well (Figure 5.8).
To verify the calculation of the oxygen related parameters of the alginate / cell 
mix, the oxygen tension in the incubator was lowered from 18.5% to 10%, and 
kept at that oxygen level till the oxygen concentration at the bottom of the 
alginate construct was stable and then was increased back to 18.5%. Results 
showed that the mathematical model was reliable as the average absolute 
relative error between experimental and predicted data was only 0.2% (Figure 
5.9).
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!4-well format
low volume welllow volume well
oxygen sensor spot
Figure 5.1: Photos of a customized well in 24-format used for the calculation of 
oxygen effective diffusivity in an alginate / cell mix and the oxygen uptake rate 
of human dermal fibroblasts. The alginate construct was formed within the well 
insert (volume of 7 pl_, diameter of 3 mm and thickness of 1 mm). It was 
incubated in static IMDM culture medium at 37°C and under 5% C 02. Oxygen 
was transferred to the alginate matrix by diffusion. Sensor spots with a diameter 
of 2  mm (polyester base) were glued at the bottom of the well insert and were 
used to provide oxygen concentration and pH on-line measurements. The 
values of the oxygen effective diffusivity and oxygen uptake rate were 
determined by inserting the data in a mathematical model set up in Comsol 
Multiphysics wrapped around Matlab.
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Figure 5.2: Oxygen profile at the bottom of newly formed alginate constructs 
with immobilized human dermal fibroblasts at a concentration of 7x106 cells 
mL"1. The constructs were formed in customized wells having cylindrical shapes 
with a volume of 7 pL and a thickness of 1 mm each. The fibroblasts were 
incubated in 1 mL static IMDM culture medium (37°C, 5% CO2). The 
experimental data are represented as average ± standard error of 
measurements acquired from 3 customized wells operating simultaneously. The 
oxygen dropped to 1% within the first 3 hours, increased to 6  % after a day. 
Medium exchange was conducted after a day (peak in DOT). It then stabilized 
at 9.5 %. The initial transient decrease in oxygen concentration was 
accompanied by a decrease in the fraction of the proliferating cells. This 
metabolic shift can be attributed to the transition from a flask to a hydrogel 
based cell culture system (section 5.3).
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Figure 5.3: Live cell concentration ( — ) and viability ( ) profile of human
dermal fibroblasts immobilized in alginate. The alginate constructs were formed 
in customized wells having cylindrical shapes with a volume of 7 pL and a 
thickness of 1 mm each. Following incubation for 2.5 days in 1 mL IMDM culture 
medium (37°C, 5% CO2), the oxygen tension in the incubator was lowered 
transiently from 18.5% to 5% in order to calculate the oxygen effective diffusivity 
in the alginate construct and the oxygen uptake rate of the fibroblasts. Live cell 
concentration and viability data were acquired as described in section 2 .3.2 .2 . 
Data are represented as average ± standard error of measurements acquired 
simultaneously from 3 customized wells. No change in the live cell 
concentration (p=0.22) and viability (p=0.21) at the 5% significance level was 
observed during the time period of 1 0  days.
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Figure 5.4: pH measurements were carried out from the bottom of alginate 
constructs with immobilized human dermal fibroblasts at a concentration of 
8x106 cells mL'1. Each of the constructs was formed in a customized well and it 
had cylindrical shape with a volume of 7 pL. The cells were incubated in 1 mL 
static IMDM culture medium (37°C, 5% CO2). HEPES, 25 mM, was used to 
buffer the medium. The pH of fresh complete medium was 7.18 ± 0.02 (3 
independent measurements) and HEPES proved to be effective for maintaining 
constant pH. pH varies from 7.15 to 7.25 (dotted lines). The fibroblasts were 
reefed with fresh medium after a day with no effect on pH. The experimental 
data are represented as average ± standard error of measurements acquired 
from 3 customized wells.
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Figure 5.5: Cell cycle distribution of human dermal fibroblasts immobilized in 
cylindrical alginate constructs. Following incubation for 2.5 days in 1 mL IMDM 
culture medium (37°C, 5% C0 2 ), the oxygen tension in the incubator was 
lowered transiently from 18.5% to 5% in order to calculate the oxygen effective 
diffusivity in the alginate construct and the oxygen uptake rate of the fibroblasts. 
Data are represented as average ± standard error of measurements acquired 
from 3 customized wells. The fractions of cells in each phase of the cell cycle 
were calculated using ModFit-LT software. The initial fractions of GO / G1, S, 
and G2 / M phase cells were 64.9 ± 0.9%, 13.6 ± 0.1% and 21.5 ± 0.9% 
respectively. The fractions remained stable for the first 3 hours (p= 0.66, p= 
0.31 and p= 0.56 respectively) and then the fraction of GO / G1 phase cells 
started increasing, accompanied by a decrease in the fraction of S phase cells. 
Their values stabilized after a day from the beginning of the incubation at 72.9 ± 
1.4% (p= 0.87) and 4.3 ± 0.3% (p= 0.97).
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Figure 5.6: Percentage of Ki-67 expression of human dermal fibroblasts 
immobilized in cylindrical alginate constructs. Following incubation for 2.5 days 
in 1 mL IMDM culture medium (37°C, 5% CO2), the oxygen tension in the 
incubator was lowered transiently from 18.5% to 5% in order to calculate the 
oxygen effective diffusivity in the alginate construct and the oxygen uptake rate 
of the fibroblasts. Data were assayed for Ki-67 expression using the Guava 
Express Plus application within the Guava cytometer software. They are 
represented as average ± standard error of measurements acquired 
simultaneously from 3 customized wells. The initial percentage of cells 
expressing Ki-67 was 85.8 ± 4.1%. However, it remained at this level for 3 days 
(p= 0.54) and then decreased to 44.4 ± 1.4% within a week.
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Figure 5.7: Oxygen profile at the bottom of alginate constructs without
immobilized cells. The constructs were formed in customized wells having 
cylindrical shapes with a volume of 7 pL and a thickness of 1 mm each. IMDM 
culture medium, 1mL, was added to the customized well. Following incubation 
(static conditions, 37°C, 5% CO2 ) for 2.5 days, the oxygen tension was lowered 
from 18.5% to 6 %. When the system reached steady state conditions (6 % at the 
bottom of the alginate construct), the oxygen tension in the incubator was 
increased back to 18.5% and the dissolved oxygen tension at the bottom of the 
construct was recorded by using the Presens device. The experimental data are 
represented as average ± standard error of measurements acquired 
simultaneously from 3 customized wells. The simulated data represent the best 
fit of the experimental data and they were obtained by combining Comsol 
Multiphysics and Matlab. The derived value for the oxygen effective diffusivity in 
alginate was 2.54 ± 0.57x1 O' 9 m2 s'1. The average absolute relative error 
between experimental and predicted data was 6.83%.
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Figure 5.8: Experimental ( -  ) and simulated ( --------) oxygen profiles at the
bottom of an alginate construct with immobilized human dermal fibroblasts at a 
concentration of 7x106 cells mL'1. The construct was formed in a customized 
well and it had a cylindrical shape with a volume of 7 pL and a thickness of 1 
mm. Following incubation in 1 mL static IMDM culture medium (37°C, 5% C 02) 
for 2.5 days, the oxygen tension in the incubator was lowered from 18.5 to 5% 
and the oxygen concentration at the bottom of the alginate construct was 
recorded. The experimental data are represented as an average ± standard 
error of measurements acquired from 3 customized wells. The simulated data 
represent the best fit of the experimental data and they were obtained by 
combining Comsol Multiphysics and Matlab. The output values for oxygen 
effective diffusivity, oxygen uptake rate and Monod constant with their 95% 
confidence intervals were 0.95 ± 0.10x1 O' 9 m2 s'1, 19.42 ± 0.07x1 O' 18 mol cell' 1 
s' 1 and 11.93 ± 1.28x1 O' 3 mM respectively. The average absolute relative error 
between experimental and predicted data is 7.3%.
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Figure 5.9: Validation of the calculation of the oxygen related parameters of the
alginate / cell mix through the comparison of experimental (  — ) and predicted
( ------- ) oxygen profile at the bottom of alginate constructs with immobilized
human dermal fibroblasts at a concentration of 7x10 6 cells mL"1. The constructs 
were formed in customized wells having cylindrical shapes with a volume of 7 
pL and a thickness of 1 mm each. Following incubation in 1 mL static IMDM 
culture medium (37°C, 5% CO2 ) for 1 day, the oxygen tension in the incubator 
was lowered from 18.5% to 10%, was kept at that level till the oxygen 
concentration at the bottom of the alginate construct was stable and then was 
increased back to 18.5%. The experimental data are represented as average ± 
standard error of measurements acquired from 3 customized wells. The 
predicted oxygen concentration profile has been generated by inserting the 
values of the oxygen related parameters of the alginate / cell mix in the 
mathematical model which describes the oxygen diffusion in the construct 
(section 5.2). The average absolute relative error between experimental and 
predicted data is 0 .2 %.
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Chapter 6 
Glucose / lactate transport and metabolism in alginate
6 .1 1ntroduction
Alginate constructs with immobilized human dermal fibroblasts were formed in 
transwells in order to measure indirectly the effective diffusivities of glucose, 
and lactate as well as the glucose consumption and the lactate production rate. 
These values in conjunction with those for oxygen which were derived from the 
customized well experiments (previous chapter) help to inform better the 
construction of windows of operation as glucose and lactate should be balanced 
properly at the time as oxygen is delivered.
The constructs were formed at the bottom of the transwell within its conical 
frustum shape. The volume was 0.15 mL and the diameter of the top and 
bottom surface was 10.9 and 10.5 mm respectively. Their initial thickness was 
1.34 mm stabilizing at 1.61 mm after 2 hours in culture medium (swelling effect) 
(Figure 6.1).
The transwells with the alginate constructs were placed in 24-format companion 
microplates and the immobilized fibroblasts were cultured in IMDM medium. 
The volume in each transwell was 0.75 mL and in each well 2.3 mL. Nutrient 
delivery and waste removal from the construct was enhanced by shaking the 
microplate at 220 rpm in an orbital shaker. The culture medium in each well and 
transwell was analysed over time for glucose and lactate. The effect of the cell 
concentration on the values of parameters of interest was studied by forming 
constructs with 25x106 and 60x106 cells mL'1.
Constructs without cells were used as controls. Serum supplemented with 18 
mM lactic acid and IMDM culture medium were used for the diffusivity studies. 
Mass transfer in the shake alginate constructs was considered to be diffusion 
dominant. The rate of diffusion of glucose and lactate is proportional to the
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difference of their concentration in (i) the serum supplemented with lactic acid 
(initially 1mM glucose, 18 mM lactate) and (ii) IMDM medium (initially 23 mM 
glucose, 0.1 mM lactate). The proportionality is governed by the relative 
diffusion coefficient. The osmolarities of the serum supplemented with lactic 
acid and the IMDM culture medium were equal (Nova Bioprofile analyser 
measurements). Therefore there was no osmotic pressure difference between 
the serum in the well and the IMDM culture medium in transwell which could 
have affected the mass transfer in the alginate construct.
It is assumed in the mathematical models which simulated the above 
experiments that the mass transfer in the alginate constructs is governed by 
diffusion and that there is negligible external mass transfer resistance. 
However, flow of culture medium between the alginate constructs and the 
sidewalls of the transwell as well as interstitial flow through the alginate 
constructs caused by shaking can lead to a convection dominant mass transfer 
in them increasing potentially the value of the calculated effective diffusivity.
Additionally, the external resistance to mass transfer is regarded as lying in a 
layer to the top and bottom surface of the alginate construct. It is possible the 
resistance to mass transfer in this layer is the same order of magnitude as for 
the alginate construct. In this case by assuming in the mathematical models a 
negligible external mass transfer resistance, the simulated one is lying only 
within the alginate construct. Therefore, the calculated effective diffusivity will be 
lower than the real one in order for the simulated mass transfer resistance to be 
balanced with the increased real one which lies within the alginate construct 
and the two layers.
The assumption of a diffusion dominant mass transfer in the alginate construct 
with negligible external mass transfer resistance was validated by comparing 
the effective diffusivity of lactate in static and shake alginate constructs without 
immobilized cells.
All experiments for the calculations of the glucose and lactate based 
parameters were started 1.5 days after incubation and lasted at most 1.5 days.
135
This was necessary because the oxygen experiments (previous chapter) have 
shown that during that period there are no significant changes in the cell cycle 
distribution and Ki-67 expression, therefore unchanged metabolic behaviour can 
be assumed in the mathematical models.
The culture medium in each well and transwell was analysed over time for 
glucose and lactate. A computer program written in Matlab 7.1 and Comsol 
Multiphysics 3.3 yielded the effective diffusivities and the consumption / 
production rates of the species of interest in alginate as well as their confidence 
intervals by using the inverse method (section 2.7).
6.2 Mathematical models
6.2.1 Mathematical model for the simulation of glucose and lactate 
diffusion and their consumption and production in alginate 
constructs with human dermal fibroblasts
A mathematical model was set up to describe glucose consumption, lactate 
production and their diffusion in alginate constructs formed in transwells. The 
equations of the mathematical model will be presented for a representative 
species n, instead of giving them for glucose and lactate separately.
The assumptions of the mathematical model are the following:
(i) the system is isothermal, (ii) the cell suspension is homogenous, (iii) glucose 
consumption is independent of its concentration, (iv) lactate level does not 
affect the cell metabolism (v) there is no convective transport in the alginate 
construct, (vi) diffusion coefficient is a time independent parameter, (vii) 
diffusion obeys Fick’s first law, (viii) there is no external mass transfer 
resistance (ix) the upper surface of the alginate construct is considered to be 
flat, (x) alginate does not contract, (xi) there is radial symmetry at the construct 
centreline, (xi) mass transfer resistance though the membrane of the transwell 
is negligible.
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The equation of continuity for the species n states
dc _ . , 1  d , dc. d2c—  = D( ( r — ) + —
dt r  dr dr dz
( ~ ( r ^ ) ^ ) - q X  (6 .1)
where c is the concentration, X  is the cell concentration, D is the effective 
diffusivity in the alginate construct and q is the production rate.
dcThe term —  represents the accumulation rate of mass of the species n per
terms D ( -  —  { r — ) + — -^) represents the mass transfer rate of species n per
unit volume for the culture medium and the alginate construct respectively. The
1 d . d c . d2c
 ( ;
r  dr dr dz‘
unit volume. The term qX represents the production rate of species n per unit 
volume based on cell metabolism. It is negative for the consumed glucose and 
positive for produced lactate.
No flux boundary conditions are applied at the alginate construct’s centreline 
and at the transwell’s sidewalls. At the construct’s centreline there is radial 
symmetry and the transwell’s sidewalls are impermeable to species n. Both 
boundary conditions are expressed mathematically by the following equation:
dc
D —  = 0 (6 .2 )
dr
It is assumed that there is no external mass transfer resistance so the 
concentration of species n at the top surface of the construct and the bottom 
surface of the transwell’s membrane is equal to its bulk concentration.
The amount of glucose in the culture medium is given by the original level 
minus the amount which has been transferred to the alginate construct and 
consumed by the cells. Similarly, the amount of lactate in the culture medium is 
equal to its initial value plus the amount which has been produced in the 
alginate construct by the cells and transferred to the culture medium. The mass 
transfer occurs because the consumption or production by the cells creates a 
concentration gradient between construct and culture medium.
The continuity equation for the species n in the culture medium of the well and 
transwell states that
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V { c - c t=0) = -A D  —  (6.3)
dz
where V is the volume of the culture medium in transwell or well, c is the 
concentration of species n after time t, ct=o is the initial concentration of species 
n and A is the area of the top or bottom surface of the alginate construct.
The term V(c -  cf=0) represents the increase of the mass of species n and the
dcterm - A D —  represents the amount which is transferred from the alginate 
dz
construct to the culture medium. Both terms are positive sign for the produced 
lactate and negative for the consumed glucose.
The initial concentration of species n in the transwell and in the well is its 
amount in the fresh culture medium. Concerning the alginate construct the initial 
condition is the concentration profile of species n developed after incubation for 
1.5 days. An approximation of this profile is provided by solving the pseudo­
steady state of the mathematical model developed above. The pseudo-steady 
state mathematical model assumes that the concentration profile of species n is 
changing very slowly within a narrow time interval because of the low 
consumption or production rate of species n by the cells. Therefore, the 
concentration profile is considered to be unchanged for the short time it takes to 
refill the well and transwell with fresh culture medium.
This mathematical model can be derived from the one developed above by 
cancelling the time dependent term of the equation 6 .1  and the differential 
equation which describes the time profile of the bulk concentration of species n.
The equation which gives the concentration profile is given below:
1 d . dc . d2c vD ( -  —  ( r — ) + — T ) - q X  (6.4)
r  dr dr dz
The boundary condition for the centreline of the well and the sidewalls of the 
transwell is given by:
D — = 0 (6.5)
dr
The concentration of species n at the top and bottom surface of the construct is 
set equal to its bulk concentration.
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6.2.2 Mathematical model for the simulation of substrate and 
metabolite diffusion in shaken alginate constructs without cells
A mathematical model with the same assumptions and boundary conditions 
with the one above was set up to simulate the glucose and lactate diffusion in 
alginate constructs without cells. The only difference was that there are no cell 
related assumptions and the term which describes mathematically the 
production of species n in alginate construct has been eliminated as there were 
no immobilized cells.
The continuity equation for species n in shake alginate construct is:
^ _  = D(l A ( r ^ ) + % )  (6 .6)
dt r d r  dr dz2 
with the following equation as boundary condition for the alginate construct’s 
centreline and for the transwell’s sidewalls:
dc
D -— = 0 (6.7)
dr
The continuity equation for species n in the culture medium is: 
dc
V ( c - c t=0) = - A D ^  (6 .8 )
6.2.3 Mathematical model for the simulation of lactate diffusion in 
static alginate constructs without cells
The assumptions of the mathematical model are all the same with the 
assumptions of the mathematical model which simulates the glucose and 
lactate diffusion in shake-alginate constructs without cells except the one which 
states that there is no external resistance in mass transfer. It has been replaced 
with the assumption of having diffusion dominant mass transfer in the culture 
medium in the transwell and in the supplemented with lactic acid serum in the 
well.
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The continuity equation for species n in the static alginate constructs, in the 
culture medium in the transwell and in the serum supplemented with lactic acid 
in the well has the following form:
dc _ , 1  d , dc . d2c .
—  = D (-  —  (r — ) + —~T ) (6.9)
dt r  dr dr dz
The boundary conditions for the well’s and transwell’s sidewalls and centrelines
are given by the following equation:
dc
D —  = 0 (6 .1 0 )
dr
and the boundaries for the culture medium-air interphase, serum-air interphase 
as well as the bottom of the transwell are given by the following equation:
d r
D - — = 0 (6 .1 1 )
dz
6.2.4 Model solution and convergence
The above equations were solved by using Comsol Multiphysics 3.3 only (see 
section 2.6). One half of the system was modelled due to the symmetrical 
shape of the alginate constructs. The linear time dependent solver was used to 
simulate the diffusion and production of the species of interest in alginate 
constructs with and without immobilized cells. The linear stationary solver was 
used to simulate the concentration profile of the species of interest in the 
alginate construct after 1.5 days in the incubator.
The linear stationary solver was set up with a relative tolerance of 10' 3 an 
absolute tolerance of 10'4, a maximum number of 25 iterations, a minimum step 
size of 1 0 * 4 and a tolerance for convergence of 1 0 '6.
The construct, the liquid in the transwell and the liquid in the well was meshed 
with 408, 1196 and 1692 triangular elements respectively and they were refined 
to 104448, 306176 and 433152 triangular elements respectively to test the 
convergence of the solution. The concentration profile was agreed up to 4 
significant figures with the one simulated by using the default mesh. The
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calculations were always completed to convergence within the number of 
iterations specified.
The glucose and lactate related parameters with their confidence intervals were 
calculated by using the inverse method (section 2.7). It is implemented in 
Comsol Multiphysics wrapped around Matlab. Briefly, the Comsol models were 
saved as Matlab functions. Their input was the glucose and lactate related 
parameters and their output the average glucose and lactate concentrations in 
the well and transwell. The parameters were derived from minimisation of the 
sum of the squared differences between the experimental and the simulated 
average glucose and lactate concentration values. The Matlab optimization 
function “Isqnonlin” gave the values of the parameters and the Matlab Statistical 
Toolbox function “nparci” gave their confidence intervals. Each parameter 
evaluation took 1 h on a Pentium IV PC with a 3 GHz processor and 2 Gb 
memory.
6.3 Results and conclusions
The effective diffusivities of glucose and lactate were calculated in alginate 
constructs with and without immobilized cells (controls). The microplate with the 
transwells were shaken at 2 2 0  rpm in order to enhance the mass transfer of 
nutrients to the constructs. The effect of the cell concentration in the values of 
parameters of interest was studied by forming alginate constructs with 25x106 
and 60x106 cells mL'1. Glucose and lactate measurements at various times 
were undertaken from the medium in the well and transwell by using the Nova 
Bioprofile analyser. The medium in the well and transwell was weighted before 
the metabolic analysis in order to take account of evaporation.
It was assumed in the mathematical models which simulated the above 
experiments that mass transfer in the alginate constructs is governed by 
diffusion and that there is negligible external mass transfer resistance. These 
assumptions were validated by comparing the effective diffusivity of lactate in 
static and shaken alginate constructs without immobilized cells.
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The calculated lactate effective diffusivity in static and shaken transwells were 
1.43 ± 0.53 and 1.53 ± 0.10x1 O' 9 m2 s' 1 respectively (Figure 6.5; Figure 6 .6 ). 
These values are equal within the error of measurement therefore it can be 
concluded that diffusion is the dominant mean of mass transfer in the alginate 
constructs whether or not shaken i.e. the external mass transfer resistance is 
negligible. Additionally, it can be concluded that the rate of diffusion of glucose 
and lactate in alginate is equal to the rate of diffusion in the culture medium as 
the effective diffusivities of glucose and lactate in alginate are equal with the 
diffusivity values in culture medium which have been reported in the literature 
(Sengers et al, 2005).
No change in the live cell concentration was observed at the 5% significant level 
during the time period of experiments for the calculation of the glucose and 
lactate based parameters for the two cultures (p=0.13 for the alginate construct 
with 25x106 cells mL' 1 and p=0.18 for the alginate construct with 60x106 cells 
mL'1) (Figure 6.2; Figure 6.3). Additionally, there was no loss in viability for the 
two cultures during the time period of the experiments (p=0.13 for the alginate 
construct with 25x106 cells mL' 1 and p=0.19 for the alginate construct with 
60x106 cells mL'1) (Figure 6.2; Figure 6.3).
The glucose effective diffusivity was 0.93 ± 0.12x1 O' 9 m2 s' 1 in alginate 
constructs without cells, 0.68 ± 0.18x1 O' 9 m2 s' 1 in alginate constructs with 
25x106 cells mL' 1 and 0.31 ± 0.07x1 O' 9 m2 s' 1 in alginate constructs with 60x106 
cells mL' 1 (Figure 6.4; Figure 6.7; Figure 6.9). The lactate effective diffusivity 
was 1.53 ± 0.10x10"9 m2 s' 1 in alginate constructs without cells, 0.88 ± 0.26x1 O' 9 
m2 s' 1 in alginate constructs with 25x106 cells mL' 1 and 0.41 ± 0.09x1 O' 9 cells 
mL"1 for the alginate constructs with 60x106 cells mL' 1 (Figure 6.5; Figure 6 .8 ; 
Figure 6.10).
The values of the glucose and lactate effective diffusivities decrease as the cell 
concentration in alginate increases. This can be attributed to ECM and cells 
occupying space within the alginate construct. The higher the cell concentration 
in the alginate constructs is the less the space available for diffusion will be.
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Therefore, the glucose and lactate effective diffusivities have their highest 
values in alginate constructs without cells.
The glucose consumption rate of the human dermal fibroblasts was 64 ± 2x1 O' 18 
mol cell s' 1 in the alginate constructs with 60x106 cells mL' 1 and 77 ± 2x1 O' 18 mol 
cell s' 1 in the alginate constructs with 25x106 cells mL' 1 (Figure 6.7; Figure 6.9). 
Concerning the lactate production rate it was 130 ± 5x1 O' 18 mol cell s' 1 in the 
alginate constructs with 25x106 cells mL' 1 and 150 ± 4x1 O' 18 mol cell s' 1 in the 
alginate constructs with 60x106 cells mL' 1 (Figure 6 .8 ; Figure 6.10).
The glucose consumption per cell is higher in alginate constructs with 25x106 
cells mL' 1 than in alginate constructs with 70x106 cells mL'1. The lower 
metabolic activity of the fibroblasts immobilized in alginate at the concentration 
of 70x106 cells mL' 1 can be attributed to anaerobic metabolism. The aerobicity 
of the cell culture can be evaluated by calculating the molar ratio of lactate over 
glucose. This ratio is approximately 1 for completely aerobic cell metabolism 
and approximately 2 for completely anaerobic metabolism. It is 1.6 in the case 
of alginate constructs with 25x106 cells mL' 1 which indicates aerobic metabolism 
and 2.2 in the case of 60x106 cells mL' 1 which indicates anaerobic metabolism.
Similar results have been reported for cardiomyocytes immobilized in PGA 
constructs cultivated in mixed and static flasks. It was demonstrated that the 
aerobic metabolism (lactate to glucose molar ratio » 1.5) in the mixed flasks 
yielded a higher glucose consumption rate per cell than the anaerobic 
metabolism (lactate to glucose molar ratio >2) in the static flasks (Carrier et al., 
1999).
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Figure 6.1: Photos of an alginate construct without immobilized cells formed in a 
transwell and incubated for 1 .5 days (37°C, 5% C02). The constructs had been 
used for the measurement of glucose and lactate effective diffusivity in an 
alginate / cell mix and the glucose consumption and lactate production rates of 
human dermal fibroblasts. The photos were analysed with the ImageJ software 
v. 1.37 (National Institute of Health, USA) in order to obtain the dimensions of 
the constructs. Their volume was 0.15 mL and the diameter of their top and 
bottom surface was 10.9 and 10.5 mm respectively. The transwells with the 
alginate constructs were placed in 24-format companion microplates and the 
immobilized fibroblasts were cultured in IMDM medium (37°C, 5% C02). The 
volume of the culture medium in each transwell was 0.75 mL and in each well 
2.3 mL. Nutrient delivery and waste removal from the construct was enhanced 
by shaking the microplate at 220 rpm in an orbital shaker. Their initial thickness 
was 1.34 mm stabilizing at 1.64 mm after 2 hours in culture medium (swelling 
effect). The culture medium in each well and transwell was analysed over time 
for glucose and lactate. The values of the effective diffusivities and the 
consumption / production rates of the species of interest in alginate as well as 
their confidence intervals were provided by a computer program written in 
Matlab 7.1 and Comsol Multiphysics 3.3 (section 2.6).
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Figure 6.2: Live cell concentration (—• —) and viability (“ ♦ “ ) profile of human 
dermal fibroblasts immobilized in alginate at the concentration of 25x106 cells 
mL'1. The alginate constructs were formed in transwells having a conical 
frustum shape, a volume of 0.15 mL and a thickness of 1.64 mm each. The 
volume of IMDM culture medium in each transwell was 0.75 mL and in each 
well 2.3 mL. Nutrient delivery and waste removal from the construct was 
enhanced by shaking the microplate at 220 rpm in an orbital shaker. The 
immobilized cells were refed after 1.5 days incubation at 37°C in 5% CO2 . 
Three constructs were sacrificed at time intervals for cell counts and viability 
determination. The data acquisition was achieved by using the Guava EasyCyte 
cytometer (section 2.3.2). They are represented as average ± standard error of 
3 independent measurements. The average cell concentration and viability was 
25.1 ± 0.6 cells mL' 1 and 89.5 ± 1.0% and respectively. No change in the live 
cell concentration (p=0.13) and viability (p=0.48) at the 5% significance level 
was observed during the time period of 35 hours.
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Figure 6.3: Live cell concentration ( — ) and viability ( <*> ) profile of human 
dermal fibroblasts immobilized in alginate at the concentration of 60x106 cells 
mL'1. The alginate constructs were formed in transwells having a conical 
frustum shape, a volume of 0.15 mL and a thickness of 1.64 mm each. The 
volume of IMDM culture medium in each transwell was 0.75 mL and in each 
well 2.3 mL. Nutrient delivery and waste removal from the construct was 
enhanced by shaking the microplate at 220 rpm in an orbital shaker. The 
immobilized cells were refed after 1.5 days incubation at 37°C in 5% C 02. 
Three constructs were sacrificed at time intervals for cell counts and viability 
determination. The data acquisition was achieved by using the Guava EasyCyte 
cytometer (section 2.3). They are represented as average ± standard error of 3 
independent measurements. The average cell concentration and viability was 
53.59 ± 0.93 cells mL' 1 and 94.64 ± 0.60% and respectively. No change in the 
live cell concentration (p=0.18) and viability (p=0.19) at the 5% significance 
level was observed during the time period of 9.5 hours.
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Figure 6.4: Glucose concentration profile for the evaluation of effective glucose 
diffusivity in alginate constructs without immobilized cells. The alginate 
constructs were formed in transwells having a conical frustum shape, a volume 
of 0.15 m l and a thickness of 1.64 mm each. The constructs had been 
incubated in IMDM medium for 1.5 days before the diffusivity experiment. 
Serum and IMDM culture medium were used for the diffusivity measurements. 
They have different glucose concentrations but the same osmolarity, therefore 
its diffusion through the alginate constructs was attributed only to the difference 
of its concentration between serum and IMDM medium. The volume of IMDM 
medium in each transwell was 0.75 mL and the volume of serum in each well 
was 2.3 mL. The microplate was shaking at 220 rpm in an orbital shaker. 
Glucose measurements at various instants were undertaken from the serum in 
the well and the IMDM medium in the transwell by using the Nova Bioprofile 
analyser. They are represented as average ± standard error of 3 independent 
measurements. The glucose effective diffusivity was 0.93 ± 0.10x10‘ 9 m2 s'1. 
The average absolute error of the measurements was 6.3%.
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Figure 6.5: Lactate concentration profile for the evaluation of effective lactate 
diffusivity in alginate constructs without immobilized cells. The alginate 
constructs were formed in transwells having a conical frustum shape, a volume 
of 0.15 mL and a thickness of 1.64 mm each. The constructs had been 
incubated in IMDM medium for 1.5 days before the diffusivity experiment. 
Serum supplemented with 18 mM lactic acid and IMDM culture medium was 
used for the diffusivity measurements. They have different lactate 
concentrations but the same osmolarity, therefore its diffusion through the 
alginate constructs was attributed only to the difference of its concentration 
between serum and IMDM medium. The volume of IMDM medium in each 
transwell was 0.75 mL and the volume of serum in each well was 2.3 mL. The 
microplate was shaking at 220 rpm in an orbital shaker. Lactate measurements 
at various instants were undertaken from the serum in the well and the IMDM 
medium in the transwell by using the Nova Bioprofile analyser. They are 
represented as average ± standard error of 3 independent measurements. The 
lactate effective diffusivity was 1.53 ± 0.10x1 O' 9 m2 s'1. The average absolute 
error of the measurements was 7.1 %.
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Figure 6.6: Lactate concentration profile for the evaluation of effective lactate 
diffusivity in static alginate constructs without immobilized cells. The alginate 
constructs were formed in transwells having a conical frustum shape, a volume 
of 0.15 mL and a thickness of 1.64 mm each. The constructs had been 
incubated in IMDM medium for 1.5 days before the diffusivity experiment. 
Serum supplemented with 18 mM lactic acid and IMDM culture medium was 
used for the diffusivity measurements. They have different lactate 
concentrations but the same osmolarity, therefore its diffusion through the 
alginate constructs was attributed only to the difference of its concentration 
between serum and IMDM medium. The volume of IMDM medium in each 
transwell was 0.75 mL and the volume of serum in each well was 2.3 mL. 
Lactate measurements at various instants were undertaken from the serum in 
the well and the IMDM medium in the transwell by using the Nova Bioprofile 
analyser. They are represented as average ± standard error of 3 independent 
measurements. The lactate effective diffusivity was 1.43 ± 0.53x1 O' 9 m2 s'1. The 
average absolute error of the measurements was 5.0%.
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Figure 6,7: Glucose concentration profile of human dermal fibroblasts 
immobilized in alginate at the concentration of 25x106 cells mL"1. The alginate 
constructs had been formed in transwells having a conical frustum shape, a 
volume of 0,15 mL and a thickness of 1.64 mm each. The constructs had been 
incubated in IMDM medium at 37°C in 5% CO2 for 2.5 days before the 
experiment. The volume of IMDM medium in each transwell and well was 0.75 
and 2.3 mL respectively. Nutrient delivery and waste removal from the 
constructs was enhanced by shaking the microplate at 220 rpm in an orbital 
shaker. Glucose measurements at various instants were undertaken from the 
medium in the well and transwell by using the Nova Bioprofile analyser. Data 
are represented as average ± standard error of 3 independent measurements. 
The glucose effective diffusivity in alginate was 0.68 ± 0.18x10"9 m2 s' 1 and the 
glucose consumption rate of the fibroblasts was 77 ± 2x1 O'18 mol cell"1 s'1. The 
average absolute error of measurements was 3.0%.
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Figure 6,8: Lactate concentration profile of human dermal fibroblasts 
immobilized in alginate at the concentration of 25x106 cells mL"1. The alginate 
constructs had been formed in transwells having a conical frustum shape, a 
volume of 0.15 mL and a thickness of 1.64 mm each. The constructs had been 
incubated in IMDM medium at 37°C in 5% C 02 for 2.5 days before the 
experiment. The volume of IMDM medium in each transwell and well was 0.75 
and 2.3 mL respectively. Nutrient delivery and waste removal from the 
constructs was enhanced by shaking the microplate at 220 rpm in an orbital 
shaker. Lactate measurements at various instants were undertaken from the 
medium in the well and transwell by using the Nova Bioprofile analyser. Data 
are represented as average ± standard error of 3 independent measurements. 
The lactate effective diffusivity in alginate was 0.88 ± 0.26x1 O' 9 m2 s' 1 and the 
lactate production rate of the fibroblasts was 130 ± 5x10"18 mol cell"1 s'1. The 
average absolute error of measurements was 7.5%.
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Figure 6.9: Glucose concentration profile of human dermal fibroblasts 
immobilized in alginate at the concentration of 60x106 cells mL"1. The alginate 
constructs had been formed in transwells having a conical frustum shape, a 
volume of 0.15 mL and a thickness of 1.64 mm each. The constructs had been 
incubated in IMDM medium at 37°C in 5% C 0 2 for 2.5 days before the 
experiment. The volume of IMDM medium in each transwell and well was 0.75 
and 2.3 mL respectively. Nutrient delivery and waste removal from the 
constructs was enhanced by shaking the microplate at 2 2 0  rpm in an orbital 
shaker. Glucose measurements at various instants were undertaken from the 
medium in the well and transwell by using the Nova Bioprofile analyser. Data 
are represented as average ± standard error of 3 independent measurements. 
The glucose effective diffusivity in alginate was 0.31 ± 0.07x1 O' 9 m2 s"1 and the 
glucose consumption rate of the fibroblasts was 64 ± 3x10"18 mol cell"1 s'1. The 
average absolute error of measurements was 1.7%
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Figure 6.10; Lactate concentration profile of human dermal fibroblasts 
immobilized in alginate at the concentration of 60x10® cells m l"1. The alginate 
constructs had been formed in transwells having a conical frustum shape, a 
volume of 0.15 mL and a thickness of 1.64 mm each. The constructs had been 
incubated in IMDM medium at 37°C in 5% C 02 for 1.5 days before the 
experiment. The volume of IMDM medium in each transwell and well was 0.75 
and 2.3 mL respectively. Nutrient delivery and waste removal from the 
constructs was enhanced by shaking the microplate at 220 rpm in an orbital 
shaker. Lactate measurements at various instants were undertaken from the 
medium in the well and transwell by using the Nova Bioprofile analyser. Data 
are represented as average ± standard error of 3 independent measurements. 
The lactate effective diffusivity in alginate was 0.41 ± 0.09x1 O'9 m2 s 1 and the 
lactate production rate of the fibroblasts was 150 ± 5x1 O' 18 mol ce ll1 s'1. The 
average absolute error of measurements was 6.4%.
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Chapter 7 
Final conclusions and future work
7.1 Final Conclusions
In this thesis a generic bioreactor design for tissue engineering applications was 
presented to cover the need for a robust, automated manufacturing process for 
the production of engineered tissues. A critical issue is the sufficient supply of 
oxygen and substrates and the efficient removal of metabolites without inhibiting 
the cell proliferation in the scaffold.
In Chapters 3 and 4 models of transport phenomena were developed in order to 
predict the fluid flow, and the mass transfer requirements of a bioreactor for the 
production of artificial tissues. Specifically, in Chapter 3 windows of operation 
were used to visualize rapidly the variable region in which it is possible to 
supply oxygen at a sufficient rate to support cell proliferation while maintaining 
the oxygen level above the prescribed minimum. The effect of each variable on 
the critical velocity in particular was addressed.
It was shown that they are more sensitive to changes in the tube wall thickness 
than in the length and effective oxygen diffusivity. It was concluded that the area 
of the window of operation can be increased either by increasing the feed rate 
to the reactor or by increasing the recycle rate in the artificial artery. The former 
will raise the operational cost of the reactor whereas the latter will lead to 
retention of metabolites inhibiting the metabolism of the cells and consequently 
increasing the time for the artery to be ready for implantation.
It was demonstrated that the higher the critical flow rate the smaller the 
difference between the maximum and minimum concentration in the artificial 
artery will be, assuming no changes in the metabolic behaviour of the cells for 
the range of the oxygen concentrations studied.
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In Chapter 4 the effect of feed and recycle rate on the substrate and metabolite 
concentration profiles and cell proliferation in the artificial artery was addressed. 
Simulations showed that the higher the feed rate the sooner the construct will 
obtain the required cell concentration in order to be ready for implantation. 
Additionally, it was demonstrated that a high recycle rate enhances the aeration 
of the artificial artery increasing the concentration of metabolites and decreasing 
the concentration of the substrates. Therefore, a high recycle rate inhibits cell 
proliferation and increases consequently the time for the cell population to reach 
a specific concentration. It was shown that there is sufficient substrate supply 
and efficient metabolite removal to produce an artificial artery with homogenous 
cell concentration for the ranges of feed and recycle rates which were studied.
In Chapters 5 and 6  micro-scale experiments were designed as a way to 
evaluate from measurements, effective diffusivities of substrates and 
metabolites in matrices as well as substrate consumption and metabolite 
production rates in matrices with immobilized cells. They have the advantage of 
generating data sets using a small number of cells in a way which predicts the 
larger scale. Such a database can be used to define the size of the biopsy, the 
operating conditions of the bioreactor as well as the time the tissue-engineered 
construct will be ready for implantation.
Specifically, in Chapter 5 alginate constructs were formed in customized 
microwells in order to measure indirectly the oxygen effective diffusivity in an 
alginate gel / cell mix and the oxygen uptake rate of human adult cells. Oxygen 
concentration was recorded and analysed in a mathematical model which was 
set up in Matlab 7.1 and Comsol Multiphysics 3.3. Additionally, the cell culture 
in alginate was evaluated by conducting cell enumeration, viability 
determination, Ki-67 expression and cell cycle analysis.
No change in the live cell concentration and viability was detected. The pH at 
the bottom of the construct was relatively constant and acceptable for fibroblast 
cell growth. It was found that the oxygen demand was higher at the beginning 
of the incubation of the construct and started decreasing as the cells were 
entering the low oxygen demanding GO / G1 phase. The high percentage of
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cells in GO / G1 phase indicated the inability of the fibroblasts to attach to 
alginate and proliferate.
The values of the parameters were in agreement with values reported in the 
literature having relatively low confidence intervals (<15%). Additionally, the 
calculations were verified by changing one of the parameters of the system and 
the results showed that the mathematical model was reliable as the average 
absolute relative error between experimental and predicted data was 0 .2 %
In Chapter 6  alginate constructs with immobilized human dermal fibroblasts 
were formed in transwells in order to measure indirectly the effective diffusivities 
of glucose, and lactate as well as the glucose consumption and the lactate 
production rate. No change in the live cell concentration and viability was 
observed. The values of the calculated parameters were lying within the range 
of values which has been reported in the literature having relatively low 
confidence intervals (<15%). It was demonstrated that glucose and lactate 
effective diffusivities decrease as the cell concentration in alginate increases 
which was attributed to formation of extracellular matrix and cells occupying 
space within the alginate construct.
7.2 Future work
An immediate project arising from this research is to demonstrate how the 
models developed and substrate / metabolite measurements made in this thesis 
relate to the actual preparation of engineered tissue. This will require exclusive 
sterile engineering to prepare a source of cells and alginate for the full scale 
preparation of a cell alginate matrix and the monitoring of cell growth. Non 
invasive monitoring of the cell growth is likely to be difficult and hence a sterile 
sampling system is needed as resource to a series of parallel runs for various 
times. An economical analysis needed for such a work and creation of a 
research team is recommended to put such a project in place.
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In this thesis the role of mass transfer in the development of engineered tissue 
was addressed by coupling mathematical models with experimental design. The 
same strategy can be followed to study other factors which affect the 
development of tissue engineering.
There is increased evidence that the mechanical stimulation affects the cell 
behaviour in tissue engineered constructs. However, the mechanism of this 
stimulation is still elusive. Better understanding of the effect of the mechanical 
stimulation on cell signalling will be of important consideration in bioreactor 
design. Studies examining the effect of mechanical factors like cyclic flexure, 
shear stress, tension and pressure may be conducted in order to understand 
their role in tissue engineering.
Another challenge in tissue engineering is the understanding of how the 
microenvironment of the scaffold affects cell function. Several scaffolds can be 
tested addressing the role of their surface chemistry, their architecture and their 
degradation rate over time in the control of cell fate.
Biochemical and mechanical signals that regulate cell function under normal 
and pathological conditions come from extracellular matrix contacts. Therefore, 
extracellular matrix production and control of its composition in a scaffold can 
be further studied in how they affect cell function.
The sufficient supply of nutrients and oxygen and the effective removal of the 
waste products of the cells from the scaffold are limited to only a few 
micrometers as a result of the slow mass transfer rate the diffusion can provide. 
Cells in a large-sized engineered tissue will consume nutrients and oxygen in a 
few hours after implantation. However, the creation of blood arteries will take 
several weeks. Therefore, the development of controlled release systems 
delivering molecules over long periods of time which can initiate angiogenesis 
can be another source of future research.
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NOMENCLATURE
Chapter 3
Ri
R 2
L
Cinitial
X m ax
Xeng
Qox
K ox
X
m
V
V m a x
lumen
oxygen
a Ig inate 
oxygen
D .
lumen
oxygen
r \a \g  inate  
oxygen
C
r
e
z
v r,
VQ
VZ
D
q
lumen radius, in m 
outer radius, in m 
axial length, in m
initial cell concentration, in cells mL-1
cell concentration of native coronary artery, in cells mL-1
cell concentration of engineered coronary artery, in cells mL-1
specific oxygen uptake rate, in mol cell-1 s-1
oxygen half-saturation constant, in mM
cell concentration, in cells mL'1
specific maintenance rate, mM cell'1 s'1
specific proliferation rate, in h'1
maximum specific proliferation rate, in h'1
concentration of component n in the lumen, mM 
concentration of component n in the lumen, mM 
diffusivity of component n in the lumen, in m2 s'1
diffusivity of component n in the lumen, in m2 s'1
concentration, in mM 
radial coordinate, in m 
angular coordinate, in m 
axial coordinate, in m
-1
radial velocity, in m s' 
angular velocity, in m s 
axial velocity, in m s'1 
diffusion constant, in m2s'1 
production rate, mM s'1
186
Chapter 4
R i lumen radius, in m
r 2 outer radius, in m
L axial length, in m
C initial initial cell concentration, in cells mL'1
X m ax cell concentration of native coronary artery, in cells mL'1
Xeng cell concentration of engineered coronary artery, in cells mL
Q m ax specific oxygen uptake rate, in mol cells mL'1
Kox oxygen half-saturation constant, in mM
CglucO glucose concentration in fresh medium, in mM
CglutO glutamine concentration in fresh medium, in mM
Y glu /O X yield of glucose from oxygen, in mol mol'1
Yglu/gln yield of glucose from glutamine, in mol mol'1
Ylac/glu yield of lactate from glucose, in mol mol'1
Ygln/amm yield of glutamine from ammonia, in mol mol'1
Kgiu glucose half-saturation constant, in mM
K lac lactate inhibition constant, in mM
Kgin glutamine half-saturation constant, in mM
Kam m ammonia inhibition constant, in mM
Kox oxygen half-saturation constant, in mM
Kgiutdec glutamine chemical decomposition rate constant, in s'1
r\lumen
glue glucose diffusivity in the lumen, in m2s'1
r\lumen
lact lactate diffusivity in the lumen, in m2s'1
plumen
glut glutamine diffusivity in the lumen, in m2s'1
r \  lumen 
amm ammonia diffusivity in the lumen, in m2s'1
plumen
ox oxygen diffusivity in the lumen, in m2s'1
F feed rate, in mL h'1
W waste rate, in mL h*1
R recycle rate, in mL h'1
V input rate to the artificial artery, in mL h'1
CF.n feed concentration to the artificial artery, in mM
187
CR,n, recycle concentration to the artificial artery, in mM
CA,n inlet concentration to the artificial artery, in mM
Cw,n waste concentration, in mM
C concentration, in mM
r radial coordinate, in m
Q angular coordinate, in m
z axial coordinate, in m
Vr, radial velocity, in m s'1
Vq angular velocity, in m s'1
v z axial velocity, in m s'1
D diffusion constant, in m2s‘1
Q production rate, mM s'1
- lu m e n concentration of component n in the lumen, mM
n a \g  in a te  
U n concentration of component n in the lumen, mM
r ^ lu m e n
n diffusivity of component n in the lumen, in m2 s'1
r \ a \ g  in a te  
n diffusivity of component n in the lumen, in m2 s‘1
X cell concentration, in cells mL'1
m specific maintenance rate, mM cell'1 s"1
V specific proliferation rate, in h'1
P m a x maximum specific proliferation rate, in h'1
half saturation constants of the substrates /? and n+1, in mM
Kp,Kpt1 inhibition constants of the metabolites p and p+1, in mM
C hapter 5
D1t oxygen diffusivity in culture medium, in m2s'1
c1 oxygen concentration in culture medium, in mM
c" oxygen concentration in the alginate matrix, in mM
X cell concentration, cells mL'1
d 2 oxygen diffusivity the alginate matrix, in m2s'1
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c /m a x  maximum uptake rate, mol cell'1 s'1
Km Monod constant, mM
Chapter 6
r radial coordinate, in m
D diffusivity in alginate consrtuct, in m2s"1
c concentration in culture medium, in mM
X  cell concentration, cells mL'1
q production rate, mol cell'1 s'1
\/ volume of culture medium, in mL
A area of the top or bottom surface of the alginate construct, in mm2
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